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Chapter 1




Gallstone disease (cholelithiasis) is a common condition that affects 5% - 22% of the
people in Western countries '" and in the Netherlands more than 30,000 patients are
diagnosed with gallstone disease vearlv". Traditionally, patients with cholelithiasis are
characterised as 'fat fertile females in their forties', however this picture deserves some
differentiation. Generally, cholelithiasis is more prevalent in women than in men
(10.5%- 11.5% vs. 6.5% - 7.8%)2, 5, 6. The male-female ratio ranges from 1:4 during
reproductive years to equality in older patients. The overall prevalence of cholelithiasis
also increases with age2, 7. Furthermore, cholelithiasis has a higher prevalence among
native populations in North and South America". Besides age and sex, hormonal
influences and ethnicity, dyspeptic symptoms, high body mass index (BMI), use of
tobacco, alcohol consumption, and use of hypolipidemic drugs are risk factors for
cholelithiasis",
Diagnosis
Although the majority of patients suffer from silent gallstones or asymptomatic
chclelithiasis", 10% - 30% of the patients report clinical symptoms9-15. Biliary pain, which
has been defined as 'a severe steady pain, lasting more than 15 - 30 minutes, usually
located in the epigastrium and/or right upper quadrant, and sometimes radiating to the
back' 7 is the most distinguishing symptom of symptomatic cholelithiasis. Biliary colic,
pain radiating to the back, and a positive reaction to standard analgesics were only with
limited significance related to the presence of gallstones": 17. Symptoms such as upper
abdominal pain, nausea, and vomiting are related to the presence of gallstones",
whereas classical dyspeptic symptoms, such as flatulence, heartburn, acid regurgitation,
bloating, and belching are not. As the clinical symptomatology of this condition gives
insufficient support for a correct diagnosis, additional ultrasound investigation is
recommended for diagnosing cholellthiasls ".
Treatment
Cholecystectomy is the golden standard in symptomatic cholelithiasis. Essentially,
elective cholecystectomy is a prophylactic treatment which prevents recurrent
symptoms and complications. Since the introduction in 1985, laparoscopic
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cholecystectomy is preferred over preceding techniques and the age standardised
cholecystectomy rate has increased with 20%20. However, the risks of cholecystectomy
are generally underestimated and cholecystectomy still entails the risk of mortality
(0% - 0.2%), complications (5.0%), and bile duct injuries (0.2% - 1.0%)21,22. In case of
conservative management, only 31% of the patients report recurrence of biliary pain
within a year23 and the risk of complications such as acute cholecystitis, acute
pancreatitis, or biliary duct obstruction is small (1% - 2% per year)24. 25. Therefore,
conservative treatment or 'wait and see', may be a safe alternative for elective
cholecystectomy. The latter treatment option however is seldomly chosen by
gastroenterologists and surgeons.
Symptomatic outcome after cholecystectomy
The majority of patients reported positive outcomes after cholecystectomy, such as a
relief of symptoms (46% - 67%), more specifically upper abdominal pain and dyspeptic
symptoms (72% and 56%, respectivelvr".
At six months postoperatively, it was found that 13% of the patients reported persistent
pain ". Colicky abdominal pain and back pain were relieved, whereas nagging abdominal
pain did not improve in the course of six months". A shift from predominantly biliary
symptoms preoperatively, to predominantly dyspeptic symptoms at six months was
observed". Nausea and vomiting improved, whereas flatulence and fat intolerance did
not27• Moreover, 3% - 18% of the patients developed diarrhoea": 27. Preoperative
bloating, constipation, and previous or current use of psychotropic medication were
associated with poor outcome at six months after cholecvstectornv".
At one year after cholecystectomy, a comparable pattern was found and 18% - 31% of
the patients reported persistence of pain28-3o. One year postoperatively, it was
demonstrated that biliary symptoms had improved, whereas symptoms of reflux,
irritable bowel syndrome, and chronic pain did not lmprove". In addition, 30% - 40.4%
of the patients did not report improvement of gastrointestinal svrnptorns'": 32and 10%
reported persistence of digestive svrnptorns'". Flatulence and dyspepsia was reported by
19% and 24% of the patients respectively". In contrast to findings of negative
symptomatic outcome, 95% of the patients rated the success of the procedure as fair to
excellent'". Higher preoperative psychological symptoms, neuroticism, and introversion
were associated with a lack of improvernent/" 29,31. Preoperative dyspeptic symptoms,
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preoperative pain characteristics, and symptoms coinciding with pain were associated
with postoperative pain at one year28, 29.
Long term follow-ups (one to three years) showed that abdominal complaints persisted
in 30.5% of the patients". More specifically, 6.4% of the patients reported persistent
biliary colics and 45.3% reported persistent flatulence. In contrast, only 3.2% of the
patients were dissatisfied with the results of cholecystectomy. At ten years after
cholecystectomy, 18.5% of the patients reported persistent symptoms". Furthermore,
at ten years after the procedure, patients with typical biliary symptoms showed more
improvement than patients with atypical svmptorns ".
In summary, after cholecystectomy, approximately one third of all patients report
persisting symptoms on long term follow-up. On the long run patients with typical biliary
symptoms report more improvements than patients with atypical symptoms or
dyspeptic symptoms. Flatulence and diarrhoea are often experienced symptoms after
cholecystectomy. Atypical symptoms, usually of dyspeptic nature, and psychological
factors tend to be related to negative symptomatic outcome after cholecystectomy.
Quality of life
Traditionally, outcome assessment has focussed on classical or mechanistic end-points
of recovery, such as survival, complications, and symptomatic relief, which represent the
perspective of medical doctors. In the last decades the patients' perspective has won
ground and hermeneutic endpoints of recovery, such as quality of life (QoL), autonomy,
and duration of absence from work, have increasingly been recognised as relevant
outcome measures of therapies and procedures. So far, outcome assessment after
cholecystectomy has primarily focussed on mechanistic endpoints'", and subjective
endpoints are scarcely investigated.
Subjective endpoints, such as health status, health related quality of life (HRQoL), and
QoL, are multidimensional concepts incorporating physical, psychological, and social
aspects:". These concepts have in common that the definition of health of the World
Health Organization (WHO) - 'A state of complete physical, mental, and social well-being
and not merely the absence of disease or infirmity' - was taken to formulate the three
core domains. There is also a difference between these concepts. Health status refers to
patients' physical, psychological and social functioning, which is not related to the
individual patient' perception, values, and expectations ". The WHO defined QoL as 'an
individual's perception of his/her position in life in the context of the culture and value
10
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system in which he/she lives and in relation to his/her goals, expectations, and
standards and concerns. It is a broad ranging concept affected in a complex way by the
person's physical health, psychological state, level of independence, social relationships,
and their relationship to salient features of their environrnent' ". Thus, apart from
incorporating the patients' functioning, QoL also focuses on patients' evaluation of that
functioning. As health status and QoL are related, but different concepts, these terms
can not be used interchangeabl/9.41. Furthermore, health-related QoL covers only the
physical, psychological, and social domains, whereas QoL covers more than the three
domains mentioned in the definition of health of the WHO (e.g. environment). In fact,
QoL is a container concept that incorporates and goes beyond health status and health-
related QoL.
While previous studies assessed subjective outcomes of recovery after cholecystectomy,
QoL according to the definition of the WHO, has not been investigated so far. The
majority of studies assessed health status" 33, 42·47 and few studies used self-constructed
ratings of patient satisfaction+" 33,48. One study indicated that in the course of one year
after cholecystectomy health status improved'" and was comparable to health status in
the general population, with exception to breathing and sleeping'". However, another
study demonstrated that five years after diagnosis, improvements of health status were
observed in patients with cholelithiasis, regardless of cholecvstectornv'". Improved
health status at one year was predicted by low surgical rtsks'". Furthermore, a clinical
presentation of typical biliary symptoms predicted higher patient satisfaction at three
months after cholecvstectornv'".
Personality traits
People differ in the way they perceive situations, how they feel under certain conditions,
and how they react to other people. Stable personality traits are characteristics that
describe differences between people with regard to enduring patterns of feelings,
thoughts and behaviour'". In fact, individuals' cognitive styles, motivational and affective
tendencies are found to be stable over time51, 52. Trait Anxiety (TA) refers to relatively
stable individual differences in anxiety proneness, i.e. differences between people in the
tendency to respond to situations perceived as threatening with heightened anxiety
intensity". TA can be understood as an underlying disposition that remains latent unless
it is activated by certain stimuli in the environrnent ". Measured with the Spielberger
State Trait Anxiety Inventory (STAI) trait-scale, TA encompasses feelings of anxiety and
11
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depression and generally refers to negative affect55. Several studies investigated the
impact of TA on early post-cholecystectomy recover/6-59 and demonstrated that TA
predicted early postoperative pain56, 57, emotional and physical well-being ", and the use
of narcotics". In contrast, two studies found that TA was not associated with early
postoperative pain and hospital sta/8, 59. Evidence of the impact of TA is inconclusive
and reserach has been limited to short-term postoperative recovery.
Aim and design of the study
In symptomatic cholelithiasis, cholecystectomy is the preferred treatment over
conservative treatment. Cholecystectomy is an elective procedure performed to
improve the patient's QoL and to prevent complications. However, a substantial group
of patients reports persisting symptoms after cholecystectomy. On the other hand, the
risk of complications related to conservative treatment is small and is usually
overestimated. Therefore, appropriateness of cholecystectomy may be a matter of
debate, especially in patients who are at risk for negative outcomes. Preoperative
recognition of these patients is essential to improve management of cholelithiasis and to
prevent unsuccessful cholecystectomies.
The aim of the present study is to identify risk factors for negative symptomatic
outcomes and low QoL among clinical symptoms and psychological variables. We
expected long term outcomes (> 6 weeks) to be most informative with regard to clinical
decision making. Potential predictors were investigated at different time points, namely
six weeks, six months, and one year after cholecystectomy.
The results of this prospective follow-up study are described in this thesis. Patients were
recruited from the Department of Surgery of the St. Elisabeth Hospital in Tilburg, the
Netherlands. Consecutive patients (18 - 65 years) with diagnosed symptomatic
cholelithiasis, awaiting an elective laparoscopic cholecystectomy were eligible for the
study. Patients undergoing an emergency procedure or intended open cholecystectomy
were not included. Furthermore, patients in the American Society of Anaesthesiologists
(ASA) class III or IV, choledocholithiasis, cholangitis, known pregnancy, known liver-
cirrhosis, history of abdominal malignancy, previous upper abdominal surgery
(precluding laparoscopic approach), psychiatric diseases, and insufficient knowledge of
the Dutch language were excluded from the study.
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Medical information
All patients underwent cholecystectomy following a standard surgical procedure. Open
introduction was performed in all patients regardless of previous abdominal surgery.
Pneumoperitoneum was created using the subumbilical trocar with an intra-abdominal
pressure up to 12 mmHg. Three trocars for instruments were inserted. The dissection of
the cystic artery and cystic duct, identifying Calor's triangle, was performed using a three
points 'flag' technique. The cystic duct and artery were clipped and transsected. After
complete dissection of the gallbladder, it was removed either through the subumbilical
or subxyphoidal trocar. Fascia defects as a result of the insertion of the 10mm trocar and
the open introduction of the subumbilical trocar were closed. No suction drains were
left in the subhepatic space at the end of the procedure.
In principle, all patients were subjected to a standard anaesthetic regime. As
premedication, patients received Paracetamol 1000 mg supp., and Atropine 0.5 mg i.m ..
Patients < 60 years and> 60 kg received Diazepam 10 mg p.o.; patients> 60 yrs. and
< 60 kg received Diazepam 5 mg p.o.. Peri-operative anaesthesia, consists of Propofol
1.5 - 2.5 mg/kg, Sufenta 0.25 ug/kg, and Rocuronium 0.6 mg/kg. Standard postoperative
analgesics were Paracetamol 4 dd. 1000 mg supp. and Morfine 6 dd. 10 mg sec during
the first 48 hours postoperatively, until patients indicated pain was acceptable. If
necessary, patients received additional Diclofenac 2 dd. 100 mg supp ..
Retrospectively, medical records were checked for preoperative comorbidity,
sphincterotomy, demonstrated biliary stones, conversion, complications, early
postoperative pain and use of analgesics (during admission), postoperative
complications, and health care consumption.
Self-report information
Preoperatively, during the patients' first surgical consultation, patients received the first
set of questionnaires and signed informed consent. Patients completed and returned
the first questionnaires before admission. After this baseline measure, patients
completed the same questionnaires at ten days, six weeks, six months, and one year
after cholecystectomy. Questionnaires contained self-report information on symptoms,
pain, trait - and state anxiety, depressive symptoms, fatigue, and QoL.
Demographic variables were obtained preoperatively and patients completed a
questionnaire that asked about sex, age, marital status, educational level, and work.
Symptoms were investigated by a symptom checklist based on information from focus
13
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groups, clinical experience, and another checklist ". Symptoms were categorised into
biliary symptoms (upper abdominal pain, nausea, vornitingr'", dyspeptic symptoms (bad
taste, heartburn, under abdominal pain, diarrhoea, and flatulence)12, and non-specific
symptoms (general malaise, fatigue, weight-change, decrease in sexual functioning, and
health complaints not mentioned in the pre-defined checklist). Patients described the
nature, severity, duration, and frequency of pain during preoperative biliary attacks on a
100 mm. visual analogue scale (VAS) and on three multiple choice items.
Trait and state anxiety were measured with the Dutch versions of the STAI trait scale'".
This questionnaire consists of two scales of 20 items each with a 4-item Likert-scale
reflecting the extent of anxiety patients feel at a specific moment in time (state anxiety)
and patients generally feel (trait anxletvr". The STAI has good and moderate test-retest
reliability for State anxiety (r:= .84 - .88) and trait anxiety (r:= .30 - .73)60. The state- and
trait anxiety scales have high internal consistencies (Cronbach's a := .93 - .96) and
(Cronbach's a:= .92 - .93), respectively)54, 60.
Depressive symptoms were assessed by the Center of Epidemiological Studies
Depression Scale (CES-D)61.The CES-D has a 4-point Likert-scale indicating how often
patients had experienced depressive symptoms in the week before. The 16-item version
used in this study measures two independent factors, namely Depressed Affect and
Positive Affect, and is a valid measure for depressive symptoms in the general
population'". The CES-Dhas good internal consistency (Cronbach's a:= .75 - .88).
Patients also completed the Fatigue Assessment Scale (FAS)62,which consists of 10 items
with a 5-point rating scale indicating how often patients usually feel tired. The FAS has
an excellent internal consistency (Cronbach's a := .90) and good reliabilitl2, 63.
QoL was measured with the WHOQOL-BREF, which is a short version of the generic
multi-dimensional WHOQOL-100, which was originally developed by the World Health
Organization". The WHOQOL-BREF consists of 26 items with a 5 point Likert-scale
measuring QoL on in four different domains (Physical, Psychological, Social, and
Environment). Two benchmark items display overall QoL and general health. The
WHOQOL-BREF has been cross-culturally validated and has good psychometric
properties, such as good internal consistency (Cronbach's a > .70) and adequate test
retest reliability, constructive and discriminative validitl4, 65, 66, 67. Self-reported
information of patients, obtained preoperatively and at different time-points up to
12 months, formed the basis of the research described in this thesis.
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Outline of this thesis
This thesis describes the systematic investigation of outcomes at different post-
cholecystectomy intervals. Clinical and psychosocial variables were assessed as
predictors of symptomatic outcome and QoL.
In chapter 2 symptomatic outcome at six weeks after cholecystectomy was investigated.
Predisposing factors for persistent and emergent biliary and dyspeptic symptoms were
identified among clinical and demographical variables.
Chapter 3 contains an examination of symptomatic outcome and health care
consumption six weeks after cholecystectomy. In addition to preoperative clinical
symptoms and demographical variables, personality (i.e. trait anxiety) was investigated
as a predictor of persisting and emerging symptoms.
In chapter 4, postoperative outcome was evaluated at six months after
cholecystectomy. Preoperative clinical symptoms, demographic variables and TA were
investigated as predictors of symptoms and pain at six months.
In chapter 5, we used a different categorization of preoperative symptoms in order to fit
our design to the demands of clinical practice. Three profiles of preoperative symptoms
were discerned, namely biliary symptoms only, dyspeptic symptoms only, and a
combination of biliary and dyspeptic symptoms. Symptomatic change was investigated
in the course of six months. Predictors were identified for several outcomes, namely the
report of any symptom, of biliary symptoms only, of dyspeptic symptoms only, and of a
combination of biliary and dyspeptic symptoms. Recommendations have been
formulated for the approach of patients in daily practice.
Chapter 6 concerns the assessment of symptomatic outcomes at one year after
cholecystectomy. A short evaluative index of overall QoL and health was added to gain
insight in the subjective experience of patients. Predictors of symptomatic outcome and
QoL at one year were identified among clinical variables and trait anxiety.
In chapter 7, the patient's subjective evaluation is highlighted, as a complete QoL
measurement was integrated in the design. Changes in QoL and psychosocial variables
were investigated and predictors of QoL one year after cholecystectomy were identified
among clinical and psychosocial variables.
In the general discussion and summary (chapter 8) the main findings of this thesis are
summarized and integrated and methodological issues are raised. This chapter further
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Abstract
Objective: Many patients with symptomatic cholelithiasis report persisting symptoms
after elective cholecystectomy. The current prospective follow-up study aims at the
identification and valuation of risk factors for negative symptomatic outcome at six
weeks.
Methods: Consecutive patients (n = 183), age 18 - 65 years, indicated for elective
cholecystectomy due to symptomatic cholelithiasis, completed a self-report
questionnaire. At six weeks postoperatively, the same self-report questionnaires were
completed (n = 129). Predictors of the persistence and emergence of biliary - and
dyspeptic symptoms at six weeks post-cholecystectomy were investigated using
univariate and multivariate logistic regression.
Results: At six weeks postoperatively, the report of postoperative biliary symptoms was
independently predicted by preoperative dyspeptic symptoms (OR = 6.60) and bad taste
(OR = 3.55). Preoperative flatulence was an independent predictor of the report of
biliary and dyspeptic symptoms ((OR = 3.33) and (OR = 3.27), respectively) and persisting
biliary symptoms (OR = 4.21). Predictors of symptomatic outcome were only identified in
women, not in men.
Conclusion: Patients with preoperative dyspeptic symptoms, notably bad taste and
flatulence, have an increased risk of negative post-cholecystectomy outcomes at six
weeks. A symptom-specific approach should lead to optimalisation of the indication of
cholecystectomy and information of patients. Known risk factors for long term outcomes
might be valuable in female patients only.
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Introd uction
Gallstone disease (cholelithiasis) is a common condition in the Western world. In the
Netherlands, 32,000 patients are yearly diagnosed with this condition", The majority of
patients remain asymptomatic and only 20% of patients develop clinical svrnptorns'".
Symptomatic gallstone disease is typically diagnosed after an episode of biliary pain,
which is defined as a severe steady pain, lasting more than 15 - 30 minutes, usually
located in the epigastrum and/or right upper quadrant, sometimes radiating to the
back" s, which is often accompanied by dyspeptic svmptorns'". However, some patients
experience mild dyspeptic symptoms without biliary colics'". Additional ultrasonography
is recommended" 9, 11, as clinical symptoms are not consistently related to the presence
of gallstonesl1-14. Professional guidelines propose conservative treatment (wait and see)
in asymptomatic cholehthiasis" 9, 15 and cholecystectomy in symptomatic cholelithiasis.
In biliary pain without stones, cholecystectomy is occasionally tndicated'" following
additional surgical consultation".
Elective cholecystectomy is widely performed in 70% of the symptomatic patients". In
the Netherlands, cholecystectomy is performed in 19,000 patients a year'. The majority
of patients report positive outcomes, and relief rates for biliary pain (86% - 96%), upper
abdominal pain (66% - 77%), and dyspepsia (46% - 89%)13 are high. However, a
substantial group of patients report persistence of pre-existent biliary (5.5% - 19.5%)
and dyspeptic symptoms (27.3% - 43.2%)8, 17,18.Thus, recognition of patients with a high
risk of negative outcomes is crucial.
In literature, preoperative dyspeptic symptoms, the use of psychotropic medication, and
a long history of pain, symptoms, and biliary attacks, are mentioned as potential
predictors of poor outcome and persisting pain17-19 at six months post-cholecystectomy.
Although clinical experience indicates that most patients experience a major reduction
of symptoms at six weeks post-cholecvstectornv'", no studies have explored predictors
of symptomatic outcome at this time-point. The present prospective follow-up study
aims at the identification and the valuation of predictors of negative symptomatic





Between March 2006 and August 2007 all patients between 18 and 65 years with
diagnosed cholelithiasis (diagnosis K80 from International Statistical Classification of
Diseases and Related Health Problems (ICD-lO)L awaiting an elective laparoscopic
cholecystectomy at the department of Surgery of the St. Elisabeth Hospital in Tilburg,
the Netherlands, were eligible for the study. Exclusion criteria were: patients with ASA III
or IV, undergoing an emergency procedure or intended open cholecystectomy,
insufficient knowledge of the Dutch language, choledocholithiasis, cholangitis, known
pregnancy, known liver-cirrhosis, history of abdominal malignancy, previous upper
abdominal surgery (precluding laparoscopic approach), and psychiatric diseases.
Procedure
During patients' visit to the outpatient clinic, the surgeon performed a physical
examination and explained the surgical and anaesthetic procedures. Patients were
informed about the general prognosis after cholecystectomy and the risk of
complications. Furthermore, the surgeon introduced the study and asked the patients to
participate. Nurses informed patients further about the operation and the study, and
handed out written information and the first set of questionnaires. Patients read the
information at home and signed informed consent before participation.
Preoperatively, records were checked for medical history, comorbidity, and medication
use. Before admission for cholecystectomy, patients completed the first questionnaires,
which could be returned by mail or delivered to the nurses at the ward. In case the
questionnaires were not returned five to three days before surgery, patients received a
telephone call to remind them to complete the questionnaire. Patients who returned
their first set of questionnaires after surgery were excluded from the study.
Six weeks after surgery, patients were sent another self-report questionnaire. Eight
weeks and ten weeks after surgery, a phone call reminded the patients to return the
postoperative questionnaire to the hospital, if necessary. The protocol of the study was
approved by the local ethics committee.
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Questionnaires and medical files
Questionnaires comprised self-reported demographic and clinical information. The
demographic questionnaire asked about sex, age, marital status, educational level, and
work. Furthermore, patients completed a self-constructed symptom-checklist, which
asked about the presence of symptoms in the past week. Symptoms were collected from
biliary patients participating in focus groups. Following a study of Weinert et a1.17,
symptoms were categorized into symptom complexes, namely biliary symptoms (upper
abdominal pain, nausea, vomiting), dyspeptic symptoms (bad taste, heartburn, under
abdominal pain, diarrhoea and flatulence), and non-specific symptoms (general malaise,
fatigue, weight-change, decrease in sexual functioning and other health complaints not-
mentioned in the checklist). Medical files were checked for the experience of biliary and
dyspeptic symptoms ever before visiting the outpatient clinic. After surgery, surgical
reports were checked for the presence of gallstones/ sludge and conversion to open
surgery.
Surgical and anaesthetic procedure
Open introduction was performed in all patients regardless of previous abdominal
surgery. Pneumoperitoneum was created using the subumbilical trocar with an intra-
abdominal pressure up to 12 mmHg. Three trocars for instruments were inserted. The
dissection of the cystic artery and cystic duct, identifying Calot's triangle, was performed
using a three points 'flag' technique. The cystic duct and artery were clipped and
transsected. After complete dissection of the gallbladder, it was removed either through
the subumbilical or subxyphoidal trocar. Fascia defects as a result of the insertion of the
10 mm trocar and the open introduction of the subumbilical trocar were closed. No
suction drains were left in the subhepatic space at the end of the procedure.
In principle, all patients were subjected to a standard anaesthetic regime. As
premedication, patients received Paracetamol 1,000 mg supp., and Atropine 0.5 mg i.m ..
Patients < 60 years and> 60 kg received Diazepam 10 mg p.o.; patients> 60 yrs. and
< 60 kg received Diazepam 5 mg p.o.. Peri-operative anaesthesia, consists of Propofol
1.5-2.5 mg/kg, Sufenta 0.25 ug/kg, and Rocuronium 0.6 mg/kg. Standard postoperative
analgetics were Paracetamol 4 dd. 1000 mg supp. and Morfine 6 dd. 10 mg sec during
the first 48 hours postoperatively, until patients indicated pain was acceptable. If




Preoperative differences between responders (patients who returned their
questionnaires at six weeks) vs. non-responders and dropouts (patients who ended
participation within six weeks) were investigated by Chi-square tests (using Fisher's
Exact test when appropriate) and Student's t-tests. Changes in symptoms were
examined by the Mc Nemar test. Analyses were performed both for specific symptoms
and symptom complexes.
Furthermore, persistence and emergence rates were calculated. Therefore, the
population under study was divided in two subgroups categorised by the presence
(group 1) or absence (group 2) of self-reported preoperative biliary - or dyspeptic
symptoms. Patients with preoperative biliary symptoms (group 1) reported biliary
symptoms only, or both biliary and dyspeptic symptoms. Patients without preoperative
biliary symptoms (group 2) suffered from dyspeptic symptoms only. Likewise, patients
with and without preoperative dyspeptic symptoms were categorised in two groups.
Persistence was defined as reporting the symptoms both before and after
cholecystectomy. Emergence was defined as not reporting the symptoms
preoperatively, but reporting the symptoms at six weeks post-cholecystectomy.
To discern which preoperative symptoms predicted the postoperative report, the
persistence, and the emergence of postoperative symptoms we used univariate logistic
regression. Furthermore, significant univariate predictors of each outcome were entered
in a multivariate regression model (method enter) to assess the relative strength of each
predictor. In both outcome and predictors, we differentiated between symptom
complexes and specific symptoms.




Figure 1 provides an overview of the population across time. Of all 241 patients visiting
the outpatient clinic and being approached for participation, 211 received the first
questionnaire. Statistical analyses were performed on 183 patients (response rate
86.7%). Within six weeks, five patients ended participation. Six weeks after
26
The predictive value of preoperative symptoms
cholecystectomy, data were available from 129 patients (response rate 70.5%). Because
of missing values, final statistical analyses were performed on 126 patients.
Figure 1. Flow chart of the population in the course of six weeks.
Preoperatively
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Ended participation within six weeks
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1 n = 1291
In 94.0% of the patients biliary stones or sludge were demonstrated by ultrasonic
tomography. Preoperatively, endoscopic sphincterotomy had been performed in eight
patients. Laparoscopic cholecystectomy was converted to an open procedure in six
patients. Table 1 shows the demographic and clinical characteristics of the patient
group. Preoperatively, participants in the study did not differ from non-responders and
patients who ended participation within six weeks. Among the participants, 74.3 % were
females and the mean age was 46.0 ± 11.4 years. Female patients were younger than
male patients (50.7 ± 9.6 yrs vs. 44.5 ± 11.6 yrs; (t = 3.30, P = .001)). Male patients more




In the week before visiting the outpatient clinic, 73.6% of the patients experienced
biliary symptoms and 66.7% of the patients experienced dyspeptic symptoms (table 1).
Furthermore, 14.3% of all patients (n = 27) did not report any biliary - or dyspeptic
symptoms. In the week before surgical consultation, female patients reported more
preoperative biliary symptoms than male patients (78.5% vs. 59.6%, p = .019), whereas
male patients more often reported to be free of symptoms than female patients
(25.5% vs. 10.4%, p = .021). Moreover, examination of medical files revealed that 84.7%
and 73.2% of the patients had ever experienced biliary- and dyspeptic symptoms. More
specifically, 26.8% had experienced only biliary symptoms, 15.3% had experienced only
dyspeptic symptoms, whereas 57.9% of the patients had ever experienced both biliary
and dyspeptic symptoms. Patients reported a mean of 5.5 ± 7.7 biliary attacks.
Preoperatively, upper abdominal pain was most frequently reported (66.5%), followed
by nausea (39.3%) and flatulence (36.1%). Moreover, 55.2% of all patients reported non-
specific symptoms. Female patients more often reported bad taste !l = 5.27, P = .022),
upper abdominal pain !l = 4.25, P = .039), nausea !l = 9.70; P = .002), diarrhoea
!l = 4.80, P = .029), and non-specific symptoms !l= 6.41, P = .011) than male patients.
Course of symptoms
In the time between the preoperative measurement and six weeks after
cholecystectomy, five patients received an endoscopic sphincterotomy, of which two
patients already received this procedure preoperatively. Furthermore, a general
improvement was observed. The number of patients reporting biliary - and dyspeptic
symptoms reduced to 25.4% and 50.8%, respectively (!l = 47.38, p < .001) and
!l = 5.56, P = .018)). More specifically, the number of patients reporting bad taste,
heartburn, upper abdominal pain, nausea, vomiting and under abdominal pain reduced
significantly over six weeks time (see table 2). The percentage of patients reporting to be
free of symptoms increased to 44.4% !l = 47.38, P < .001) (see figure 2).
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Table 1. Baseline characteristics.
Demographic characteristics
Female patients (%)
Age (M ± SO)
Highest level of education
Primary or lower vocational education (%)
Secondary education (%)
Higher education (%)
Higher professional education or university (%)
Working under payment (%)
Marital status
Single (%)
Widowed or divorced (%)
Married or cohabitant (%)
Comorbidities














Free of symptoms (%)
Frequency of biliary colics (M ± SO)
Demonstrated gallstones (%)
Preoperative symptoms :5 6 months (%)




























Chi square tests, Fisher's Exact Test, and Student's r-test were used to analyze
preoperative patient characteristics.
* significance p < .050.
In spite of the general improvements over six weeks time, biliary symptoms persisted in
27.8% of the patients with preoperative biliary symptoms, whereas biliary symptoms
emerged in 17.1% of the patients with only preoperative dyspeptic symptoms.
Persistence of dyspeptic symptoms was reported in 57.3% of the patients with
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preoperative dyspeptic symptoms. At six weeks, dyspeptic symptoms emerged in 38.6%
of the patients who reported preoperative biliary symptoms only.
Symptom- and sex-specific patterns of the course of symptoms
At six weeks post-cholecystectomy, patients with and without demonstrated biliary
stones and/or sludge, reported postoperative biliary and dyspeptic symptoms to the
same extent. Subgroups of patients with and without preoperative biliary symptoms
experienced postoperative dyspeptic symptoms to the same extent (45.7% and 52.2%,
respectively). Furthermore, patients with preoperative dyspeptic symptoms reported
postoperative biliary symptoms more often, than patients without preoperative
dyspeptic symptoms (35.4% vs. 6.8%; l = 10.86, p = .001).
Stratifying the self-reported improvements at six weeks post-cholecystectomy by sex, a
different pattern of change was observed for male and female patients (see figure 3).
Furthermore, no sex-bound patterns were found with regard to the emergence and
persistence of biliary and dyspeptic symptoms after cholecystectomy.
Table 2. Self-reported symptoms preoperatively and six weeks after cholecystectomy
(total population).
Symptoms Baseline Follow-up 6 weeks p
(n = 183) (n = 126)
Bad taste (%) 24.0 12.7 .001*
Heartburn (%) 25.1 15.1 .015
,
Upper abdominal pain (%) 66.5 19.8 <.001'
Nausea (%) 39.3 13.5 <.001'
Vomiting (%) 14.8 3.2 .001'
Under abdominal pain (%) 24.6 8.7 .003*
Diarrhoea (%) 18.0 13.5 .839
Flatulence (%) 36.1 26.2 .082
Other health complaints (%) 55.2 46.8 .268
McNemar tests were used to analyze changes in symptoms over time.
• significance p < .050.
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Figure 2. Pre- and postoperative symptoms in the total population.
I~ Preoperatively I
o Six week postoperatively
p <.001"
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Preoperative symptoms in the prediction of symptomatic outcome
Univariate logistic regression analyses were used to identify the predictors of
postoperative biliary - and dyspeptic symptoms, and the persistence and emergence of
biliary - and dyspeptic symptoms (see table 3). Duration of preoperative symptoms and
preoperative medication use were no significant predictors. No univariate predictors





The differential value of the identified predictors was further explored in multivariate
logistic regression analyses, inserting the univariate predictors for each outcome as
variables (method enter). The report of biliary symptoms at six weeks postoperatively
was independently predicted by preoperative dyspeptic symptoms, bad taste, and
flatulence (see Table 4). Both the report of postoperative dyspeptic symptoms and the
persistence of biliary symptoms were independently predicted by preoperative
flatulence. Other univariate predictors of postoperative symptomatic outcomes were
non-significant.
Eligibility of preoperative symptoms in the prediction symptomatic outcome
First of all, sex-specific predictors were investigated by univariate logistic regression
analysis (Table 5). Predictors of the postoperative report and the persistence of biliary-
and dyspeptic symptoms were identified in female patients only, and not in male
patients. In both men and women, no predictors were distinguished for the
development of biliary - and dyspeptic symptoms. Moreover, the univariate predictors
of each outcome were simultaneously entered in multivariate logistic regression
analyses. These analyses could only be performed on the population of female patients.
In female patients, the postoperative experience of biliary symptoms was independently
predicted by bad taste only (OR = 3.73, P = .008; 95% Ci: 1.42 - 9.84). At six weeks, the
report of dyspeptic symptoms was predicted by heartburn and flatulence ((OR = 2.70,
P = .040; 95% C/: 1.04 - 6.96) and (OR = 2.91, P = .020; 95% C/: 1.19 - 7.13), respectively).
For the prediction of persisting biliary symptoms, no independent predictors could be
identified.
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Table 3. Univariate predictors of postoperative symptoms at six weeks (total population).
Postoperative outcome Preoperative predictor OR 95% CI P
Report of biliary symptoms Dyspeptic symptoms 7.48 2.13 - 26.27 .002*
Sex 4.10 1.15 -14.58 .029*
Bad taste 4.00 1.67 -9.55 .002*
Heartburn 2.38 1.01-5.60 .047*
Nausea 2.38 1.05 - 5.38 .038*
Flatulence 3.36 1.46-7.73 .004*
Report of dyspeptic symptoms Dyspeptic symptoms 2.13 1.01-4.51 .047*
Heartburn 2.60 1.14- 5.95 .024*
Flatulence 3.54 1.62 -7.75 .002*
Persistent biliary symptoms Dyspeptic symptoms 6.73 1.46- 31.09 .015*
Bad taste 3.69 1.37- 9.96 .010*
Flatulence 2.83 1.09 -7.35 .033*
Emergent biliary symptoms Flatulence 13.13 1.32 - 130.24 .028*
Persistent dyspeptic symptoms Flatulence 3.28 1.32-8.17 .011*
Univariate logistic regression analysis was used to investigate the prediction of postoperative outcomes at six weeks
post-cholecystectomy
• significance p < .050
Table 4. Predictors of postoperative symptomatic outcome (total population).
Report of biliary symptoms
Preoperative predictor OR 95%CI p
Dyspeptic symptoms 6.60 1.86-23.45 .005*
Bad taste 3.55 1.38- 9.17 .009*
Flatulence 3.33 1.48-7.26 .004*
Flatulence 3.27 1.48-7.26 .004*
Flatulence 4.21 1.46-12.19 .008*
Postoperative outcome
Report of dyspeptic symptoms
Persistent biliary symptoms
Multivariate logistic regression analysis was used to investigate the prediction of postoperative outcomes at six weeks
post-cholecystectomy.
significance p < .050.
Table 5. Univariate predictors of postoperative symptoms at six weeks (female patients).
Report of biliary symptoms
Preoperative predictor OR 95%CI P
Dyspeptic symptoms 5.29 1.45 -19.28 .012*
Bad taste 3.81 1.48 - 9.82 .006*
Under abdominal pain 2.75 1.04-7.30 .042*
Heartburn 2.90 1.15 -7.28 .024*
Flatulence 3.09 1.29-7.43 .012*
Heartburn 2.94 1.08- 8.05 .036*
Flatulence 2.94 1.08- 8.05 .036*
Flatulence 3.15 1.15 -8.60 .025*
Postoperative outcome
Report of dyspeptic symptoms
Persistent biliary symptoms
Persistent dyspeptic symptoms
Univariate logistic regression analysis was used to investigate the prediction of postoperative outcomes at six weeks
post-cholecystectomy.




Most people with gallbladder stones never become patients, as they remain
asymptomatic. Elective cholecystectomy is performed in 70% of patients with
symptomatic chclelithiasis'" aiming at a release from pain and symptoms and preventing
complications. Postoperatively, a significant group of patients report persisting
symptomsl7-19,21.23. Furthermore, cholecystectomy entails the risk of common bile duct
injury and mortality in 0.5% and 0.2% of the patients, respecttvelv". Therefore,
performance of elective cholecystectomy should be considered critically and recognition
of patients with a high risk of negative outcomes is crucial. In this prospective follow-up
study, we investigated the role of preoperative symptoms in the prediction of negative
symptomatic outcome. The results of this study show that preoperative dyspeptic
symptoms, or more specifically bad taste and flatulence, are independent predictors for
the experience of biliary- and dyspeptic symptoms and the persistence of biliary
symptoms. Although sex does not predict postoperative outcome, predictors are only
identified in female patients.
In the current study, all abdominal symptoms decrease after cholecystectomy (with the
exception of diarrhoea), which is also reported in studies with follow-up at six
months17,25 or more than one year23. 26. In line with other studies" 17, greatest improve-
ment was found for biliary symptoms, whereas dyspeptic symptoms more often
persisted and emerged. At six months after cholecystectomy or later, biliary symptoms
are found to be persistent in 5.6% - 20.0% of the oatlents" and dyspeptic symptoms are
persistent in 10.0% - 40.2% of the patlents'?: 23, 27. In the current study we found higher
percentages of 27.8% and 57.3% for persistent biliary and dyspeptic symptoms, which
may be attributed to the timeframe of six weeks before follow-up. Approximately one
third of the patients with biliary or dyspeptic symptoms only developed another type of
symptoms at six weeks postoperatively. Although one studv" reports a one-directional
shift from preoperative biliary - to postoperative dyspeptic symptoms, the findings from
the current study suggest a bidirectional shift from preoperative biliary symptoms to
postoperative dyspeptic symptoms and vice versa.
As cholecystectomy is not beneficial to all patients, distinguishing patients with a
heightened risk of persisting and emerging symptoms at six weeks is important.
Literature mentions preoperative dyspeptic symptoms, preoperative flatulence, and
experiencing over 3 symptoms of flatulent dyspepsia as predictors of negative post-
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cholecystectomy outcomes, such as post-cholecystectomy syndrome and persistence of
a bothersome svmptorni" 25, 28. In addition, the current study asserts that preoperative
dyspeptic symptoms, bad taste and flatulence are associated with a 3 to 7 times greater
risk of postoperative biliary and dyspeptic symptoms. Furthermore, preoperative
flatulence is associated with a 4 times greater risk of persisting biliary symptoms after
cholecystectomy. Awareness of these risk-factors might have strong implications for
clinical practice. Surgeons should be alert on the recognition of these patients during
anamnesis and patients should be informed about their symptom-specific risk of
negative post-cholecystectomy outcome. Furthermore, the existing knowledge on risk
factors for negative symptomatic outcome should be integrated in clinical decision-
making, with regard to guidelines for the indication of cholecystectomy and
consideration of alternative treatment options.
Sex has an ambiguous position as a predictor of post-cholecystectomy symptomatic
outcome. Although male sex is found to be a predictor of a 'not very successful'
outcome " in literature, the current study indicates that sex is no predictor of self-
reported symptoms or the persistence or emergence of these symptoms. However,
predictors are only identifiable in female patients, and not in male patients. The latter
point has implications for knowledge from the existing literature on predictors of post-
cholecystectomy outcome. As the bulk of studies do not differentiate between male and
female patients, we recommend a careful interpretation of results and the inclusion of
the variable 'sex' in the design of future studies on cholecystectomy.
This study has several limitations. As this is a single-institution study, generalisation of
the results to other health care centres might be limited. We investigated the predictive
value of preoperative symptoms, taking biliary - or dyspeptic symptoms as feature of a
clinical representation of cholelithiasis. COinciding with biliary stones, dyspeptic
symptoms are easily interpreted as a clinical feature of cholelithiasis. However,
dyspeptic symptoms are quite common in the general population and may still be an
isolated condition, even in the context of biliary stones. Therefore, although our results
imply a relation between dyspeptic symptoms and postoperative outcome at six weeks,
results should be interpreted with care. Unfortunately, we did not specifically
investigate the combination of either both biliary and dyspeptic symptoms or the
interaction between biliary - and dyspeptic symptoms on the prediction of six weeks
symptomatic outcome. We recommend that this issue will be addressed in future
research. Furthermore, this study investigated preoperative symptoms as predictors of
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negative symptomatic outcome at six weeks post-cholecystectomy. Future studies
should investigate the relation between symptomatic outcome at six weeks and long
term outcomes, or the post-cholecystectomy syndrome. Despite the small sample of
male patients (n = 46), we found a sex difference in terms of the impossibility to identify
predictors of negative symptomatic outcome in male patients, in contrast to several
predictors in female patients. Extensive exploration of predictors should be aimed at in a
bigger sample of male patients and studies on predictors of long term post-
cholecystectomy outcomes should integrate sex as a potential variable. Another
shortcoming in this study is the fact that symptomatic outcome is a one-dimensional
outcome, indicating the presence of symptoms only. Within this measure,
differentiation should be sought by investigating severity and duration, implications for
all day living, and psychosocial consequences.
In summary, at six weeks post-cholecystectomy, 27.8% and 57.3% of the patients
reported the persistence of preoperative biliary and dyspeptic symptoms, respectively.
Furthermore, 17.1% and 38.6% of the patients with only dyspeptic or only biliary
symptoms developed another type of symptoms after cholecystectomy. Sex is no
predictor of postoperative outcome, whereas preoperative symptomatology is. Patients
reporting preoperative dyspeptic symptoms, bad taste, or flatulence have a heightened
risk of experiencing postoperative biliary symptoms. Besides, patients with preoperative
flatulence are at risk for the experience of postoperative dyspeptic symptoms and the
persistence of pre-existing biliary symptoms. Management of cholelithiasis should be
patient-tailored, thereby considering the prognosis after cholecystectomy differentially,
based on the clinical presentation of preoperative symptoms. So far, predictors of
postoperative symptomatic outcome have only been identified in female patients and
not in male patients.
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Background: Surgical removal of the gallbladder (cholecystectomy) is the standard
treatment in patients with gallstone disease. As many patients do not experience benefit
from this procedure, early recognition of patients with a high risk of negative
postoperative outcome is important. The aim of the current prospective follow-up study
is to identify predictors (clinical symptoms and trait anxiety) of negative symptomatic
outcomes at six weeks after cholecystectomy.
Methods: Consecutive patients (n := 133), ASA I and II, age 18-65 years, with
symptomatic gallstone disease completed symptom-checklists and the STAI Trait-scale
preoperatively and at six weeks after cholecystectomy. Cholecystectomy was performed
under a standard surgical and anaesthetic regime. Risk factors were identified using
univariate and multivariate regression analyses.
Results: Preoperative dyspeptic symptoms and High Trait Anxiety (HTA) predicted the
experience of biliary symptoms at six weeks post-cholecystectomy (OR := 6.31) and
(OR:= .69), respectively). Only HTA predicted the persistence of biliary symptoms at six
weeks (OR := 6.88). HTA and the number of preoperative dyspeptic symptoms both
predicted the number of persisting biliary symptoms after cholecystectomy (6 :=.32 and
6:= .27, respectively).
Conclusions: In addition to clinical symptoms, HTA is a predictor of negative
symptomatic outcome at six weeks after cholecystectomy. These findings suggest the
need for a patient-tailored management of gallstone disease, based on specific
personality traits like HTA. Tightening the indication for cholecystectomy in patients with
HTA may reduce the number of unsuccessful cholecystectomies.
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Introduction
Surgical removal of the gallbladder (cholecystectomy) is the standard procedure in case
of symptomatic gallstone disease. Positive outcomes are reported after
cholecystectomy, such as a relief of biliary pain (74% - 96%), a decrease of lower
abdominal pain (66% - 91%), and less dyspepsia (46% - 89%)1,2. On the other hand,
cholecystectomy may lead to disappointing results as a substantial group of patients
report the persistence and development of new symptoms and pain2-7. Early recognition
of these patients is crucial to optimise clinical decision making in gallstone disease.
Poor cholecystectomy outcome is associated with clinical factors, such as comorbidity,
heightened pain sensitivity, a long history of complaints (biliary pain, symptoms,
attacks), preoperative dyspeptic symptoms, and use of psychotropic medication" 5,8.12.
Stable personality traits, such as negative affectivity13-15 and introverslon'" 15also have
an impact on several long- and short-term outcomes after cholecystectomy, such as
medication use and pain. Trait Anxiety (TA)16 is a relatively stable individual difference in
the tendency to react with heightened anxiety to threatening situations, which remains
stable between pre- and postoperative conditions ". The impact of TA on post-
cholecystectomy recovery is indistinct": 17-19,as studies investigated small populations ":
18,19 and focussed on the first five days after cholecystectomy only. Evidence of the
impact of TA on post-cholecystectomy outcome is further flawed as studies used
different procedures and outcome variables, and controlled for different pre- and
postoperative factors. We hypothesised that High Trait Anxiety (HTA) is a predictor for
post-cholecystectomy recovery. As clinical experience learns that most patients report a
relief of symptoms and return to work at six weeks after discharge'", we investigated the
impact of TA on symptomatic outcome at six weeks after discharge.
Methods
Patients
The current study was performed at the department of Surgery of the St. Elisabeth
Hospital in Tilburg, the Netherlands. Between March 2006 and July 2007, consecutive
patients (18 - 65 years) with diagnosed symptomatic gallstone disease, awaiting an
elective laparoscopic cholecystectomy, were eligible for the study. Exclusion criteria
were: patients with ASA III or IV, undergoing an emergency procedure or intended open
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cholecystectomy, insufficient knowledge of the Dutch language, choledocholithiasis,
cholangitis, known pregnancy, known liver-cirrhosis, history of abdominal malignancy,
previous upper abdominal surgery (precluding laparoscopic approach), and psychiatric
diseases. All patients were subjected to a standard surgical and anaesthetic procedure.
Procedure
The protocol of the study was approved by the local ethics committee. Preoperatively,
surgeons introduced the study and asked the patients to participate in the study during
the patients' visit to the outpatient clinic. Nurses further instructed the patients about
the research procedures, and handed out written information and the first set of
questionnaires. Patients signed informed consent before participation. Furthermore,
records were checked for medical history, comorbidities, and medication use. Before
admission for cholecystectomy patients completed and returned the first
questionnaires. At five to three days before surgery, patients received a reminder
telephone call to complete the questionnaire. Patients who returned their first set of
questionnaires after surgery were excluded from the study. Six weeks after surgery,
patients received the same self-report questionnaire by mail. Eight weeks and ten weeks
after surgery, a phone call reminded the patients to return the postoperative
questionnaire to the hospital, if necessary.
Questionnaires
The demographic questionnaire was completed preoperatively and asked about sex,
age, marital status, educational level, work, and profession. Preoperatively and at six
weeks after cholecystectomy, patients completed a symptom checklist, that asked about
the presence of symptoms in the past week. Symptoms were obtained from clinical
experience and information from focus groups. Categorisation of these symptoms was
based on the study of Weinert et a1.6. As symptomatic gallstone disease is traditionally
diagnosed after right upper abdominal colicky pain, generally after the ingestion of food,
sometimes accompanied by nausea and vomiting, these symptoms were subsumed as
biliary symptoms. Peptic and lower abdominal symptoms, such as bad taste, heartburn,
under abdominal pain, diarrhoea, and flatulence, were categorised as dyspeptic
symptoms. General malaise, fatigue, weight-change, decrease in sexual functioning, and
other health complaints not mentioned in the pre-defined checklist were defined as
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non-specific symptoms. All included patients had experienced biliary or dyspeptic
symptoms before surgical consultation.
After surgery, surgical reports were checked for the presence of gallstones/ sludge and
conversion for a laparoscopic procedure to open cholecystectomy, which is indicated in
case of peri-operative complications. At six weeks postoperatively, medical reports were
checked for mean time surgical consultations, visits to the emergency ward, and
admissions to the hospital in relation to the cholecystectomy.
Patients completed the State-Trait Anxiety Inventory (STAI) preoperatively. The STAI-
trait exists of 20 items with a 4-item Likert-scale reflecting the extent of anxiety patients
generally feel. The STAI Trait Anxiety measure has good 3 months test-retest reliability
(r = .75) and internal consistency (Cronbach's a = .84 - .92) 21. Patients with a score
above the so" percentile were indicated as patients with 'High Trait Anxiety' (HTA).
Statistical analyses
Preoperative differences were investigated between responders (patients returning
their questionnaires) and the group of non-responders and drop-outs (patients who
ended participation < six weeks), using Chi-square tests and Student's r-tests. Further
analyses were limited to the group of responding patients. Preoperatively, Chi-square
tests, Student's r-tests, and Mann-Whitney U tests were used to observe differences
between patients with and without HTA. If possible, effect sizes were calculated.
Changes in the experience of symptoms over time, regarding the absence or presence of
symptoms, were calculated using the McNemar Test with Chi-square or Binomial
distribution when appropriate. Differences in the number of symptoms over time were
investigated using Wilcoxon Signed Ranks Tests. Following Weinert et a1.6, analyses were
performed for broad symptom complexes and specific symptoms.
Persistence of symptoms was defined as patients reporting a specific symptom or a
complex of symptoms both before and after cholecystectomy. Emergence was defined
as patients not reporting a specific symptom or a category of symptoms preoperatively,
but reporting the experience of these symptoms at six weeks post-cholecystectomy.
Persistence and emergence rates were calculated using frequencies. Predictors of the
experience of postoperative symptoms and persistence of emergence of symptoms
were calculated by univariate logistic regression and multivariate logistic regression,
inserting sex, age, preoperative biliary, dyspeptic, and non-specific symptoms, and HTA
(Method Enter). The number of postoperative symptoms experienced was investigated
43
Chapter 3
using multiple linear regression analyses, entering HTA, sex, age and number of
preoperative biliary, dyspeptic, and non-specific symptoms.
Statistical analyses were performed using SPSS version 14.0.1. P < .050 indicated
statistical significance.
Results
In total, 239 patients were found eligible for this study. Six patients were not contacted
before cholecystectomy, in 23 patients an expectative management was chosen, and 15
patients refused to participate. Preoperatively, 195 patients received the first
questionnaire, which was not returned by 28 patients. In the course of six weeks, 6
patients ended their participation. At six weeks postoperatively patients received a
second questionnaire, which 25 patients did not return. Only patients who returned
their questionnaires both preoperatively and six week postoperatively were included
(n = 136) (response rate 69.7%). Because of missing data, statistical analyses were
performed on 133 patients. Clinical and demographic characteristics are shown in
table 1. No differences were found between participating patients and patients who did
not return their questionnaires or ended participation within six weeks. Preoperatively,
21.5% of the patients, more specifically 12.5% of the male patients and 24.7% of the
female patients, had HTA (STAI-trait P ~ 80). Patients with HTA did not differ from other
patients on clinical and demographic characteristics.
All patients had biliary and / or dyspeptic symptoms before visiting the outpatient clinic.
Gallstones or sludge were demonstrated in 90.4% and 8.8% of the patients, respectively.
Preoperatively, sphincterotomy was performed in 5.1% of the patients. In five patients
laparoscopic cholecystectomy was converted to an open procedure.
Pre- and postoperative symptoms and TA
Patients with HTA experienced more preoperative dyspeptic and non-specific symptoms
than patients with lower levels of TA (U = 917.50, P = .037) and (U = 758.50, P = .001),
respectively). HTA patients also reported more postoperative biliary (U = 734.50,
P < .001) and non-specific symptoms (U = 735.00, P < .001), than patients without HTA.
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Health care consumption within six weeks
Ten days after cholecystectomy, the majority of patients (78.9%) paid a single visit to the
outpatient clinic to check the healing of the wounds and to remove the sutures.
However, 13.5% of the patients had one to three additional surgical consultations
because of persistent pain or delayed healing of the wound. Moreover, within the first
six weeks, 4.6% of the patients visited the emergency ward because of postoperative
symptoms and 3.1% of the patients were admitted to the hospital within six weeks post-
cholecystectomy. Differences were neither observed between patients with and without
HTA, nor between patients with and without biliary, dyspeptic and non-specific
symptoms.
Benefit of surgery
In the course of six weeks, biliary and dyspeptic symptoms reduced significantly (see
figure 1). Still, postoperatively 25.6% of the patients reported biliary symptoms and
46.6% of the patients reported dyspeptic symptoms. The report of non-specific
symptoms did not change.
Figure 1. Benefit at six weeks post-cholecystectomy (n = 133).
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Differences in the experience of pre- and postoperative symptoms were calculated for
patients with and without HTA ((n = 26) and (n = 95), respectively). In patients with HTA
the experience of symptoms did not reduce significantly (Figure 2), whereas the number
of patients without HTA experiencing biliary, dyspeptic, and non-specific symptoms
reduced significantly over six weeks time (see figure 3). In patients without HTA, the
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number of biliary (Z = - 6.72, P < .001), dyspeptic (Z = - 3.96, P < .001), and non-specific
symptoms (Z = - 2.11, P = .035) dropped significantly over 6 weeks time. In HTA patients,
the number of biliary (Z = - 2.11, P = .035) and dyspeptic (Z = - 2.70, P = .007) symptoms
also reduced across time. However, in the latter group of patients the number of non-
specific symptoms did not change over time.
Compared to patients without HTA, HTA patients more often reported the persistence of
pre-existing biliary symptoms and the emergence of new biliary symptoms
postoperatively ((18.6% vs. 57.9%, l = 10.704, P = .001) and (4.0% vs. 42.9%, l = 4.415,
P = .025), respectively). Patients with and without HTA did not differ with regard to the
report of persisting and emerging dyspeptic symptoms and persisting non-specific
symptoms. However, at six weeks post-cholecystectomy HTA patients reported the
emergence of new non-specific symptoms more often (95.0% vs. 49.0%; l = 10.93,
P = .001).
Figure 2. Percentage of patients with High
Trait Anxiety reporting pre- and postoperative
symptoms.
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Figure 3. Percentage of patients without High
Trait Anxiety reporting pre- and postoperative
symptoms.
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Prediction of postoperative symptoms
Univariate regression analyses identified HTA as a predictor of postoperative biliary
(OR = 6.75, P < .001; 95% C/: 2.59 -17.58), dyspeptic (OR = 2.51, P = .043; 95% CI: 1.03-
6.12), and non-specific symptoms (OR = 7.54, P < .001; 95% C/: 2.61 - 21.79).
Multivariate logistic regression analyses indicated that preoperative dyspeptic
symptoms and HTA predicted the report of postoperative biliary symptoms (table 2).
HTA was the only predictor of postoperative dyspeptic symptoms. Preoperative non-
specific symptoms and HTA predicted the experience of postoperative non-specific
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symptoms. Moreover, multivariate logistic regression analyses revealed that HTA was
the only significant predictor of persisting biliary symptoms at six weeks after
cholecystectomy. Preoperative biliary symptoms and HTA both predicted the
persistence of non-specific symptoms. No predictors could be identified for the
persistence of dyspeptic symptoms or the emergence of new symptoms at six weeks
post-cholecystectomy.
Table 2. Predictors of symptomatic outcomes at six weeks post-cholecystectomy.
Symptomatic outcome Preoperative predictor OR 95%CI P
Report of biliary symptoms Dyspeptic symptoms 6.31 1.31-30.38 .021*
HTA 7.69 2.31- 25.59 .001*
Report of dyspeptic symptoms HTA 2.79 1.02-7.66 .047*
Report of non-specific symptoms Non-specific symptoms 3.95 1.59-9.75 .003*
HTA 6.56 1.98-21.75 .002*
Persistent biliary symptoms HTA 6.88 1.78- 26.58 .005*
Persistent non-specific symptoms Biliary symptoms 5.22 1.03 - 26.45 .046*
HTA 45.86 4.31- 488.51 .002*
Multivariate logisticregression,method enter was usedentering sex,age,HTA, preoperativebiliary,
dyspeptic,andnon-specificsymptomsasvariables.
* Significancep < .050.
Multiple linear regression (entering sex, age, HTA, and the number of preoperative
biliary, dyspeptic, and non-specific symptoms) demonstrated that HTA and the number
of preoperative dyspeptic symptoms both predicted the number of biliary symptoms
reported postoperatively ((8 = .30, p = .001) and (6 = .25, P = .007), respectively). The
number of preoperative dyspeptic symptoms was the only significant predictor of the
number of postoperative dyspeptic symptoms (6 = .21, p = .047). Furthermore, HTA and
the number of preoperative non-specific symptoms both predicted the number of
postoperative non-specific symptoms at six weeks ((8 = .32, p = .002) and (8 = .18,
P = .037), respectively).
Differentiating between persisting and emerging symptoms, we found that the number
of persistent biliary symptoms was predicted by HTA (8 = .32, P = .003) and the number
of preoperative dyspeptic symptoms (6 = .27, P = .011). No other predictors were
identified. Furthermore, the number of biliary symptoms emerging after
cholecystectomy was not predicted by any of the inserted variables. The number of
preoperative dyspeptic symptoms predicted the number of persisting dyspeptic
symptoms (6 = .26, P = .037), whereas the number of preoperative non-specific
48
Trait anxiety predicts outcome six weeks after cholecystectomy
symptoms predicted the number of new dyspeptic symptoms emerging after
cholecystectomy (8 = .43, P = .017). HTA predicted the number of persisting non-specific
symptoms (8 = .36, P = .006), whereas the number of dyspeptic symptoms was a
predictor of the number of non-specific symptoms that developed de novo at six weeks
post-cholecystectomy (8 = .38, P = .017).
Discussion
Although cholecystectomy is the golden standard to resolve biliary or dyspeptic
symptoms in symptomatic gallstone disease, a substantial group of patients report
persisting svmptorns'i". The key issue is to identify patients with a heightened risk of
negative outcomes. This prospective follow-up study demonstrates that HTA has an
impact on the experience of gallstone disease and recovery after cholecystectomy.
Preoperatively, patients with HTA experience more dyspeptic and non-specific
symptoms than patients without HTA. Moreover, the current study provides evidence
that HTA has an impact on post-cholecystectomy recovery after controlling for
differences in preoperative symptom report. At six weeks after cholecystectomy, both
patients with HTA and preoperative dyspeptic symptoms have a seven times greater risk
to report biliary symptoms. However, HTA is the only predictor of persisting biliary
symptoms post-cholecystectomy, whereas preoperative symptomatology is not.
Besides, HTA patients have a heightened risk to report postoperative dyspeptic and non-
specific symptoms. Patients with dyspeptic symptoms are at risk to report new non-
specific symptoms at six weeks after cholecystectomy. Despite differences in symptom
report, health care consumption within the first six weeks post-cholecystectomy is
similar for patients with and without HTA.
Preoperative symptoms are most thoroughly investigated as markers of negative
outcomes after cholecystectomy. Dyspeptic symptoms, such as flatulent dyspepsia and
diarrhoea, are mentioned as predictors of long-term negative outcomes (> 6 monthsl'" 9.
10.22,23. Findings of the current study indicate that other predictors might be of value in
addition to these clinical symptoms. Moreover, in the current study, dyspeptic
symptoms did not predict persistence of biliary symptoms, which is considered as the
prominent feature of an unsuccessful cholecystectomy so far, but HTA did. However, the
current study investigated recovery at six weeks after discharge, whereas the majority of
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studies have focused on long term outcomes (> 6 months). We recommend that future
studies investigate the impact of HTA on long term post-cholecystectomy outcomes.
Psychological factors, varying from psychopathological svrnptorns'" 24 and social
support" to personality traits'" 10, are found to be associates of a lack of post-
cholecystectomy improvement next to clinical characteristics. The current study
demonstrates that, after controlling for clinical features, personality is the only predictor
of persisting biliary symptoms at six weeks. The fact that other studies focused on long
term outcomes (> one year), different outcome measures and psychological variables,
may account for this difference. Previous studies on TA and post-cholecystectomy
recovery 15, 17, 19, 26, based on small populations and with a focus on short-term post-
cholecystectomy outcomes (maximum five days postoperatively), came to inconsistent
results. Conversely, the current study, based on a bigger population, demonstrates that
HTA is associated with several symptomatic outcomes at six weeks post-
cholecystectomy. Additional research is needed to clarify the predictive qualities of TA
and to gain insight in the mechanisms underlying the relation between HTA and
postoperative recovery.
Generally, patients with HTA are known to have a higher pain sensitivitv'", which may
result in an increased report of symptoms. However, as differences between patients
with HTA and without HTA are primarily prominent at six weeks postoperatively, this
explanation might not be viable. As TA is the tendency to interpret situations as
threatening, patients with HTA are more vulnerable to experience (psychological)
distress because of surgery. Higher, distress-related, levels of noradrenalin in patients
with HTA28 may lead to impaired wound healing and long lasting report of postoperative
symptoms. Furthermore, diagnostic criteria for symptomatic gallstone disease are
indistinct and patients with gastro-intestinal symptoms may erroneously be indicated for
cholecystectomy. As HTA patients more often suffer from gastro-intestinal conditions/",
they may be at risk for poor decision making in cholecystectomy with negative
symptomatic outcomes as a result.
This study has a prospective follow-up design, which enables us to follow the
development of symptoms across time. As all patients (i.e. patients with and without
symptoms at six weeks) were included in the preoperative measurement, the influence
of confounding variables at six weeks postoperatively is minimised. As all consecutive
patients visiting the outpatient clinic and matching the criteria for inclusion were eligible
for the study, selection bias was avoided and generalisability to the general population
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was optimised. Preoperatively, participants and patients who did not return the second
questionnaire or ended participation (drop-outs) did not differ on demographic and
clinical characteristics, the report of symptoms and HTA. Furthermore, participants and
drop-outs did not differ from non-participants on demographic and clinical
characteristics. However, a patient bias cannot be precluded as non-participants, who
did not complete any of the measures at any time point in the study, may differ from
participants on the report of preoperative symptoms and HTA. Moreover, in the current
study we used a self-constructed symptom checklist to assess biliary, dyspeptic, and
non-specific symptoms. This checklist was based on the existing literature, checklists,
clinical experience, and information from focus groups. Preferably, a standard
gastrointestinal symptom questionnaire, that is developed to measure the symptoms we
were interested in, would have been used. However, existing questionnaires, such as the
Gastrointestinal Symptom Rating Scale (GSRS)3o,are extensive and do not contain all
symptoms specific for gallstone disease.
Another limitation of the present study is that we did not control for confounders, such
as comorbidity. We investigated the influence of personality, more specifically HTA, in
the context of clinically relevant variables, such as the presentation of symptomatic
gallstone disease, age and sex. Further research should enable a broad insight in
predictors of negative post-cholecystectomy outcome, thereby controlling for potential
confounders. Six weeks after discharge is chosen as moment of follow-up, as clinical
experience learns that most symptoms are relieved and most patients are able to go
back to work as this time poinr'", We believe that this time point may be suitable as a
first inventory of post-cholecystectomy outcomes. However, the results of this six weeks
follow-up yet cannot be extended to long-term post-cholecystectomy outcomes or the
post-cholecystectomy syndrome. Further research is needed to establish a relationship
between HTA and long-term post-cholecystectomy outcomes and to corroborate the
following recommendations.
Since HTA is associated with a heightened risk of negative post-cholecystectomy
outcomes and approximately 20% of all patients have HTA, TA is a predictive factor
worth paying attention to in clinical decision making. Information on TA could be easily
obtained from a short self-report personality questionnaire, such as the STAI Trait
Anxiety measure", which can be completed within five minutes during the patient's visit
to the outpatient clinic. Integrating information about current symptoms, medical
history, and level of TA, may be essential to come to a genuine patient-tailored approach
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in gallstone disease. In patients with HTA, expectative management or alternative
treatment options, such as biliary salts, should be considered besides cholecystectomy.
Cholecystectomy is widely performed in symptomatic gallstone disease, even though
patients' and surgeons' expectations often are not met. Clinical decision making
concerning cholecystectomy is often demanding, as the clinical presentation of
symptomatic gallstone disease is often indistinct. In recent years, expectative
management is gaining popularity in patients with endoscopic demonstrated gallstones
and vague abdominal complaints. To reduce the amount of clinically unsuccessful
cholecystectomies, guidelines for the indication of a cholecystectomy may be tightened,
integrating new insights on the impact of personality. As cholecystectomy is a costly
procedure 32, greater selectivity in the performance of cholecystectomies will lead to a
greater cost-effectiveness in health care.
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Abstract
Objective: Cholecystectomy (surgical removal of the gallbladder) is the preferred
treatment in gallstone disease. After cholecystectomy, a substantial number of patients
report persistence of symptoms. The aim of the study is to identify predictors of
negative symptomatic outcomes at six months after surgery.
Methods: In this prospective follow-up study, consecutive patients (n = 172) diagnosed
with symptomatic gallstone disease and indicated for elective cholecystectomy, were
investigated. Preoperatively and at six months, patients completed self-report symptom
checklists. The STAI trait scale was completed preoperatively and patients with a score
::::P 80 were considered having High Trait Anxiety (HTA). Multivariate regression analyses
were used to investigate independent predictors of persisting symptoms.
Results: Six months after cholecystectomy, HTA patients were more likely to report
persisting biliary symptoms than patients without HTA (NHTA) (45.5% vs. 14.3%;
t = 8.78, P = .002). HTA was identified as an independent predictor of persisting biliary
symptoms at six months (OR = 3.08, p = .047; 95% C/: 1.02 - 9.34), in addition to the
report of non-specific symptoms (OR = 6.16, P = .024; 95% C/: 1.27 - 29.82), and the use
of psychotropic medication (OR = 4.76, P = .023; 95% C/: 1.24 - 18.34).
Conclusion: HTA patients have a three times higher risk at persisting biliary symptoms at
six months after cholecystectomy, than NHTA patients. Both clinical factors and patients'
personality should be considered in clinical decision making and risk estimation in
elective cholecystectomy.
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Introduction
Gallstone disease (cholelithiasis) is a common condition in the Western world" 2. In the
Netherlands, more than 30,000 patients yearly are diagnosed with gallstone disease".
Overall, 20% of all patients with gallstone disease experience clinical symptoms" 5.
Laparoscopic cholecystectomy (surgical removal of the gallbladder) is considered the
golden standard in symptomatic cholelithiasis, beyond expectative management.
Although the majority of patients report symptomatic benefit after surgery, such as a
relief of all symptoms (53% - 81.5%)6, 7, a relief of dyspeptic symptoms (56%)8, and
biliary pain (72%)8, a substantial group of patients (40.4%)9 does not experience any
improvement after cholecystectomy. In many patients symptoms and pain persist
(5.6% - 57.3%) or symptoms develop de novo postoperatively (12.0% - 38.6%)10'17.
Moreover, cholecystectomy entails the risk of mortality (0% - 0.2%), complications
(5.0%), and bile duct injuries (0.2% - 1.0%)18. As the risk of negative outcomes in
cholecystectomy is considerable, performance of cholecystectomy should be considered
carefully in each individual patient. Therefore, preoperative recognition of high-risk
patients is crucial.
So far, risk assessment has emphasised the importance of clinical characteristics and
symptoms. Preoperative dyspeptic svrnptorns'" 19, 20, previous and current use of
psychotropic drugs", characteristics of preoperative pain and svmptorns" 19·21 (e.g.
duration, level, nature), pain sensitivity, and age21,22 have been found as predictors of
negative post-cholecystectomy outcomes. The patient's personality is found to predict
several long and short term post-cholecystectomy outcomes= 22-25. Personality is
considered to be a set of relatively enduring traits and mechanisms that influence the
individual's interactions with, and adaptations to, the environment. With respect to Trait
Anxiety (TA), which can be defined as 'a relatively stable individual difference in anxiety
proneness'r", studies have focussed on short term outcomes « five days post-
cholecvstectomvj" 25, 27 and found that TA predicted early postoperative pain23,
emotional and physical well-being " and the use of narcotics". However, conclusive
evidence could not be established due to the differential selection of procedures and
outcome variables and the control for different pre- and postoperative variables. As we
believe that personality is a predictor of long-term postoperative outcomes, we
hypothesised that TA is a predictor of post-cholecystectomy outcomes at six months in





Patients for the current study were recruited from the Department of Surgery of the St.
Elisabeth Hospital in Tilburg, the Netherlands. Consecutive patients (18 - 65 years) with
diagnosed symptomatic cholelithiasis, awaiting an elective laparoscopic
cholecystectomy who visited the hospital between March 2006 and January 2008, were
eligible for the study. Only patients with American Society of Anaesthetists (ASA) class I
and II, i.e. healthy patients or patients with mild systemic diseases, were included.
Patients undergoing an emergency procedure or intended open cholecystectomy,
patients with choledocholithiasis, cholangitis, known pregnancy, known liver-cirrhosis,
history of abdominal malignancy, previous upper abdominal surgery (precluding
laparoscopic approach), and psychiatric diseases were excluded. Furthermore, as
patients had to complete multiple questionnaires by themselves, patients with
insufficient knowledge of the Dutch language were excluded. All patients underwent a
standard surgical and anaesthetic procedure. The protocol of the study was approved by
the local ethics committee.
Procedure
Preoperatively, participation was asked during the patients' first surgical consultation at
the outpatient clinic. The surgeon introduced the study, whereas subsequently nurses
informed patients about the research procedures. Patients received the first set of
questionnaires, which also contained written information about the study, and signed
informed consent. Medical history and comorbidities were obtained from medical
records. Patients completed and returned the first questionnaires before admission for
cholecystectomy. If necessary, patients received a reminder telephone call to return the
questionnaires three to five days before the operation. Patients who returned the
questionnaires after admission were excluded from the study. At six months after
cholecystectomy, patients received the same questionnaire which could be returned in a
prepaid envelope. If needed, patients were contacted by telephone twice, usually two
and four weeks after sending the questionnaires. Patients returning their second
questionnaire> 9 months after surgery were considered as non-responders.
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Questionnaires
The demographic questionnaire was completed preoperatively and asked about sex,
age, marital status, educational level, and work. Preoperatively and at six months post-
cholecystectomy, patients completed a symptom checklist based on information from
focus groups. Patients should tick off whether they experienced cholelithiasis-specific
symptoms (upper abdominal pain, nausea, vomiting), dyspeptic symptoms (bad taste,
heartburn, under abdominal pain, diarrhoea, and flatulence), and non-specific
symptoms (general malaise, fatigue, weight-change, decrease in sexual functioning, and
health complaints not mentioned in the pre-defined checklist) in the past week.
Symptoms were considered as dichotomous items (yes/no) and were categorised
following the study of Weinert et a1.14. Furthermore, patients indicated the nature,
severity, duration, and frequency of pain during preoperative biliary attacks on a
100 mm. visual analogue scale (VAS) and on three multiple choice items. All included
patients had experienced biliary or dyspeptic symptoms in medical history. After
surgery, surgical reports were checked for the presence of gallstones/ sludge and
conversion to open surgery.
Patients completed the trait scale of the State-Trait Anxiety Inventory (STAI)
preoperatively. The STAI-trait exists of 20 items with a 4-item Lickert-scale reflecting the
extent of anxiety patients generally feel. The STAI Trait Anxiety measure has good
three months test-retest reliability (r .75) and internal consistency
(Cronbach's a = .84 - .92)28. Patients scoring the so" percentile or higher were indicated
as patients with 'High Trait Anxiety' (HTA), whereas patients with a score below the so"
percentile were indicated as patients with 'Non High Trait Anxiety' (NHTA).
Statistical analyses
Preoperative differences between responders (patients returning their questionnaires)
and patients that refused, ended participation within six months, or did not return their
questionnaires on time, were investigated using Chi-square tests and Student's t tests
with an adjusted alpha level (a = .0042) (Bonferroni correction) for multiple
comparisons. Further analyses were limited to the group of responding patients.
Preoperatively, Chi-square tests, Student's t tests, and Mann-Whitney U tests were used
to observe differences between patients with HTA and NHTA and male and female
patients. Bonferroni correction was applied to obtain a more stringent alpha level. As we
computed group differences on 12 preoperative variables, i.e. the report (yes/no) and
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the number of biliary, dyspeptic and non-specific symptoms, age, medication use, and
sex or HTA, the alpha level was set at .0042. Postoperatively, group differences were
computed for the report, the persistence, and the emergence (yes/no), and the number
of biliary, dyspeptic, and non-specific symptoms reported at sis months. For this subset
of 12 variables, the alpha level was also set at .0042. Changes in the experience of
symptoms over time, regarding the absence or presence of symptoms, were calculated
using the Mc Nemar Test with Chi-square or Binomial distribution when appropriate.
Differences in the number of symptoms over time were investigated using Wilcoxon
Signed Ranks Tests. Differences between HTA and NHTA patients over time were
calculated using within-between ANOVA for repeated measures (Greenhouse-Geiser
test for sphericity, repeated contrasts). Bonferroni correction was applied and the alpha
level for these ANOVA's was set at .017.
All analyses were performed on broad categories of symptoms (biliary, dyspeptic and
non-specific) following Weinert et a1.14. Persistence of symptoms was defined as
'patients reporting a complex of symptoms both before and after cholecystectomy'.
Emergence was defined as 'patients not reporting a category of symptoms
preoperatively, but reporting the experience of these symptoms at six weeks post-
cholecystectomy'. Persistence and emergence rates were calculated using frequencies.
Predictors of the experience of postoperative symptoms, the persistence, and the
emergence of symptoms were identified using univariate logistic regression. The report
of preoperative biliary, dyspeptic and non specific symptoms was represented as a
dichotomous (presence) and a categorical variable (number of symptoms). To serve
clinical application, only the dichotomous variable was used in multivariate regression
analyses. Multivariate logistic regression, inserting sex, age, preoperative biliary,
dyspeptic, and non-specific symptoms, and HTA (Method Enter), was used to identify
independent predictors of the report, the persistence and emergence of biliary and
dyspeptic symptoms at six months. Collinearity was checked for this set of variables.
Statistical analyses were performed using SPSS version 17.0.1. P < .050 indicated
statistical significance.
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Results
Thirteen patients were excluded because of insufficient knowledge of the Dutch
language. These patients did not differ in terms of gender and age from the patients in
the sample. A flow chart of the population under study is shown in figure 1. In total, 307
patients visiting the outpatient clinic met the criteria for inclusion, of which 253 patients
received the first set of questionnaires. At 6 months postoperatively, 172 patients
returned their questionnaires (response rate 68.0%). Clinical and demographic
characteristics of the population are shown in table 1. Preoperative symptoms are
shown in table 2. Most commonly reported were biliary symptoms (74.4%), followed by
dyspeptic (65.5%) and non-specific (56.1%) symptoms. Cholecystectomy was performed
by surgeons and assistant surgeons in 27.9% and 72.1% of the patients, respectively.
Laparoscopic cholecystectomy was converted to open surgery in 4.1% of the patients.
Furthermore, differences were investigated between participants (n = 172) and patients
that were missed, refused participation, or did not return the first set of questionnaires.
Participants reported longer duration of symptoms than non-participants !I= 11.85,
P = .003). Furthermore, differences were investigated between participants and patients
that ended participation or not returned their questionnaires at six months. Participants
were older (t = 3.18, P = .002) than drop-outs and non-responders at six months.
At baseline, patients with HTA and NHTA did not differ on demographic and clinical
characteristics, reported the same frequency and nature of biliary attacks (in
rest/movement), and reported the same level of pain during biliary attacks (VAS scores).
Preoperatively, HTA patients reported more non specific symptoms (Z = - 3.65, P < .001)
(see figure 2).
In addition to differences between HTA and NHTA patients, sex-differences were
identified. Preoperatively, male patients were older than female patients (51.61 ± 9.53
vs. 46.23 ± 11.57; t = 2.99, P = .004). Furthermore, male and female patients reported
the experience of preoperative biliary, dyspeptic, and non-specific symptoms to the
same extent. Furthermore, female patients reported a greater number of biliary and
dyspeptic symptoms ((.85 ± .83 vs. 1.36 ± .96, t = - 3.07, P = .002) and (.83 ± .93 vs. 1.38 ±
1.25, t = - 3.04, P = .003), respectively). The use of H-2 antagonists and proton pump
inhibitors, pathology of gallstone disease, conversion to open cholecystectomy, and the
level of surgical experience were not associated with the report (yes/no) and number of
biliary, dyspeptic, and non-specific symptoms.
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Figure 1. Flowchart of the population under study.
Ended participation within six months
In = 307 I
n 10 I
n 28 I
I n = 269 I
n -16 I
In = 253 I
n 35 I
In = 218 I
n-ll I
In = 207 I
I n =35 I
In=l72 I
Meeting criteria for inclusion





Not returned preoperative questionnaire
Returned preoperative questionnaire
Received questionnaire at six months
Not returned the questionnaire at six months
Population under study
Impact of cholecystectomy
In the total population, the percentage of patients reporting biliary symptoms reduced
in the first six months post-cholecystectomy from 75.6% to 17.2% (x2 = 85.50, P < .001).
The number of patients reporting dyspeptic and non-specific symptoms reduced from
66.1% and 55.0% of the patients preoperatively to 49.7% and 37.0% at six months post-
cholecystectomy (~= 12.85, P < .001) and (x2= 16.36, P < .001), respectively). Besides,
the number of biliary and dyspeptic symptoms reported by patients also reduced
significantly ((l = - 8.81, P < .001) and (l = - 5.32, P < .001), respectively). The number of
non-specific symptoms did not change over time (l = - .58, P = .565). At six months, the
percentage of patients using proton pump inhibitors or H-2 antagonists decreased from
21.5% to 7.6% (x2= 14.69, P < .001). The preoperative use of H-2 antagonists and proton
pump inhibitors, pathology of gallstone disease, conversion to open surgery, and level of
surgical experience were not associated with the report (yes/no), persistence,
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emergence, and number of biliary, dyspeptic, and non-specific symptoms reported at six
months.
Table 1. Demographic and clinical characteristics (n = 172).
Demographic characteristics
Female patients (%)
Age (M ± SO)
Highest level of education
Primary or lower vocational education (%)
Secondary education (%)
Higher education (%)
Higher professional education or university (%)
Working under payment (%)
Marital status
Single (%)
Widowed or divorced (%)















Proton pump inhibitors / H-2 blockers (%)
Comorbidities

















At six months after cholecystectomy, biliary symptoms persisted in 20.0% of the patients
with preoperative biliary symptoms (n = 24). In this subgroup the number of biliary
symptoms did not change over time (Z = - 1.80, P = .079). In total 7.5% of the patients
without preoperative biliary symptoms reported new biliary symptoms at six months
(n = 3). At six months post-cholecystectomy, 57.9% of the patients with preoperative
dyspeptic symptoms (n = 62) reported persistence of these symptoms. Among these
patients the number of dyspeptic symptoms reduced significantly (Z = - 3.63, P < .001).
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At six months, 30.2% of the patients without preoperative dyspeptic symptoms (n = 16)
reported new postoperative dyspeptic symptoms.
HTA and benefit farm surgery
Six months after cholecystectomy, comparison of patients with HTA and NHTA showed
that HTA patients more often reported biliary symptoms (36.7% vs. 12.5%; 1= 8.17,
P = .004). HTA and NHTA patients reported the same amount of biliary, dyspeptic and
non-specific symptoms (figure 2).
Among NHTA patients, the number of patients reporting biliary (j= 76.01, P <.001),
dyspeptic (1= 9.50, P = .002) or non-specific symptoms ti= 14.67, P < .001) dropped
significantly over six months time. In addition, at six months post-cholecystectomy, the
group of patients with HTA (n = 30) reporting biliary symptoms had decreased as well
(p < .001). However, HTA patients reported dyspeptic symptoms to the same extent as
before cholecystectomy (p = .11). Over six months time, the number of symptoms
reduced both in patients with HTA and NHTA. Patients with NHTA reported a decrease
of the number of biliary (Z = - 8.09, P < .001), dyspeptic (Z = - 4.68, P <.001), and non
specific symptoms ((Z = - 3.51, P < .001). Patients with HTA also reported a smaller, but
also a significant reduction of the number of biliary symptoms over time (Z = - 2.98,
P = .003).
Investigating changes over time, within-between repeated measures ANOVA
demonstrated a significant reduction of biliary symptoms across time (F = 78.96,
P < .001). No main effect of HTA or interaction-effect of time and HTA was found.
Performing a within-between repeated measures ANOVA, demonstrated a significant
change of dyspeptic symptoms over time (F = 24.35, P < .001) and a significant effect of
HTA (F = 9.52, P = .002). No significant interaction-effect was obtained. Concerning non-
specific symptoms, time and HTA both had a significant effect ((F = 26.71, P < .001) and
(F = 15.08, p < .001), respectively). Besides, an interaction effect was found between
time and HTA (F = 5.79, P = .017).
At six months post-cholecystectomy, HTA patients more often reported persistent biliary
symptoms than NHTA patients (45.5% vs. 14.3%; 1= 8.78, P = .002) (figure 3). Patients
with HTA and NHTA reported persisting dyspeptic and non-specific symptoms to the
same extent. The number of biliary, dyspeptic and non-specific symptoms remained
constant in both patients with HTA and NHTA. With regard to the development of new
symptoms, no differences were found between patients with HTA and NHTA.
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At six months after cholecystectomy, men and women reported the persistence and
emergence of biliary, dyspeptic, and non-specific symptoms to the same extent. At six
months, no sex differences were obtained with regard to the number of biliary,
dyspeptic, and non-specific symptoms reported.


















Decreased sexual functioning (%)
Other health complaints (%)
Duration of symptoms
< 1 month (%)
1-6 months (%)
> 6 months (%)
Preoperative biliary attacks (M ± SO)
Pain during biliary attack
Pain in rest and movement (%)
VAS* pain severity in rest (M ± SD)
VAS* pain severity in movement (M ± SD)
VAS* pain duration in rest (M ± SD)
VAS* pain duration in movement (M ± SD)
VAS* pain frequency in rest (M ± SD)
VAS* pain frequency in movement (M ± SD)


































Fibrosis or inflammation (%) 72.1
Both cholesterolosis and fibrosis / inflammation (%) 16.3
Adenoma / dysplasia / polyp (%) .6
No abnormality (%) 2.3
Other pathology (%) 5.8
•~ 1 of the following symptoms: upper abdominal pain, nausea, vomiting.
§ ~ 1 of the following symptoms: bad taste, heartburn, under abdominal pain, diarrhoea,
flatulence.
t ~ 1 of the folowing symptoms: general malaise, fatigue, weight-change, decreased sexual
functioning, other health complaints.
'VAS = 100 mm. visual analogue scales
Prediction of six months symptomatic outcome
Univariate logistic regression analyses were used to identify predictors of reporting the
presence, persistence, and development of new symptoms in the first 6 months after
surgery. The report and the number of preoperative biliary, dyspeptic, or non-specific
symptoms, sex, age, pathology of biliary disease, self-reported preoperative medication
use and HTA were considered potential predictors of postoperative symptom report.
The results of the univariate logistic regression analyses are shown in table 3. No
predictors could be identified for the development of new biliary, dyspeptic, and non-
specific symptoms at six months. Moreover, persistence of non-specific symptoms was
not predicted by any of the potential predictors. HTA predicted the report of
postoperative biliary symptoms and more specifically the report of persisting biliary
symptoms. Sex and preoperative pain characteristics were not found to be predictive of
outcomes at six months.
Multivariate regression analyses were performed (entering the univariate predictors for
each differential outcome (see table 3)). The dichotomous variable that indicated the
report of biliary, dyspeptic, or non-specific symptoms was entered in the multivariate
regression, whereas the ordinal variable that indicated the number of biliary, dyspeptic,
or non-specific symptoms was not. Results are shown in table 4. HTA predicts the report
of biliary symptoms at six months, in addition to the clinical variables 'use of
psychotropic medication' and 'report of non-specific symptoms'. The report of dyspeptic
and non-specific symptoms at six months was predicted by clinical variables only, more
specifically the report of dyspeptic and non-specific symptoms. Moreover, HTA
predicted persistent biliary symptoms at 6 months, next to the report of preoperative
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non-specific symptoms and the use of psychotropic medication. Persistent dyspeptic
symptoms were predicted by preoperative non-specific symptoms only. After the
insertion of 'sex' as an extra covariate in the multivariate regression analyses, exactly
the same variables were identified as independent predictors of different outcomes at
six months.
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Bonferroni correction was applied. p < .0042 indicated statistical significance.
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Discussion
The current study demonstrated that many patients do not benefit from
cholecystectomy. Indeed, at six months post-cholecystectomy, biliary and dyspeptic
symptoms persisted in 20.0% and 57.9% of the patients respectively. Furthermore, in
patients with only biliary symptoms, 30.2% of the patients had developed new dyspeptic
symptoms at six months after surgery. In patients who presented gallstone disease with
preoperative dyspeptic symptoms only, 7.5% developed new biliary symptoms after six
months. We further investigated the predictive value of the personality trait HTA for six
months post-cholecystectomy outcomes. Patients with HTA experienced a greater
number of preoperative non-specific symptoms than patients with NHTA.
Postoperatively, HTA patients were more likely to report biliary symptoms than NHTA
patients. Both groups of patients showed a different profile of six month post-
cholecystectomy recovery. Patients with HTA reported persistence of biliary symptoms
more often than patients with NHTA. In case of persisting biliary symptoms, the number
of symptoms reduced in NHTA patients, but not in patients with HTA. HTA patients have
a three times higher risk of persisting biliary symptoms at six months post-
cholecystectomy, than NHTA patients. Besides, patients with non-specific symptoms and
patients using psychotropic medication have a five to six times higher chance of
persisting biliary symptoms than patients without these preoperative characteristics.
Persisting dyspeptic symptoms were not predicted by HTA, but were predicted by
preoperative non-specific symptoms only.
Comparison with other studies
In literature, three other studies have focussed on follow-up at approximately six
months'?' 14, 17. These studies report persistence of biliary symptoms (nausea and
vomiting) in 16.2% - 45% and 5.5% - 50% of the patients, respectively'!' 14, 17. Although
one study reported that biliary type pain had disappeared in all patients". we found that
upper abdominal pain persisted in 12.8% of our respondents. Percentages of patients
reporting persisting dyspeptic symptoms (57.6%) were comparable with results of other
studies focussing on six months symptomatic outcome (27.3% - 60.0%)11,14. Percentages
of emerging biliary and dyspeptic symptoms at six months were also in line with
literature" (1.7% - 9.2% and 9.6% - 24.5%, respectively). Comparability of the studies
might be hampered by the use of different criteria in- or exclusion and the use of broad
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categories of symptoms (indicating the presence of one or more symptoms) as
dichotomous variable in the current study vs. individual symptoms in other studies.
However, symptoms complexes are categorised in accordance with literature " and the
use of these complexes facilitates the clinical application of the results.
So far, preoperative dyspeptic symptoms and the use of psychotropic medication are
found to be predictors of short term14, 16, 20 and long term17, 19 negative outcomes after
cholecystectomy. In accordance with previous studies, we found that psychotropic
medication predicted the postoperative report and persistence of biliary symptoms only.
Dyspeptic symptoms also had an impact on high symptom report at six months after
cholecystectomy, but not on the persistence of pure biliary symptoms. Weinert et al.14
found that dyspeptic symptoms predicted persistence of 'a single abdominal symptom
subjectively rated as the most bothersome symptom'. This undifferentiating outcome is
not comparable to the more objective outcome measures used in the current study.
Furthermore, the present study identified the presence of preoperative non-specific
symptoms as a predictor of negative symptomatic outcome at six months. To the
authors knowledge, the impact of non-specific symptoms, which may be of
psychosomatic origin, has not been investigated yet in relation to post-cholecystectomy
outcomes. We believe that investigation of these symptoms may offer a new
perspective to risk estimation in post-cholecystectomy recovery and well-being.
Other studies have identified preoperative pain characteristics (e.g. duration, level,
nature, location) as predictors of postoperative outcomesl" 19, 21. The current study did
not replicate these findings. Neither the often used VAS's, nor multiple choice items
indicating the length, severity, and duration of preoperative pain, predicted
postoperative persisting symptoms. As methods of pain measurement were different,
this may indicate that the nature of pain measurement may be decisive for the
outcomes. Likewise, in contrast to other studles": 22, the current study demonstrates
that age is no risk factor for negative symptomatic outcome at six months. Moreover,
Weinert et al.14 found that male sex was a risk factor of persistence of the most
bothersome symptom. Although preoperative sex differences were identified with
regard to symptom report, sex was no predictor of symptomatic outcome at six months.
In contrast to the findings of Weinert et a1.14, we also demonstrated that the use of H-2
antagonists and proton pump inhibitors was no univariate predictor of symptomatic
outcome at six months.
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The results of the current study indicate that personality, or more specifically Trait
Anxiety which can be defined as 'a relatively stable individual difference in anxiety
proneness", has an impact on biliary symptoms reported at six months after
cholecystectomy. HTA patients may be more sensitive to the experience of pain in
general28 and for gastro-intestinal svrnptorns" in particular, which might result in overall
heightened symptom report in this study. However, our results suggest that HTA
influences the persistence of biliary symptoms only. Postoperatively, HTA patients might
misinterpret postoperative abdominal symptoms as persistent biliary symptoms.
However, HTA patients might also objectively experience persistence of preoperative
symptoms more often. As the relation between abdominal symptoms and demonstrated
gallstones is difficult to establish" and the indication for cholecystectomy is not clear-
cut, patients with long-lasting abdominal complaints may be operated on wrong
indications resulting in persistence of their preoperative symptoms. As HTA patients
more often experience gastro-intestinal symptoms, they are at risk for persistence of the
same preoperative symptom. However, additional research is needed to corroborate
these findings and to investigate the mechanisms of influence.
Strengths and limitations
The current study has some methodological advantages beyond other studies
investigating predictors of post-cholecystectomy outcomes. As this study was performed
under a prospective follow-up design and consecutive patients were approached,
selection bias is limited and the control for confounding influences is optimized.
However, we acknowledge that this is a single center study with a relatively small
sample size, which may hamper generalisability of our results. Other studies in the field
included non-consecutive patients!" 23, patients with simply demonstrated gallstones",
an indication for acute cholecvstectornv'" 17, or did not define criteria for in- and
exclusion explicitly14, 21. The current study has a relatively homogeneous sample due to
more restricted criteria for inclusion, namely patients with uncomplicated symptomatic
gallstone disease with an indication for elective cholecystectomy. As a consequence, the
findings are only applicable to a restricted field of surgery where consideration of pros
and cons matters most: strictly elective procedures.
The results of this study on long-term post-cholecystectomy outcomes are preliminary.
Up to now, research on TA has focussed on short term post-cholecystectomy outcomes
« five days), which has led to inconclusive evidence23-25, 27. The role of TA should be
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investigated at longer follow-up (> 6 months) investigating the impact of TA on the
development of the post-cholecystectomy syndrome and other long term outcomes,
such as quality of life and health care consumption. Furthermore, knowledge on the
impact of TA on other post-surgical outcomes and on the prevalence of abdominal
symptoms in the general population may provide a context in which the results of this
study could be better understood. These issues may be addressed in future studies. As
patients were questioned preoperatively and at six months, the results of the study do
not clarify whether symptoms actually persisted or recurred in six months time. No
predictors could be identified for the development of biliary, dyspeptic and non-specific
symptoms over time, possibly because of small sample sizes. Future research should aim
at the course of symptoms over time, in an extended sample. Furthermore, findings of
the current study may be flawed by the fact that we did not control for other medical
conditions in the course of six months. Temporary health conditions that are not related
to cholecystectomy, such as gastroenteritis, may influence the results at six months. Due
to the use of a self-constructed, non-standardised symptom checklist, results of the
current study are difficult to compare with other studies. Therefore, we plead for the
construction of a disease-specific instrument that represents a uniform view on the
symptomatology of gallstone disease and can be used to identify patients with a
heightened risk of negative outcomes.
Implications
The outcomes of this study may have implications for clinical practice. Hitherto,
considering the pros and cons of performing cholecystectomy, surgeons focus on
preoperative symptomatology and information of ultrasound examinations only. The
current study demonstrated that psychosocial variables, more specifically personality or
HTA, have an impact on outcome after elective cholecystectomy. Therefore, clinical and
psychological factors may be integrated to come to an improved risk estimation of
negative post-cholecystectomy outcomes. Besides known clinical risk factors, such as
the presence of preoperative dyspeptic symptoms, non-specific symptoms should be
considered as an additional risk factors of negative symptomatic outcome at six months.
Patients with HTA and non-specific symptoms should be informed about their
heightened risk on negative outcome after an elective cholecystectomy. Ideally, clinical
decision making should be based on comprehensive knowledge on personality and other
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predictors of negative post-cholecystectomy outcomes. In future, clinical decision
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Background and aim: Cholecystectomy is the standard procedure in symptomatic
gallstone disease (cholelithiasis). As many patients with cholelithiasis do not benefit
from cholecystectomy, pre-operative recognition of such high-risk patients is important.
This study aims at the identification of predictors of persisting symptoms at six months
after cholecystectomy for patients with different preoperative symptomatology.
Method: This prospective follow-up study was executed in a Dutch teaching hospital.
Consecutive patients (n = 172), age 18 - 65 years, with symptomatic cholelithiasis,
undergoing a laparoscopic cholecystectomy were investigated using self-report
symptom checklists and questionnaires. Predictors were identified using uni- and
multivariate regression analyses.
Results: At six months post-cholecystectomy, patients reporting only preoperative biliary
symptoms were most often free of symptoms (62.5%). Non-specific symptoms predicted
the report of post-operative symptoms in patients with only biliary or only dyspeptic
symptoms ((OR = 6.11, P = .043; 95% C/: 1.06 - 35.35) and (OR = 4.53, P =.002;
95% C/: 1.77 - 11.60), respectively). Persistence of the pre-existing pattern of symptoms
was predicted by the use of psychotropic medication (OR = 5.27, p = .010; 95% C/: 1.50-
18.55) and dyspeptic symptoms (OR = 16.69, P < .001; 95% C/: 4.59 - 60.68).
Postoperative biliary symptoms were predicted by High Trait Anxiety (HTA) (OR = 10.64,
P = .031; 95% C/: 1.24 - 90.96).
Conclusion: The management of cholelithiasis should be based on individual-specific
risks. Expectative management may be the first choice in patients with non-specific
symptoms, with dyspeptic symptoms only, with HTA, and in patients using psychotropic
medication.
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Introduction
Gallstone disease (cholelithiasis) is a common condition that affects 5% to 22% of the
people in Western countries" 2. Most patients are unaware of their condition" and only
10% - 30% of these patients develop clinical symptoms?", such as classical biliary colics
or other gastrointestinal symptoms. Laparoscopic cholecystectomy is the golden
standard in the management of uncomplicated symptomatic cholelithiasis. As
cholecystectomy entails the risk of peri- and early postoperative complications (0.2% -
9.4%)5, 8 and a substantial number of patients (40.4%) report negative outcome after
cholecvstectornv" 10, critical consideration of pros and cons of cholecystectomy is
required. Identification of potential predictors of negative outcomes is essential for
decision making in elective cholecystectomy.
Clinical characteristics, such as preoperative dyspeptic symptomsll-13, medication use'",
age14, 15, characteristics of preoperative pain and svmptoms= 13, 15, 16 have been
identified as associates of long- and short term post-cholecystectomy outcomes.
However, the comparability of these results is hampered as studies used different
criteria for inclusion, moments of follow-up, definitions and operationalizations of
variables and outcomes. Besides 'hard', clinical characteristics, 'soft' predictors such as
self rated health status", personality traits12, 17-19, and other psychological variables"
have been identified as predictors of negative outcomes as well. Despite the fact that
the symptomatology of cholelithiasis is ambiguous and only the minority of patients
report classical biliary colics" 21, preoperative symptoms (in combination with ultrasound
examination) are used as a reference point for diagnosis and indication of
cholecystectomy in clinical practice. Therefore, in the current study we aimed at the
identification of predictors of postoperative symptoms at six months post-
cholecystectomy for patients with different preoperative symptomatology.
Methods
Patients
Patients for the current study were recruited from the Department of Surgery of the St.
Elisabeth Hospital in Tilburg, the Netherlands. Consecutive patients (18 - 65 years) with
diagnosed symptomatic cholelithiasis, awaiting an elective laparoscopic chole-
cystectomy who visited the hospital between March 2006 and January 2008, were
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eligible for the study. Exclusion criteria were: patients with ASA III or IV, undergoing an
emergency procedure or intended open cholecystectomy, insufficient knowledge of the
Dutch language, choledocholithiasis, cholangitis, known pregnancy, known liver-
cirrhosis, history of abdominal malignancy, previous upper abdominal surgery
(precluding laparoscopic approach), and psychiatric diseases. All patients underwent a
standard surgical and anaesthetic procedure. The protocol of the study was approved by
the local ethics committee.
Procedure
Preoperatively, participation was asked during the patients' first surgical consultation at
the outpatient clinic. The surgeon introduced the study, whereas subsequently nurses
informed patients about the research procedures. Patients received the first set of
questionnaires, which also contained written information about the study, and signed
informed consent. Medical history and comorbidities were obtained from medical
records. Patients completed and returned the first questionnaires before admission for
cholecystectomy. If necessary, patients received a reminder telephone call to return the
questionnaires three to five days before the operation. Patients who returned the
questionnaires after admission were excluded from the study. At six months after
cholecystectomy, patients received the same questionnaire which could be returned in a
prepaid envelope. If needed, patients were contacted by telephone twice, usually two
and four weeks after sending the questionnaires. Patients who returned their second
questionnaire> 9 months after surgery were considered as non-responders.
Questionnaires
The demographic questionnaire was completed preoperatively and asked about sex,
age, marital status, educational level, and work. Preoperatively and at six months post-
cholecystectomy, patients completed a symptom checklist based on information from
focus groups and clinical experience. Patients should tick off whether they experienced
biliary symptoms (upper abdominal pain, nausea, vomiting), dyspeptic symptoms (bad
taste, heartburn, under abdominal pain, diarrhoea, and flatulence), and non-specific
symptoms (general malaise, fatigue, weight-change, decrease in sexual functioning, and
health complaints not mentioned in the pre-defined checklist) in the past week.
Symptoms were categorised following the study of Weinert et al.B. Furthermore,
patients indicated the nature, severity, duration, and frequency of pain during
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preoperative biliary attacks on a 100 mm. visual analogue scale (VAS) and on three
multiple choice items. All included patients had experienced biliary or dyspeptic
symptoms in medical history. After surgery, surgical reports were checked for the
presence of gallstones/ sludge and conversion to open surgery.
Patients completed the Trait scale of the State-Trait Anxiety Inventory (STAI)
preoperatively. The STAI-trait exists of 20 items with a 4 item Likert-scale reflecting the
extent of anxiety patients generally feel. The STAI Trait Anxiety measure has good three
months test-retest reliability (r = .75) and internal consistency (Cronbach's a = .84-
.92)22. Patients scoring the so" percentile or higher were indicated as patients with 'High
Trait Anxiety' (HTA), whereas patients with a score below the so" percentile were
indicated as patients with 'Non High Trait Anxiety' (NHTA).
Statistical procedure
Differences between groups of patients with preoperative biliary, dyspeptic, or a
combination of these symptoms were calculated using Chi Square tests for dichotomous
and ordinal variables and a one way ANOVA between subjects for continuous variables.
Friedman's tests were used to calculate an overall difference in symptom report
between the preoperative and the six months measurement. Changes in symptom
report across time were investigated using Wilcoxon Signed Rank tests (for ordinal
variables) and McNemar tests (for dichotomous variables). Significance was obtained
from Chi Square tests and Binominal Tests if necessary.
Persistence and emergence rates were obtained for 'any symptom'. Persistence was
defined as patients reporting the same symptom preoperatively and at six months. An
overall score was calculated for biliary, dyspeptic, and biliary/dyspeptic symptoms.
Emergence was defined as patients who did not report a symptom preoperatively, but
who did report that symptom at six months. Again an overall score was obtained for
biliary, dyspeptic, and biliary/dyspeptic symptoms.
Univariate logistic and multinominal regression analyses, taking 'symptom free' as
reference group, were performed to identify predictors of postoperative symptoms at
six months. These analyses were used for dichotomous and categorial outcomes,
respectively. Significant predictors were selected and inserted in multivariate logistic or
multinominal regression analysis (Backward procedure, Method Likelihood Ratio) to
identify independent predictors of postoperative symptom report. 'Symptom free' was
used as reference category in multinominal regression analyses. A p value < .05
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indicated statistical significance. Statistical analyses were performed using SPSS
version 16.0.
Figure 1. Flow chart of the population under study.
Meeting criteria for inclusion





Not returned preoperative questionnaire
Returned preoperative questionnaire
Ended participation within six months
Received questionnaire at six months
Not returned questionnaire at six months
Population under study
Results
I n = 3071
n 10 I
n = 281
I n = 2691
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I n = 2071
n =35 I
I n=l721
A flow-chart of the population under study is shown in figure 1. In total, 253 patients
received the first set of questionnaires, of which 172 patients returned their
questionnaires at six months after cholecystectomy (response rate 68.0%). Clinical and
demographic patient characteristics are shown in table 1. The majority of patients
(61.9%) reported both biliary and dyspeptic symptoms (Table 2). Moreover, 24.5% of the
patients only reported biliary symptoms, and 13.6% of the patients only reported
dyspeptic symptoms. In this study, groups of patients were based on the report of
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preoperative biliary symptoms (group 1), dyspeptic symptoms (group 2), or both
(group 3). These groups did not differ on any clinical or demographic characteristics.
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Secondary education (%)
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Higher professional education or university (%)
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High trait anxiety (HTA) STAI-Trait ~ P80 (%) 20.1
Six months benefit of cholecystectomy
At six months after the operation, the majority of patients had started their normal daily
activities (95.5%). Of the patients who had paid work (n = 117), 99.1% had returned to
work, whereas 0.9% of the patients had not returned to work. At six months, a
substantial group of patients still reported specific postoperative health complaints,
such as wound pain (7.2%), shoulder pain (10.1%), and pain in the upper right abdomen
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(13.7%). Six months after cholecystectomy, 47.8% of the patients were free of symptoms
(see figure 2), whereas persistence and emergence of any symptom was reported by
17.9% and 34.0% the patients, respectively. Over six months time, the number of
patients with biliary symptoms only and a combination of biliary and dyspeptic
symptoms decreased from 24.5% to 3.1% and from 61.9% to 14.3%, respectively.
However, the number of patients that reported dyspeptic symptoms increased from
13.6% preoperatively to 34.8% at six months postoperatively (see figure 2).
Patient groups were compared with regard to postoperative symptomatic outcome at
six months. Regardless of specific outcomes, the overall symptomatic outcome of
patients in group 2 differed significantly from the outcome of the other patient groups
ti = 8.30, P = .040). At six months, the three patient groups differed significantly with
regard to the report of any postoperative symptom (biliary or dyspeptic)
ti = 6.29, p = .043). Postoperative symptoms were reported by 68.4% of the patients in
group 2, whereas postoperative symptoms were reported by 37.5% and 60.2% of the
patients in group 1 and 3, respectively. Group 3 (n = 53) differed significantly from the
other two groups.
Furthermore, the groups differed significantly with respect to the persistence of the
same pattern of preoperative symptoms ti = 25.02, p < .001). Pre-existing symptoms
persisted most often in group 2 (63.2%), followed by patients in group 3 and group 1
(18.2% and 3.1% of the patients, respectively). Furthermore, preoperative groups
differed significantly regarding the development of new symptoms postoperatively
ti = 11.64, P = .003). Six months after cholecystectomy, patients in group 2 less often
developed symptoms from another category than patient in the other groups
(5.3% vs. 37.8% ti = 6.52, P = .011)). Patients in group 3 were most likely to develop
symptoms of another category, compared to patients in the other groups (42.0% vs.
24.3% ti = 4.87, P = .027)). In fact, 4.5% and 37.5% of all patients in group 3, reported
only postoperative biliary or only postoperative dyspeptic symptoms, respectively. This
implicates that preoperative biliary symptoms subsided more often. Preoperative groups
did not differ with regard to the report of postoperative non-specific symptoms.
Figure 3 gives an overview of postoperative symptoms at six months for each group.
Within each group, the number of patients reporting the prominent preoperative
symptom decreased. In group 1, a significant number of patients developed a different
pattern of complaints with dyspeptic symptoms only (p = .005). Furthermore, over six
months time, the number of patients with non-specific symptoms decreased within
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group 1 (p = .002) (figure 4). In contrast, in group 2 the number of patients with non-
specific symptoms did not decrease. In group 3, a decrease of patients with non-specific
symptoms (p < .001) and a change to individual biliary (p = .046) or dyspeptic symptoms
(p < .001) was observed at six months.
Table 2. Preoperative presentation of cholelithiasis.
Preoperative symptom report





Under abdominal pain (%)
Diarrhoea (%)
Flatulence (%)
Biliary symptoms' only (%)
Dyspeptic svmptoms" only (%)
Biliary' and dyspeptic§ symptoms (%)
Demonstrated stones or sludge (%)
Preoperative biliary attacks (M ± SO)
Pain during biliary attack
Pain in rest and movement (%) 94.3
Pain only in rest (%) 4.5















f Biliary symptoms = one or more of the following symptoms: upper
abdominal pain, nausea, and vomiting.
§ Dyspeptic symptoms = one or more of the following symptoms: bad
taste, heartburn, under abdominal pain, diarrhoea, and flatulence.
*Non-specific symptoms = one or more of the following symptoms:
general malaise (9.4%), fatigue (49.7%), weight change (2.9%)' decreased
sexual functioning (10.5%)' and other health complaints (12.3%).
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Figure 2. Report of symptoms preoperatively and at six months post-cholecystectomy.
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Predictors of six months outcome
Univariate logistic regression analyses were performed to identify predictors of the
report of (any) symptoms at six months. These results are shown in table 3. Multivariate
regression analyses demonstrated that the postoperative report of biliary and/or
dyspeptic symptoms was predicted by preoperative non-specific symptoms only
(OR = 3.06, P = .003; 95% Cl: 1.46 - 6.42). When groups of patients were investigated
separately, preoperative non-specific symptoms were the only predictor of any
postoperative symptom in group 1 (OR = 6.11, P = .043; 95% Ci: 1.06 - 35.35) and
group 2 (OR = 4.53, P = .002; 95% Ci: 1.77 - 11.60). No predictors were identified for the
report of any postoperative symptom in group 3.
Predictors of persistence of existing symptoms were investigated by univariate logistic
regression analyses (see Table 4). Multivariate logistic regression analysis demonstrated
that the use of psychotropic medication (OR = 5.27, P = .010; 95% C/: 1.50 - 18.55) and
the preoperative report of dyspeptic symptoms only (OR = 16.69, P < .001;
95% Ci: 4.59 - 60.68) were independent predictors of persisting symptoms. Univariate
and multinominal regression analyses were performed to identify predictors of
postoperative biliary symptoms, dyspeptic symptoms and a combination of biliary and
dyspeptic symptoms. Results of univariate regression analyses are shown in table 5.
Entering these predictors simultaneously in a multivariate multinominal regression
analysis demonstrated that postoperative biliary symptoms were predicted by HTA only,
whereas postoperative dyspeptic symptoms were independently predicted by
preoperative dyspeptic and non-specific symptoms. Furthermore, non-specific
symptoms and the use of psychotropic medication predicted a postoperative course
with both biliary and dyspeptic symptoms (see Table 6).
Table 3. Univariate predictors of symptom report (biliary and/or dyspeptic) at six months after
cholecystectomy.
















* p < .050 indicated significance. Significant results are reported only.
89
Chapter 5
Table 4. Univariate predictors of persistence of preoperative symptoms.
Postoperative outcome Preoperative predictor OR 95%CI P
Persistence of Dyspeptic symptoms only 12.71 4.40- 36.70 <.001*
preoperative symptoms
HTA 2.89 1.16-7.18 .023*
Number of non-specific symp. 1.50 1.02 - 2.20 .041*
Psychotropic medication 5.51 1.90-15.96 .002*
Abdominal comorbidity 2.78 1.16-6.63 .022*
* p < .050 indicated significance. Significant results are reported only.
Table 5. Univariate predictors of postoperative symptoms (category yes/no).
Postoperative outcome Preoperative predictor OR 95%CI P
Biliary symptoms only HTA 12.19 1.76- 84.30 .011*
Dyspeptic symptoms only Dyspeptic symptoms only 3.23 1.13 -9.22 .029*
Neurologic comorbidity 4.72 1.22 -18.35 .025*
Non-specific symptoms 2.11 1.04-4.26 .038*
Biliary and dyspeptic Use of psychotropic medication 9.73 2.59-36.53 .001*
symptoms
HTA 5.00 1.59-15.74 .006*
Biliary and dyspeptic symptoms 2.74 1.01- 7.42 .047*
Non-specific symptoms 8.01 2.19 - 29.33 .002*
* p < .050 indicated significance. Significant results are reported only.
Table 6. Independent predictors of postoperative symptoms (based on multivariate
multinominal regression analyses).
Postoperative outcome Preoperative predictor OR 95%CI P
Biliary symptoms HTA 10.64 1.24-90.96 .031*
Dyspeptic symptoms Dyspeptic symptoms only 5.69 1.50-21.63 .011*
Non-specific symptoms 2.50 1.10- 5.64 .028*
Biliary and dyspeptic Non-specific symptoms 9.53 1.86-48.92 .007*
symptoms
Use of psychotropic medication 8.01 1.75 - 36.75 .007*
* p < .050 indicated significance. Significant results are reported only.
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Discussion
The results of cholecystectomy can be disappointing for many patients. Currently, the
indication of an elective cholecystectomy is such that many patients are operated
without critical consideration of individual expectations and risks. At six months after
cholecystectomy, only 47.8% of the patients were symptom free. In addition, 17.9% and
34.0% of the patients reported persistence and emergence of new symptoms,
respectively. As it concerns a substantial numbers of patients, preoperative recognition
of patients with an increased risk of negative outcomes is essential to optimise the
management of cholelithiasis. The present study demonstrated that patients with
preoperative dyspeptic symptoms and patients using psychotropic medication are both
at risk of persistence of the pre-existing pattern of health complaints after
cholecystectomy. Furthermore, patients with non-specific symptoms and patients using
psychotropic medication are at risk of the experience of biliary and/or dyspeptic
symptoms at six months. Patients with High Trait Anxiety have a ten times greater
chance to experience specifically postoperative biliary symptoms.
The current study investigated six month outcomes, as the greatest improvement after
cholecystectomy is seen within this time period'", Overall, comparability of studies
focussing at approximately six months is limitedlO, 13, 15, 24, because of differences in
criteria for inclusion, designs, classification, definition and operationalisation of
outcomes, and variability in moments of follow-up. The percentage of patients who are
free of symptoms or report persisting symptoms is comparable to results of other
studies focussing at six months.'?' 13, 15. The percentage of patients who develop new
symptoms (34.0%) is higher than those percentages found in other studies {1.7% -
24.5%)10,13,15,24. This may be attributed to patients in group 3 who recover partially and
report only biliary or dyspeptic symptoms after cholecystectomy.
In the current study, dyspeptic symptoms persisted more often than biliary symptoms,
which is in line with other studies focussing at six months after cholecvstectornv'v 24.
Differentiation between patient groups showed that patients with only dyspeptic
symptoms have the worst prognosis: dyspeptic symptoms often tended to persist
(63.2%) over six months time. In patients with a combined symptom profile dyspeptic
symptoms tend to persist" and dyspeptic symptoms developed in 25% of the patients
with preoperative biliary symptoms. The latter findings support a shift towards
dyspeptic symptomatology at six months, as mentioned in previous studies": 15. This
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shift may be related to pre-existent gastrointestinal symptoms". postoperative changes
in duodenogastric reflux24, retained stones, the formation of new gallstones.", or the
impact of psychological variables such as HTA.
We found that patients with preoperative non-specific symptoms are also at risk for any
postoperative dyspeptic or combined dyspeptic and biliary symptoms. The cause of
these non-specific symptoms is unclear. Non-specific symptoms may coincide with
biliary, dyspeptic or other symptoms, or comorbid conditions. Otherwise, non-specific
symptoms may contain a more subjective component and may be influenced by
psychological variables, such as depressive symptoms or personality. Weinert et al.13
demonstrated that a subjective measure, namely self-rated preoperative health status
(SF-36) predicts outcomes at six months after cholecystectomy. However, the SF-36
contains some general items such as bodily pain, which could also be related to biliary
and dyspeptic symptoms. Therefore, we believe that a parsimonious list of non-specific
symptoms may be more precise and better differentiates general symptoms from pure
biliary and dyspeptic symptoms. Although preliminary results suggest that patients with
non-specific symptoms are at risk of negative post-cholecystectomy outcomes, further
research needs to corroborate this finding and to address the issue of subjectivity.
As persistent biliary symptoms are decisive for the subjective perception of a successful
procedure", special attention needs to be paid to patients with HTA, who are at risk to
report persisting biliary symptoms at six months post-cholecystectomy. So far, HTA has
been identified as a potential predictor of short-term post-cholecystectomy outcomes
only26. 27. Patients with HTA are predisposed to react with heightened anxiety to
threatening situatlons/", and may misinterpret a broad range of gastrointestinal
symptoms as being of biliary nature. Misinterpretations may be mediated by the fact
that HTA patients have higher pain sensitivitl9 and experience more gastrointestinal
symptoms than other patlents'", Because of these characteristics, HTA patients may be
easily misdiagnosed as suffering from cholelithiasis and abusively be subjected to
cholecystectomy. Consequently these patients will report persistence of pre-existing
symptoms. Possibly, psychosomatic mechanisms typically for HTA patients, such as
heightened activity of the sympathetic nervous system" and production of higher levels
of noradrenaline ", may influence digestion, wound healing or other bodily processes,
which could be related to the experience of pain after removal of the gallbladder. The
role of HTA on long-term post-cholecystectomy outcomes and underlying mechanisms
should be further corroborated in future research.
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The present study has several strengths, such as the prospective design and the
participation of consecutive patients, which prevents a selection bias. In contrast to
other studies" 13, 15, 24, we used strict criteria for inclusion of patients, such as
symptomatic cholelithiasis, ASA I and II, limited age differences, indicated for elective
cholecystectomy only, and used a big sample size (n = 172). Follow-up was limited to the
period of 6 to 9 months postoperatively. These conditions create a homogenous sample,
which enables strong conclusions which are applicable to the field of action where
critical consideration matters most: elective surgery. Another advantage of the study is
the fact that clinical presentation of preoperative symptoms was used as a basis for
further investigation of predictors. This enlarges the specificity of the predictors for
cholelithiasis and enables the clinical application of the results. The fact that we
dichotomised many variables (yes/no) enhances the convenience to apply our findings in
surgical practice. On the other hand, it entails the risk of oversimplification of our
conclusions.
Other limitations of the study are the fact that we used a self-constructed symptom
checklist, instead of a standardised gastrointestinal questionnaire. We found it
legitimate to use such a checklist, because we carefully based our symptom checklist on
information from focus groups, other symptom checklists, and clinical experience.
Currently no disease specific symptom checklist exists for cholelithiasis. The fact that we
used broad symptom categories, according to a leading article of Weinert et al.13,
increased the comparability to this study in particular. However, as categorising
symptoms into biliary or dyspeptic symptoms is highly arbitrarily, comparability with
other studies might be hampered. Given the ambiguous clinical presentation of
cholelithiasis and the vague diagnostic criteria, classification of symptoms as being
purely biliary or dyspeptic in nature seems to be extremely difficult. Furthermore, this
study has the disadvantage that we have two separate measures, at baseline and at
follow-up at six months. Therefore the study does not differentiate between the
persistence of symptoms and the development of symptoms after initial disappearance
after cholecystectomy. Comparing findings shortly after cholecystectomy (e.g. six weeks)
with findings at six months may convey the course of symptoms over time. Finally, in the
current study we did not control for confounding postoperative variables, such as
comorbid diseases and major life events. Therefore, results at six months may be




The results of the present study may have implications for the management of
symptomatic cholelithiasis. Surgeons should be aware that less than half of their
patients are free of symptoms at six months after cholecystectomy. Patients should be
informed about the considerable risk of persistent and developing symptoms at six
months. Generally, cholecystectomy is used to prevent further episodes of biliary colics
and compllcattons", whereas expectative management is often disregarded. The use of
ursodeoxycholic acids (in combination with lithotripsy) remains a matter of debate ". If
treated expectatively, the risk of complications such as acute cholecystitis, acute
pancreatitis, or biliary duct obstruction is small (1% - 2% a year)34, 35 and biliary pain
recurs only in 31% of the patients with previous biliary attacks > 1 year36. Most
interesting is that over a period of five years, pain reduction, the rate of complications,
and improvements of quality of life (QoL) are equal for expectative management and
cholecystectomy. Starting expectatively, only 23% - 49% of the patients underwent
cholecystectomy because of recurred pain and complications within 2.5 - 5 years23,37.As
expectative management is safe and offers a good prospective in cholelithiasis, it should
be a preferred treatment to start with in patients with a high risk of postoperative
symptoms.
Recognition of high risk patients is crucial to gear the treatment to the patient's
characteristics. In patients with classical biliary symptoms (alone or together with
dyspeptic symptoms), surgeons should be attentive to non-specific symptoms during
anamnesis. In patients using psychotropic medication and patients reporting dyspeptic
symptoms only, wait-and-see should be considered as the treatment of choice. Limiting
our recommendations to the persistence of biliary symptoms, which are most indicative
of a successful procedure, patients with HTA should be treated alternatively or at least
be informed about their heightened risk. Alternatively, psychotherapeutic interventions
stemming from cognitive behavioural therapy or mindfulness may teach patients how to
deal with anxiety provoking situations and may reduce stress in HTA patients.
Consequently, the negative influence of HTA may be reduced and postoperative
symptomatic outcomes may be improved. Summarised, in cholelithiasis surgeons should
offer patients a treatment which is based on individual risks and expectations. Hopefully,
the rate of unsuccessful treatments will be reduced, which will lead to greater cost-
efficiency in health care.
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Background: Many patients report persisting symptoms after cholecystectomy. The aim
of this study is to examine symptomatic outcome and overall QoL one year after
cholecystectomy and to identify predictors for these outcomes.
Method: This prospective follow-up study was conducted in a teaching hospital in the
Netherlands. Consecutive patients (n = 156), age 18 - 65 yrs, diagnosed with
uncomplicated symptomatic gallstone disease, awaiting an elective cholecystectomy,
were included in this the study. Cholecystectomy was performed under a standard
anaesthetic regime. Predictors of symptomatic outcome (i.e. 'free of symptoms', 'biliary
symptoms only', 'dyspeptic symptoms only', and 'biliary and dyspeptic symptoms') and
QoL were investigated one year after cholecystectomy.
Results: Patients with different preoperative symptoms (biliary symptoms, dyspeptic
symptoms or a combination of both) showed different symptomatic improvements one
year after cholecystectomy. Preoperative non-specific symptoms predicted the report of
biliary and dyspeptic symptoms at one year (OR = 2.63, 95% C/: 1.03 - 6.70). In the
course of one year, overall QoL improved in patients with biliary symptoms only and a
combination of biliary and dyspeptic symptoms. Patients with dyspeptic symptoms only
showed no improvement in overall QoL. Overall QoL at one year is predicted by the
preoperative clinical picture (6 = - .24), abdominal comorbidity (6 = - .33) and high trait
anxiety (6 = - .43).
Conclusions: The clinical presentation of gallstone disease has an impact on symptomatic
outcome and overall QoL at one year. Preoperative symptoms and other risk factors of
low improvements in symptoms and overall QoL should be considered, to aim at an
optimal treatment for each patient. Clinical decision making in gallstone disease should
focus on improvements in overall QoL instead of symptoms.
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Introduction
In the Western world up to 22% of all individuals suffer from gallstone disease
(cholellthlasisj'". A relatively small percentage of these patients (10 - 30%) develop
clinical significant symptoms, varying from classical biliary colics to a chronic pattern of
dyspeptic symptoms, in which case removal of the gallbladder (cholecystectomy) is
indicated4-7• Guidelines recommend the use of additional ultrasonography to detect
gallstones. However, it often remains uncertain whether abdominal pain is purely
related to demonstrated gallstones. Nevertheless, cholecystectomy is the golden
standard and thus the most frequently used treatment. Alternative treatment options or
conservative management are considered in high-risk surgical patients only.
Many patients, percentages mount from 13% to 44% of all patients8-13, report persisting
symptoms and pain regardless of treatment. Research has identified several risk factors
of negative outcomes. Clinical characteristics, more specifically dyspeptic symptoms14-16
and preoperative pain14, 16-18, preoperative medication use", and age18 are associated
with short- and long term outcomes after cholecystectomy. In the realm of psychological
characteristics, self-rated health status14, personality traits16, 19, and other psychological
vartables '" 19,20 are considered to have an impact on post-cholecystectomy outcomes.
However, these predictors have not found their way to clinical practice and seldom lead
to changes in decision making. So far, Quality of Life (QoL), which is a subjective
measure, has not been investigated as an outcome after cholecystectomy. Predictors of
post-cholecystectomy QoL are unknown.
The purpose of the present study was to investigate symptomatic outcome and overall
QoL at one year after cholecystectomy, taking the clinical picture of gallstone disease as
a starting point. Another aim of the study was to identify predictors of symptomatic
outcome and overall QoL at one year after cholecystectomy.
Methods
Patients
Patients were recruited from the Department of Surgery of the St. Elisabeth Hospital in
Tilburg, the Netherlands. Consecutive patients (18 - 65 years) with diagnosed
symptomatic cholelithiasis, visiting the hospital between March 2006 and January 2008,
who awaited an elective laparoscopic cholecystectomy, were eligible for the study.
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Exclusion criteria were: patients with ASA class III or IV, undergoing an emergency
procedure or intended open cholecystectomy, insufficient knowledge of the Dutch
language, choledocholithiasis, cholangitis, known pregnancy, known liver-cirrhosis,
history of abdominal malignancy, previous upper abdominal surgery (precluding
laparoscopic approach), and psychiatric diseases. All patients underwent a standard
surgical and anaesthetic procedure. The protocol of the study was approved by the local
ethics committee.
Procedure
Preoperatively, participation was asked during the patients' first surgical consultation at
the outpatient clinic. The surgeon introduced the study, whereas subsequently nurses
informed patients about the research procedures. Patients received the first set of
questionnaires, which also contained written information about the study, and signed
informed consent. Medical history and comorbidities were obtained from medical
records. Patients completed and returned the first questionnaires before admission for
cholecystectomy. If necessary, patients received a reminder telephone call to return the
questionnaires three to five days before the operation. Patients who returned the
questionnaires after admission were excluded from the study. At six months after
cholecystectomy, patients received the same questionnaire which could be returned in a
prepaid envelope. If needed, patients were contacted by telephone twice, usually two
and four weeks after sending the questionnaires. Patients returning their second
questionnaire> 15 months after surgery were considered as non-responders.
Questionnaires
The demographic questionnaire was completed preoperatively and asked about sex,
age, marital status, educational level, and work. Preoperatively and at one year after
cholecystectomy, patients completed a symptom checklist based on information from
focus groups, literature and clinical experience. Patients should tick off whether they
experienced biliary symptoms (upper abdominal pain, nausea, vomiting), dyspeptic
symptoms (bad taste, heartburn, under abdominal pain, diarrhoea, and flatulence), and
non-specific symptoms (general malaise, fatigue, weight-change, decrease in sexual
functioning, and health complaints not mentioned in the pre-defined checklist) in the
past week. Symptoms were categorised following the study of Weinert et a1.14. All
included patients had experienced biliary or dyspeptic symptoms in medical history.
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Preoperatively and at one year, patients reported medication use by indicating the dosis
and name of medications.
Patients completed the trait scale of the State-Trait Anxiety Inventory (STAI)
preoperatively. The STAI-trait exists of 20 items with a 4-item Likert-scale reflecting the
extent of anxiety patients generally feel. The STAI Trait Anxiety measure has good 3
months test-retest reliability (r = .75) and internal consistency (Cronbach's a = .84 -
.92)21. Patients scoring the so" percentile or higher were indicated as patients with 'High
Trait Anxiety' (HTA), whereas patients with a score below the so'' percentile were
indicated as patients with 'Non High Trait Anxiety' (NHTA).
Preoperatively and at one year patients completed the World Health Organization
Quality of Life (WHOQOL)-BREF, which has been developed from the WHO definition of
QoL as ' an individual's perceptions of their position in life in the context of the culture
and value systems in which they live and in relation to their goals, expectation,
standards and concems' ". The WHOQOL-BREF has adequate to moderate internal
consistency (Cronbach's a = .68 - .80) and adequate test-retest reliability (r = .71- .91)23,
24. The WHOQOL-BREF originally comprises 26 items with a 5-point Likert-scale,
representing different domains of the patient's quality of life (QoL). Two items referring
to overall QoL and general health were used in this studv".
Statistical procedures
Differences between participants and non-participants were investigated using Chi
square tests (with Yates' Continuity Correction and Fisher Exact Test if necessary) and
Students t-tests. Patients with different preoperative characteristics were categorized in
three groups. Pre- and postoperative outcomes were investigated separately for
patients with preoperative biliary symptoms only (group 1), preoperative dyspeptic
symptoms only (group 2), and preoperative biliary and dyspeptic symptoms (group 3).
Pre- and postoperative differences between the groups were initially investigated by
Kruskal-Wallis tests and one-way independent ANOYA's (post-hoc tests using Tuckey
HSD tests and planned comparisons if possible). Paired samples t-tests and Wilcoxon
Signed Ranks Tests were used to calculate changes over time for continuous and
categorical variables, respectively. Repeated measure ANOYA was used to examine
changes in the number of symptoms in the course of one year.
Univariate and multivariate logistic regression analyses were performed to identify
predictors of several outcomes at one year, namely 'free of symptoms', 'only biliary
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symptoms', 'only dyspeptic symptoms', 'biliary and dyspeptic symptoms', and QoL. Sex,
age, medication use, frequency of biliary attacks, pain during biliary attacks, non-specific
symptoms, HTA, and preoperative patient groups were investigated as univariate
predictors of one year symptomatic outcomes after cholecystectomy. To optimize
clinical application, preoperative patient groups were inserted as dichotomous items
(yes/no). Significant univariate predictors were entered simultaneously in multivariate
logistic regression analyses (Method enter). If two overlapping items, such as presence
and number of symptoms, were both significant univariate predictors, the dichotomous
item was selected as predictor in the multivariate regression analyses. To facilitate
interpretation, outcome variables were recoded if odds ratios were < 1.0.
Univariate linear regression was used to identify possible predictors of overall QoL and
general health at one year. Independent predictors of overall QoL at one year after
cholecystectomy were identified using multiple regression (Method Enter).
Figure 1. Flow chart of the population under study.
Meeting criteria for inclusion
Missedat the outpatient clinic
Expectative management




Not returned preoperative questionnaire
Returned preoperative questionnaire
Endedparticipation within a year
Receivedquestionnaire at one year
Not returned the questionnaire at one year
Population under study
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Results
Preoperative symptoms
Preoperatively, 266 patients were approached for study, of which 250 patients received
the first questionnaire. At one year follow-up, 156 participants completed the
questionnaire (response rate 62.4%). A flow chart of the population is shown in figure 1.
The only difference between patients that ended participation or did not return the
second questionnaire and participants concerned biliary attacks. Participants reported
more preoperative biliary attacks (6.07 ± 8.53 vs. 3.75 ± 3.70; t = 2.65, P = .009), than
non-responders and patients that ended participation. Demographic and clinical
characteristics of the sample are shown in table 1.
Preoperatively all patients reported symptoms: 24.3% reported biliary symptoms only
(groupl), 14.7% reported dyspeptic symptoms only (group 2), and 61.0% of the patients
biliary and dyspeptic symptoms (group 3) (see Table 2). HTA was represented equally in
the three groups. The patient groups differed with respect to the number of
preoperative non-specific symptoms reported (F = 5.45, P = .005). Patients in group 3
reported most non-specific symptoms (p = .006), whereas patients in group 1 reported
fewest non-specific symptoms (p = .039). Preoperatively, patient groups did not differ
with respect to overall QoL and general health (F = 2.76, P = .067).
Postoperative symptoms
Postoperative outcomes for the sample are shown in table 2. Overall, 50.0% of all
patients were free of symptoms at one year after cholecystectomy. At one year the
three groups differed with respect to the report of heartburn (Kruskal Wallis 1= 6.64,
P = .036) and the number of biliary symptoms (F = 5.45, P = .005). With regard to broad
symptomatic outcomes, in comparison with the other two patient groups, patients in
group 1 were most often relieved of symptoms at one year (66.7% vs. 44.7%,1 = 4.00,
p = .045), whereas patients in group 2 were most likely to report only dyspeptic
symptoms one year after cholecystectomy (72.7% vs. 38.6%; 1= 3.08, P = .050). In
addition, patients in group 1 reported less non-specific symptoms than patients in the
other groups (p = .006), whereas patients in group 2 reported less biliary symptoms than
patients in the other groups (p = .018). At one year, patients in group 3 reported a
greater number of biliary and non specific symptoms than the other patients did
((p = .012) and (p = .012), respectively). At one year after cholecystectomy, medication
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use had not changed for patients in groups 1 and 2, whereas the use of other than
analgesic and psychiatric medication has increased significantly in group 3 (Z = - 3.21,
P = .001).
One year after cholecystectomy overall QoL and general health differed between the
patient groups (F = 4.75, P = .0lO). Patients in group 1 reported higher overall QoL than
patients in group 2 and 3 ((p = .046) and (p = .012), respectively). Postoperative QoL did
not differ between patients in group 2 and 3 (p = .951).
Table 1. Demographic and clinical characteristics ( n = 155).
Demographic characteristics
Female patients (%)
Age (M ± 50)
Highest level of education
Primary or lower vocational education (%)
Secondary education (%)
Higher education (%)
Higher professional education or university (%)
Working under payment (%)
Marital status
Single (%)
Widowed or divorced (%)
Married or cohabitant (%)
Comorbidities
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Table 2. Pre- and postoperative disease-specific characteristics.
Disease-specific characteristics Preoperatively Postoperatively Z p
Free of symptoms (%) 0.0 50.0 -8.25 <.001*
Biliary symptoms only (%) 24.3 8.3 -.47 .67
Upper abdominal pain (%) 68.8 21.2 -8.27 <.001*
Nausea (%) 40.0 9.0 -6.20 <.001*
Vomiting (%) 18.1 2.6 -4.24 <.001*
Dyspeptic symptoms only (%) 14.7 25.0 -3.80 <.001*
Bad taste (%) 19.4 7.1 -3.41 .001*
Heartburn (%) 26.5 16.7 -2.53 .011*
Under abdominal pain (%) 20.0 12.2 -1.95 .052
Diarrhoea (%) 18.7 10.3 -2.34 .020*
Flatulence (%) 36.8 22.6 -2.78 .005*
Combination of biliary and dyspeptic 61.0 16.7 -3.77 <.001*
symptoms (%)
Non-specific symptoms* (%) 61.0 33.0 -4.59 <.001*
Self-reported medication use
Analgesics (%) 34.8 30.4 -1.88 .061
Psychotropic medication (%) 9.7 17.9 .00 1.00
Other medication (%) 49.7 85.1 4.59 <.001*
M ±SD M±SD P
Number of symptoms reported
Number of biliary symptoms 1.27 ± .97 .32 ± .64 10.70 <.001*
Number of dyspeptic symptoms 1.20 ± 1.14 .69 ± .98 4.52 <.001*
Number of non-specific symptoms .86 ± .96 .48 ± .81 4.13 <.001*
General QoL and general health 7.21 ± 1.69 7.78 ± 1.64 -4.35 <.001 *
*Non specific symptoms = one or more of the following symptoms general malaise, fatigue, weight
change, decreased sexual functioning, and other health complaints.
* p < .050 indicated statistical significance.
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Benefit from cholecystectomy at one year
Overall, patients benefited from cholecystectomy in terms of a significant decrease of
symptoms (see Table 2). In the course of one year after cholecystectomy, the use of
analgesics and psychotropic medication did not change, whereas the use of other
medication increased significantly. Differential benefits for patients within the
preoperative patient groups are shown in table 3.
Changes in overall QoL and general health over time for different patient groups are
shown in figure 2. Patients in group 1 and group 3 reported an improvement of overall
QoL (F = 7.20, P = .012; £2 =.19) and (F = 13.52, P < .001; £2 = .14). Patients in group 2 did
not report an increase in QoL (p = .078). With respect to QoL, repeated measure ANOVA
demonstrated a main effect for time (F = 9.40, P = .003; £2 = .07) and preoperative
category (F = 5.14, P = .007; £2 = .07), but no interaction effect for time * preoperative
category (p = .31). Overall QoL and general health changed over one year time and
differed between patients in different groups. However, the observed changes in QoL
over time were equal for the different patients groups.
Table 3. Changes in symptom report in the course of one year after cholecystectomy.
Group 1 Group 2 Group 3
Z P Z P Z P
Biliary symptoms
Upper abdominal pain -5.20 <.001* - 1.00 .317 • -6.86 <.001*
Nausea -3.46 .001* .00 1.000 • -5.31 <.001*
Vomiting -1.89 .059 .00 1.000 • -3.80 <.001*
Dyspeptic symptoms
Bad taste 1.00 .317 • -2.00 .046* • -3.40 .001*
Heart burn 1.00 .317 -1.41 .157 • -2.87 .004*
Under abdominal pain 1.73 .083 -1.27 .206 • -2.71 .007*
Diarrhoea 1.41 .157 -1.34 .180 • -2.96 .003*
Flatulence 0 2.65 .008* • -2.11 .035* • -4.23 <.001*
Non-specific symptoms • -2.89 .004* -1.51 .132 • -3.55 <.001*. decrease of symptoms 0 emergence of symptoms
- no change p < 0.050 indicated statistical significance
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Preoperatively At one year
Overall QoL
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Prediction of postoperative outcomes
Table 4 shows univariate predictors of the postoperative outcomes 'free of symptoms',
'biliary symptoms only', 'dyspeptic symptoms only', 'biliary and dyspeptic symptoms'.
No univariate predictors could be identified for the outcome of both biliary and
dyspeptic symptoms at one year. The univariate predictors were simultaneously entered
for each postoperative outcome. Since the variables 'non specific symptoms' (yes/no)
and 'number of non specific symptoms' were both univariate predictors, the former was
chosen. Multivariate logistic regression (Method Enter) identified only one independent
predictor for the outcome 'free of symptoms'. Patients with preoperative nonspecific
symptoms had a smaller chance to be free of symptoms (OR = .21, P = .02; 95% C/: .14-
.86), or alternatively patients with non-specific symptoms have a greater risk to report
biliary and dyspeptic symptoms at one year post-cholecystectomy (OR = 2.63, P = .043;
95% C/: 1.03 - 6.70). No multivariate predictors could be identified for other post
operative outcomes.
Predictors of overall QoL and general health at one year were identified by univariate
linear regression analyses. QoL was predicted by HTA (8 = - AD, P < .001), number of
non-specific symptoms (8 = - .22, P = .007), number of dyspeptic symptoms (8 = - .35,
P < .001), preoperative patient group (8 = - .23, P = .009), only biliary symptoms (8 = .26,
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p = .003), neurological comorbidity (6 = - .22, p = .019), abdominal comorbidity (6 = - .23,
p = .014), and other comorbidities (6 = - .21, P = .026). Predictors were entered
simultaneously in a multivariate linear regression with QoL at one year as outcome.
Because of high correlations (r = - .91, P < .001) between 'patient group' and 'biliary
symptoms only (yes/no), the latter variable was not entered in multivariate analyses.
HTA (6 = - .43), patient group (6 = - .24), and abdominal comorbidity (6 = - .33) predicted
overall QoL at one year after cholecystectomy (see Table 5).
Table 4. Univariate predictors of postoperative symptomatic outcomes at one year after
cholecystectomy.
Postoperative outcomes Predictors OR 95%CI P
Free of symptoms Only preoperative biliary 2.48 1.09 - 5.64 .030*
symptoms
Cardiovascular comorbidity .36 .13- .93 .030*
Non-specific symptoms (yes/no) .35 .18 - .67 .002*
Number of non-specific .62 .43- .89 .009*
symptoms t
HTA .31 .13 - .73 .007*
Only biliary symptoms
Only dyspeptic symptoms Only dyspeptic symptoms 4.24 1.02 -17.73 .048*
Preoperative use of analgesics .31 .12 - .80 .015*
Biliary and dyspeptic symptoms -
* p < .050 indicatedstatisticalsignificance.Significantresultsare reported only.
t 'Number of nonspecificsymptoms'wasnot selectedaspredictor in multivariate logisticregression
Table 5. Multivariate predictors of overall QoL and general health at one year.
Predictor 6 p Adjusted If F P
HTA -.43 <.001*
Patient group -.24 .033*
Number of non specific symptoms .03 n.s.
Number of dyspeptic symptoms -.01 n.s.
Abdominal comorbidity -.33 .001*
Neurological comorbodity -.14 n.s.
Other comorbidities -.16 n.s. .38 7.46 <.001*
* p <.050 indicatedstatisticalsignificance.
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Discussion
Results of cholecystectomy can be disappointing, as clinical decision making is
insufficiently tuned to profiles of individual patients. Patient groups based on the clinical
picture of gallstone disease showed different patterns of postoperative recovery.
Patients with preoperative biliary symptoms only (group 1) were most often free of
biliary and dyspeptic symptoms and reported higher overall QoL and general health at
one year. At one year, patients with a combination of preoperative biliary and dyspeptic
symptoms (group 3) reported most biliary and non-specific symptoms and increased
medication use. In the course of one year, overall QoL improved in groups 1 and 3, but
not in group 2. Furthermore, preoperative biliary and/or dyspeptic symptoms were not
identified as independent predictors of the relief of abdominal symptoms at one year.
Patients without non-specific symptoms had a threefold chance to be free of symptoms.
In addition, clinical presentation of gallstone disease as well as trait anxiety and
abdominal comorbidity had an impact on overall QoL and general health at one year.
Comparison with literature
In the course of one year after cholecystectomy, the report of biliary and dyspeptic
symptoms, with exception of lower abdominal pain, decreased. Although 50.0% of the
patients are free of symptoms at one year, the prevalence of abdominal symptoms in
the sample is higher than the prevalence in the healthy population (21% _ 25%)26. 27.
However, findings of the current study indicate that symptomatic improvements are
highly dependent on preoperative symptomatology. Patients in group 1 are most often
free of symptoms at one year. Patients in group 2 show minimal improvements of
preoperative symptoms (bad taste and flatulence only), whereas patients in group 3
show improvements of practically all biliary and dyspeptic symptoms. In contrast, other
studies do not find differential benefits between pre-defined patient groups, such as
patients with severe vs. mild biliary svmptoms ", or dyspeptic pain symptoms and biliary
pain symptoms". The choice of characteristics for stratification may be decisive for the
usefulness of group differences. We believe that the most simple model, that is able to
differentiate in a meaningful way between patients, should be preferred.
With respect to flatulent dyspepsia which often persists and develops de novo after
cholecvstectornv'" 12, 17, 18,28,29, a differential symptomatic outcome is found for groups
with other preoperative clinical presentations. In group 1 a significant group of patients
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developed flatulence after cholecystectomy, whereas a decrease of patients reporting
flatulence was observed in group 2 and 3. Furthermore, non-specific symptoms, which
were most prevalent in group 3, decreased in groups 1 and 3, but not in the group
patients with dyspeptic symptoms only (group 2). Several studies, investigating 12 - 19
months outcome after cholecystectomy, indicated that symptomatic outcome after
cholecystectomy could not be predictedi" 17. However, our findings suggest that
prediction of post-cholecystectomy outcomes is possible and patients with non-specific
symptoms have a smaller chance to be free of symptoms at one year. Possibly, a
heightened sensitivity for general somatic symptoms or visceral pain, may be the
underlying cause of the experience of biliary and dyspeptic symptoms in patients with
non-specific symptoms. Additional investigation of the pathology of gastrointestinal
symptoms in these patients should clarify, whether biliary or dyspeptic complaints are
the most outstanding symptom in the clinical picture.
With respect to the subjective experience of patients, differential improvements in
overall QoL were found. Across time a large improvement of overall QoL was found in
groups 1 and 3, whereas patients in group 2 did not report an improvement in QoL. As
other studies used visual analogue scales to get an impression of the postoperative
satisfaction 30 or rated the successfulness of their surgical procedure on self-constructed
4 or 5 point scales": 31, comparability of findings is limited. Our findings indicated that
patient group and abdominal comorbidity were found to be predictive of overall QoL
and general health. This may be in accordance with colicky upper abdominal pain, and
steady non-colicky abdominal pain that were found to predict patient satisfaction in
another studlo. Other studies also identified preoperative health status, physical
functioning, longer symptom duration, and Chronic Obstructive Pulmonary Disease as
predictors of satlsfacticn": 30. In line with results of QoL in irritable bowel svndrorne "
and breast cancer patlents ", the current study identified HTA has a negative impact on
overall QoL at one year.
Recommendations for future research
To investigate pitfalls in clinical decision making in cholecystectomy, comparison of
postoperative symptomatic outcomes and QoL measures may be interesting for further
study. A review on QoL after laparoscopic surgery recommends the use of a generic and
disease-specific HRQoL measure at one and six months". The Short Form 36 Health
Survey (SF-36), the Psychological General Well-Being Index (PGWB) and the
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Gastrointestinal Quality of Life Index (GIQLI) are recommended as measures. However,
these are measures for psychological wellbeing and health status only, whereas a QoL
instrument, such as the WHOQOL, not only inquires into patients physical, psychological,
and social functioning, but also patients' (dis)satisfaction with that functloning '" 36 37.
Therefore, future studies should investigate QoL as the subjective evaluation of post-
cholecystectomy outcomes. Moreover, the current study demonstrated that non-
specific symptoms predict abdominal symptoms at one year. The relationship between
non-specific symptoms, such as general malaise, fatigue, weight change and decreased
sexual functioning, and the continued experience of gastrointestinal symptoms should
be further examined. Furthermore, the impact of HTA on postoperative recovery should
be examined in other syndromes than gallstone disease.
Strengths and weaknesses
The present study has several strengths compared with previous studies. It has a
prospective design and consecutive patients were included in order to prevent as much
as possible a selection bias. Possible differences between participants and dropouts
were examined to contribute to maximum generalizability of outcomes. However, some
bias may still exist as this is a single centre study. Furthermore, the current study
investigated postoperative outcome using self-reported pre- and postoperative
symptoms. Although one study showed that only physician-derived information led to
valuable predtctors", we considered the patient's experience as leading. As a recent
study demonstrated that physicians underestimate the number and severity of
gastrointestinal symptoms in patients'", we believe that self reports optimally reflect the
experience of patients. Furthermore, patients were categorised in three groups based
on these self-reported symptoms. A point of criticism may be that nuances may be lost
by categorisation. On the other hand, the use of categories enhances the clinical
applicability of the results. Finally, the addition of two short evaluative questions
indicating overall QoL, that correlate highly with general health in breast cancer
survivors ", gives this study additional value over studies measuring only symptomatic
improvement. As QoL and health status represent the patients' well being from a
different perspective, it has been recommended to use both measures in clinical
decision making ". However, it should be acknowledged that the current study can only
give an indication of QoL, which is not comparable with a full QoL measurement. We
recommend further elaboration of QoL measurements after cholecystectomy.
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Implications for clinical practice
The results of this study teach us that close attention should be paid to the clinical
picture of gallstone disease, as it gives valuable information for clinical decision making.
From the perspective of patient-centered care, patients with different profiles demand a
different approach. Although it is often claimed that cholecystectomy is beneficial for
both patients with biliary and patients with dyspeptic symptoms, our results show that
only patients with purely biliary symptoms should be operated right away. In patients
with a combination of biliary and dyspeptic symptoms, cholecystectomy should be
considered critically, especially in patients who report many non-specific symptoms.
Conservative treatment should be considered in patients with dyspeptic symptoms only,
as they show minimal symptomatic benefit and no improvement in QoL after chole-
cystectomy. Although cholecystectomy is often thought inevitable, risk of postoperative
complications such as acute cholecystitis, pancreatitis, or biliary duct obstruction is
actually quite small {1%-2% a year)39,40. Besides, after a first biliary attack, only one third
of the patients experiences a new attack within a vear'", Furthermore, physicians should
also consider other than abdominal symptoms. The fact that non specific symptoms are
identified as the sole predictor of abdominal symptoms at one year, makes clear that the
scope of physicians should be broadened from gallstones to the patient as a whole, with
his/her abdominal symptoms, non-specific symptoms, and eventually psychological risk
factors. Findings of the study also imply that the patient's subjective evaluation of life
should be at the core of a patient-centred approach. Information of patients should be
tailored to the individual patient's profile and based on improvements of QoL. The
preoperative clinical picture has an effect on QoL, as patients with biliary symptoms only
experience best QoL postoperatively. Furthermore, HTA and abdominal comorbidity
have a negative impact on QoL. Instead of symptomatic outcome, QoL should be taken
as a starting point for clinical decision making in cholecystectomy. As cholecystectomy is
an elective procedure, the performance should be considered in terms of gain of QoL,
based on the patient's clinical picture. Optimally, clinical decision making in elective
cholecystectomy should be a collective choice of the doctor and patient, instead of a
case of doctors only. Changing common practice in gallstone disease will eventually lead
to a decrease of unsuccessful cholecystectomies in patients with atypical biliary
symptoms, and eventually to greater cost-effectiveness.
In conclusion, preoperative symptoms are relevant for clinical decision making, as
patients with only biliary symptoms show the best symptomatic and QoL outcomes at
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one year. Cholecystectomy is not beneficial for patients with only dyspeptic symptoms,
as they experience minimal symptomatic improvements and no improvement in QoL
across time. Overall, patients with non-specific symptoms have a greater risk of negative
symptomatic outcome, whereas patients with HTA and abdominal comorbidity have a
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Purpose: Removal of the gallbladder (cholecystectomy) is considered as the golden standard
in gallstone disease. The aims of the current study are to investigate changes in quality of life
(QoL) and to identify predictors of QoL one year after cholecystectomy.
Methods: Consecutive patients (n = 142), age 18 - 65 yrs, with uncomplicated symptomatic
gallstone disease, awaiting an elective cholecystectomy, completed a symptom checklist and
psychological questionnaires (WHOQOL-BREF, STAI, CES-D, FAS), pre-operatively, six weeks,
and one year after surgery.
Results: One year after cholecystectomy, QoL had improved (E2 = .04 - .35) in all domains
except Social Relationships. This improvement was reached within the first six weeks after
surgery. Preoperative fatigue (6 : - .23 to - .45) and trait anxiety (6: - .30 to - .48) were the
strongest predictors of QoL at one year. Fatigue (6 : - .21 to - .30) and trait anxiety (6 = - .30)
had a negative impact on improvements in QoL, whereas depressive symptoms had a
positive impact on QoL (6 = .59).
Conclusion: Cholecystectomy results in improvements in QoL. Negative effects of
psychological risk factors on QoL may be minimised by psychological interventions.
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Introduction
Gallstone disease is a common condition which affects 5% to 22% of all people in Western
countrtes!". However, gallstone disease often remains clinically undiagnosed as only 10% -
30% of all patients experience svmptoms'i", such as upper abdominal pain or dyspeptic
symptoms. Elective cholecystectomy, or surgical removal of the gallbladder, is the treatment
of choice in uncomplicated symptomatic gallstone disease. However, 13% - 44% of the
patients report negative outcomes after cholecystectomy, such as persisting symptoms and
pain8.B. Studies who attended the patient's subjective experience after cholecystectomy
found high rates for patient satisfaction (96.8% - 97.6%)14, 15and improvements of Health
Related Quality of Life (HRQoL)16.19. However, all studies measured HRQoL, which is the
impact of gallstone symptoms on life, and did not measure Quality of Life (QoL), which is a
subjective evaluation of the individual's health status, psycho-social status, and other
aspects of life (World Health Organization). With regard to the issue of patient centered
care, QoL measures should be preferred above HRQoL.
Insight in risk factors of negative outcomes or dissatisfaction after cholecystectomy is
important to establish a patient tailored approach and inform patients adequately about
individual-specific risks. Both cllnlcal'" 20·22and psychological factors/" 23-25are found to
predict objective health outcomes after cholecystectomy. However, predictors of subjective
outcomes are less understood. One study found that asymptomatic patients with high
surgical risks were at risk of worse improvement of HRQoL three months after
cholecvstectomv"', Another study found that good, fair or poor preoperative health status,
worse physical functioning, symptom duration> 6 months, and previous episode of chole-
cystitis predicted an unsuccessful outcome after cholecvstectomv", However, the impact of
psychological factors on QoL outcomes after cholecystectomy has not been examined so far.
Therefore, the objectives of this study were to investigate changes in QoL within one year
after cholecystectomy and to identify clinical and psychological predictors of QoL.
Methods
Patients
Patients were recruited from the Department of Surgery of the St. Elisabeth Hospital in
Tilburg, the Netherlands. Consecutive patients (18 - 65 years) with diagnosed symptomatic
cholelithiasis, awaiting an elective laparoscopic cholecystectomy who visited the hospital
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between March 2006 and January 2008, were eligible for the study. Exclusion criteria were:
patients with ASA III or IV, undergoing an emergency procedure or intended open
cholecystectomy, insufficient knowledge of the Dutch language, choledocholithiasis,
cholangitis, known pregnancy, known liver-cirrhosis, history of abdominal malignancy,
previous upper abdominal surgery (precluding laparoscopic approach), and psychiatric
diseases. All patients underwent a standard surgical and anaesthetic procedure. The
protocol of the study was approved by the local ethics committee.
Procedure
Preoperatively, participation was asked during the patients' first surgical consultation at the
outpatient clinic. The surgeon introduced the study, whereas subsequently nurses informed
patients about the research procedures. Patients received the first set of questionnaires,
which also contained written information about the study, and signed informed consent.
Medical history and comorbidities were obtained from medical records. Patients completed
and returned the first questionnaires before admission for cholecystectomy. If necessary,
patients received a reminder telephone call to return the questionnaires three to five days
before the operation. Patients who returned the questionnaires after admission were
excluded from the study. At six weeks and one year after cholecystectomy, patients received
the same questionnaire which could be returned in a prepaid envelope. If needed, patients
were contacted by telephone twice, usually two and four weeks after sending the
questionnaires. Patients who returned their second or third questionnaire later than
3 months or 15 months, respectively, were considered as non-responders.
Questionnaires
The demographic questionnaire was completed preoperatively and asked about sex, age,
marital status, educational level, and work. Other self report information, with exception of
the STAI trait scale, was obtained three times, namely preoperatively, at six weeks, and one
year after cholecystectomy.
Patients completed a symptom checklist that was based on information from focus groups.
Patients ticked off whether they experienced biliary symptoms (upper abdominal pain,
nausea, vomiting}", dyspeptic symptoms (bad taste, heartburn, under abdominal pain,
diarrhoea, flatulencer", and non-specific symptoms (general malaise, weight-change,
decrease in sexual functioning, health complaints not mentioned in the pre-defined
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checklist) in the past week. All patients included had experienced biliary or dyspeptic
symptoms in medical history.
Patients also completed the WHOQOL-BREF, which is a short version of the generic multi-
dimensional WHOQOL-100, originally developed by the World Health Organization'". The
WHOQOL-BREF consists of 26 items with a 5 point Likert-scale measuring QoL on in four
different domains (Physical, Psychological, Social, and Environment). Two benchmark items
display overall QoL and health. The WHOQOL-BREF has been cross-culturally validated and
has good psychometric properties, such as good internal consistency (Cronbach's a > .70)
and adequate test retest reliability, constructive and discriminative validit/8-31.
The Center of Epidemiological Studies Depression Scale (CES-D)32 was completed
preoperatively, at six weeks and one year follow-up. The CES-D has a 4-point Likert scale
indicating how often patients had experienced depressive symptoms in the week before.
The 16-item version used in this study measures two independent factors, namely
Depressed Affect and Positive Affect, and is a valid measure for depressive symptoms in the
general populatiorr". The CES-Dhas good internal consistency (Cronbach's a = .75 - .88).
Patients also completed the Fatigue Assessment Scale (FAS)33, which consists of 10 items
with a 5-point rating scale indicating how often patients feel tired usually. The FAS has has
an excellent internal consistency (Cronbach's a = .90)34 and good reliabilitv".
The Dutch versions of the Spielberger State-Trait Anxiety Inventory (STAll, consists of two
scales of 20 items each with a 4-item Likert-scale reflecting the extent of anxiety patients
feel at a specific moment in time (state anxiety) and patients generally feel (trait anxiety)35.
Preoperatively, patients completed both scales, whereas at follow-up at six weeks and one
year, only the STAI State scale was completed. The STAI has good and moderate test-retest
reliability for State anxiety (r = .84 - .88) and trait anxiety (r = .30 - .73)36. Internal
consistency is high for both the state- and trait anxiety scale (Cronbach's a = .93 - .96) and
(Cronbach's a = .92 - .93), respectively)35,36.
Statistical procedures
Differences between outcomes at two time points were investigated by Paired t-tests and
Wilcoxon Signed Ranks test. Measures of overall change (3 time points) were obtained by
one way repeated-measures ANOVA. Results were checked for sphericity and, dependent
from outcome, ANOVA's were interpreted as univariate tests (using Greenhouse Geiser or
Huynh-Feldt correction when appropriate) or as multivariate tests (using Wilk's Lambda).
Friedman's test was used to investigate changes in symptom report in the course of one
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year. In case of a significant change, paired t-Tests were performed to investigate the change
in QoL between two time points. Difference scores between the preoperative QoL and QoL
at one year were calculated for each domain of the WHOQOL-BREF and overall QoL and
health.
Multivariate linear regression analyses (Method Forward Stepwise) were performed to
investigate preoperative psychosocial variables and symptoms as predictors of QoL at one
year. Prior to multivariate regression, correlations between preoperative clinical and
psychosocial variables and QoL at one year (Pearson's product moment correlation and
Spearman's Rank order correlation) were calculated to check for multicollinearity and
singularity. None of the correlations between FAS, CES-D, STAI state, STAI trait anxiety,
preoperative symptoms and QoL exceeded > .70. Stepwise regression was performed.
Stepwise regression implicates that predictors are entered in the regression equation one by
one, starting with the strongest predictor. Redundant predictors (p > .050) are removed
from the regression analysis each time a new predictor is added. To minimise the number of
predictors in the regression analyses, several sets of predictors were investigated separately.
Preoperative symptom group (nominal item) and non-specific symptoms (dichotomised
item) were inserted as predictors besides fatigue, depressive feelings, and state and trait
anxiety (set I). Further investigation of biliary, dyspeptic, and non-specific symptoms (set II),
and psychosocial variables (set III) resulted in a selection of significant predictors for in the
final regression analyses (set IV).
Multivariate linear regression was performed with difference scores in QoL as outcome. First
of all, preoperative symptom group, non-specific symptoms, fatigue, depressive symptoms,
and state and trait anxiety were inserted as variables (set V). After investigating biliary,
dyspeptic, and non-specific symptoms (set VI), and psychosocial variables (set VII)
separately, significant predictors were entered in final regression analyses (set VIII). A P
value < 0.05 was considered statistically significant. All analyses were performed using SPSS
version 17.0.
Results
In total 266 patients were approached for participation, of which 250 patients participated in
the study. At one year, 144 patients had returned their questionnaires at all three time
points (preoperatively, six weeks and one year) (overall response rate: 57.6%). A flow chart
of the study participation is shown in figure 1.
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Patients that did not respond or ended participation within one year did not differ on
demographic variables, preoperative symptom report, comorbidities, medication use, and
psychosocial variables from participants. Demographic characteristics of the sample are
shown in table 1. Preoperative symptom report, comorbidities, medication use, and values
of psychosocial and QoL measures are reported in table 2.
Figure 1. Flowchart of the population under study.
Meeting criteria for inclusion
Missed at the outpatient clinic
Expectative management




Not returned preoperative questionnaire
Returned preoperative questionnaire
Ended participation within six weeks
Received questionnaire at six weeks
Not returned the questionnaire at six weeks
Returned the questionnaire at six weeks
Ended participation within a year
Received questionnaire at one year
Not returned the questionnaire at one year
Population under study
1n = 307 1
10 1n
n - 30 1
n-1 1
1 n = 2661
n = 16 1
r n = 2501
n - 32 1
1 n = 218-1
n-5 1
1 n = 2131
n = 34 1
1 n=1791
9 1n
1n = 170 1
n 26 1
1 n = 1441
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Table 1. Demographic characteristics (n = 142).
Demographic characteristics
Female patients (%)
Age (M ± SO)
Highest level of education
Primary or lower vocational education (%)
Secondary education (%)
Higher education (%)
Higher professional education or university (%)
Working under payment (%)
Marital status
Single (%)
Widowed or divorced (%)












Between baseline and one year follow-up, QoL significantly improved in all domains, except
the QOL domain Social Relationships (Figures 2a and 2b). In the first six weeks after
cholecystectomy, QoL improved significant in the domains Physical Health (t = - 8.64,
P < .001), Psychological Health (t = - 3.27, P = .001), Environment (t = - 3.34, P = .001), and
overall QoL (t = - 6.15, P < .001), but not in the domain Social Relationships (t = - .67, P = .50).
In the period between 6 weeks and one year after surgery no significant changes were
observed. The same pattern was observed for state anxiety and depressive symptoms (see
figures 3a and 3b). Both state anxiety and depressive feelings decreased significantly in the
first six weeks after surgery ((t = 4.53, P < .001) and (t = 3.46, P = .001), respectively). No
changes were observed in the period between six weeks and one year. With regard to
fatigue, no differences were found.
In the course of one year, all individual biliary and dyspeptic symptoms decreased with the
exception of diarrhoea (see Table 2). The number of patients experiencing non-specific
symptoms remained stable over time. With the exception of diarrhoea (Z = - .58, P = .564)'
the report of individual biliary and dyspeptic symptoms changed within the first six weeks,
but not in the period between six weeks and one year after cholecystectomy. The use of
analgesics (F = .63, P = .54), psychotropic medication (F = .93, P = .40), and other medication
(F = .93, P = AD) remained stable over time.
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Table 2. Pre- and postoperative clinical and psychosocial characteristics.
Clinical characteristics Preoperatively 6 weeks One year p*
Free of symptoms (%) 0.0 44.4' 50.3 <.001'
Biliary symptoms (%) 24.2 3.5' 8.4' .024*
Upper abdominal pain (%) 69.5 19.0' 22.4 <.001*
Nausea (%) 40.1 14.1' 9.1 <.001'
Vomiting (%) 19.0 1.4' 2.8 <.001'
Dyspeptic symptoms (%) 14.5 30.3' 23.3' .010*
Bad taste (%) 21.1 9.9' 7.7 <.001'
Heartburn (%) 69.5 16.9' 16.8 .03*
Lower abdominal pain (%) 19.7 8.5' 11.9 .008'
Oiarrhoea (%) 17.6 14.8 9.8 .11
Flatulence (%) 36.6 26.1' 21.8 .008*
Biliary and dyspeptic svmptoms" (%) 61.3 21.8' 17.5 .001*
Non-specific symptoms (%) 27.5 26.1 21.0 .52
General malaise (%) 9.9 3.5 5.6 .07
Weight change (%) 2.8 11.3' 8.4 .02*
Oecreased sexual functioning (%) 9.9 4.9 7.0 .13
Other non-specific health complaints(%) 14.1 9.9' 6.3 .02'
Co-morbidities
Coronary arterial disease (%) 18.9
Pneumonal disease (%) 5.7
Abdominal disease (%) 27.4
Kidney disease (%) .9
Urogenital disease (%) 8.5
Neurological disease (%) 8.5
Other comorbidities (%) 49.1
Self-reported medication use
Analgesics (%) 35.9 35.8 29.2 .53
Psychotropic medication (%) 10.6 19.4 19.0 .31
Other medication (%) 50.7 80.6 85.7 .40
Psychosocial characteristics
Trait anxiety (STAITrait) (M ± SO) 36.89 ± 9.69
State anxiety (STAIState) (M ± SO) 38.7 ± 11.50 34.62 ± 10.53t 35.71 ± 10.41 <.001'
Fatigue (FAS) (M ± SO) 22.37 ± 5.22 21.92 ± 5.08 22.82 ± 5.99 .22
Oepressive symptoms (CES0) (M±SO) 22.63 ± 7.14 20.79 ± 6.49t 21.38 ± 7.34 .006'
QoL domains (WHOQOL-BREF)
Physical Health (M ± SO) 14.14 ± 2.74 15.99 ± 2.75t 15.75 ± 2.92 <.001'
Psychological Health (M ± SO) 14.68 ± 2.64 15.26 ± 2.76t 15.19 ± 2.69 .003'
Social Relationships (M ± SO) 15.87 ± 2.67 16.00 ± 2.83 15.76 ± 2.91 .42
Environment (M ± SO) 15.72 ± 2.19 16.23 ± 2.48t 16.06 ± 2.36 .008'
Overall QoL and general health (M ± SO) 7.19 ± 1.72 7.93 ± 1.55t 7.77 ± 1.65 <.001'
* P < .050 indicated statistical significance.
t Significant change (p < .050) compared to the measurement at former time point.
* p- values obtained from differences between preoperative measures and measures at one year.
oj, Combination of ~ 1 biliary symptoms (upper abdominal pain, nausea, and vomiting) and ~ 1 dyspeptic
symptoms (bad taste, heartburn, lower abdominal pain, diarrhoea, and flatulence).
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Figure 2a. Post-cholecystectomy changes in QoL within the domains Physical Health, Psychological
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Figure 3b. Changesin depressive feelings in the course of one year after cholecystectomy.
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Prediction of QoL at one year after surgery
Results of multivariate regression analyses (set I) are shown in table 3. Preoperative
symptoms (only biliary symptoms, only dyspeptic symptoms, or a combination of both) did
not predict any of the domains of QoL at one year.
In the subsequent analyses separate preoperative symptoms were entered as predictors in a
multivariate regression with each domain of QoL as outcome (set II). Physical health was
129
Chapter 7
predicted by diarrhoea (6 = - .27, P = .001), bad taste (6 = - .20, P = .015), and other non-
specific symptoms (6 = - .18, P = .024; adjusted R2=.131, F = 7.93, P < .001). Psychological
health was predicted by general malaise (6 = - .18, P = .007), other non-specific symptoms
(6 = - .25, P = .001), lower abdominal pain (6 = - .21, P = .008), and heartburn (6 = - .16,
P = .040; adjusted R2 = .203, F = 9.77, p < .001). QoL in the domain Social Relationships was
predicted by several preoperative symptoms, namely general malaise (6 = - .18 , P = .037),
other non-specific symptoms (6 = - .27 , P = .001), decreased sexual functioning (6 = - .22,
P = .009), heartburn (6 = - .20, p = .010), and weight change (6 = .16, P = .034; adjusted
R2 = .250, F = 10.14, P < .001). With respect to Environment, QoL was predicted by other
non-specific symptoms (6 = - .30, P = <.001) and diarrhoea (6 = - .18, P = .025; adjusted
R2 = .106, F = 9.15, P < .001). Overall QoL was predicted by general malaise (6 = - .14,
P = .088), lower abdominal pain (6 = - .16, P = .058), bad taste (6 = - .17, P = .040), and
diarrhoea (6 = - .17, P = .043; adjusted R2 = .121, F = 9.15, P < .001). Investigation of
psychological variables (set III) indicated that fatigue and state anxiety predicted Physical
Health at one year after cholecystectomy ((6 = = - .37, P < .001) and (6 = - .26, P = .002),
respectively; adjusted R2 = .292, F = 25.50, P <. 001). Depressive symptoms (6 = - .37,
P < .001) and trait anxiety (6 = - .38, P < .001) were independent predictors of Psychological
Health at one year (adjusted R2 = .441, F = 47.92, P < .001). QoL in the domain Social
Relationships was predicted by depressive symptoms (6 = - .31, P = .002) and trait anxiety
(6 = - .25, P = .014; adjusted R2 = .233, F = 19.06, P < .001), whereas QoL in the domain
Environment was predicted by trait anxiety only (6 = - .46, P < .001; adjusted R2 = .207,
F = 32.11, p < .001). Overall QoL and health was independently predicted by trait anxiety and
fatigue ((6 = - .38, P < .001) and (6 = - .23, P = .014), respectively; adjusted R2 = .282,
F = 24.26, P < .001). Subsequently, all psychological and clinical variables that emerged from
the separate analyses (sets II and III) were entered simultaneously in a multivariate
regression analysis (Method stepwise forward) with the different domains of QoL as
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In order to control for QoL scores at baseline, the same regression analyses were performed
with difference scores in QoL as outcome and preoperative psychological variables,
preoperative symptom groups, and non specific symptoms as possible predictors (set V).
Results of these analyses are shown in table 5. No predictors were found for differences in
QoL within the domains Psychological Health, Environment, and overall QoL and health.
When separate preoperative symptoms were entered as predictors in multivariate
regression analyses with difference scores in QoL as outcome (set VI), the following results
were found. Preoperative vomiting and flatulence predicted differences in Physical Health
((8 = .18, P = .03) and (8 = .17, P = .046), respectively; adjusted R2 = .052, F = 4.73, P = .010).
Changes in QoL within Social Relationships were predicted by general malaise (8 = - .17,
P = .048; adjusted R2 = .021, F = 3.93, P = .048). Other non-specific symptoms was the only
predictor of changes in QoL within the domain Environment (8 = - .21, P = .014; adjusted
R2 = .044, F = 6.24, P = .014). No predictors were identified for improvements in the domains
Psychological Health, Social Relationships and overall QoL and health.
Likewise, all psychological variables were entered to investigate which variables predicted
difference scores in QoL (set VII). Depressive symptoms (8 = .61, P < .001), fatigue (8 = - .31,
P = .006), and trait anxiety (8 = - .25, P = .03) predicted changes in Physical Health in the
course of one year (adjusted R2 = .212, F = 10.86, P < .001). Fatigue was the only predictor of
changes in the domain Social Relationships (8 = - .22, P = .02; adjusted R2 = .041, F = 5.66,
P = .019). None of the psychological variables predicted changes in QoL within the domains
Psychological Health and Environment. Depressive symptoms and trait anxiety predicted
changes in overall QoL and health in the first year after cholecystectomy ((8 = .37, P = .001)
and (8 = - .27, P = .049), respectively; adjusted R2 = .078, F = 5.64, P = .005).
Finally, predictors from sets VI and set VII were entered simultaneously in multivariate linear
regression with changes in QoL within each domain as outcome (set VIII). Results of these
analyses are shown in table 6. No predictors were found for the outcome differences in QoL
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Discussion
Despite the high percentages of patients reporting persisting symptoms, cholecystectomy
remains the golden standard in gallstone disease. As cholecystectomy is an elective
procedure intended to improve and not to save the patient's life, it is important to evaluate
post-cholecystectomy outcomes from the perspective of the patient. One year after elective
cholecystectomy, the current study showed improvements in all domains of QoL, except in
the domain of Social Relationships. Furthermore, the report of biliary and dyspeptic
symptoms, depressive symptoms and state anxiety decreased in the course of one year.
Improvements in symptom report and QoL took place within the first six weeks after
surgery. Preoperative fatigue and trait anxiety had a negative impact on QoL at one year
after cholecystectomy. The impact of preoperative biliary and dyspeptic symptoms was
limited: only diarrhoea had a small negative effect on the QoL domain Physical Health.
Preoperative fatigue and trait anxiety also had a negative effect on relative improvements in
QoL in the course of one year. Furthermore, patients with depressive symptoms had greater
relative improvements in QoL. Flatulence was the only disease-specific symptom with some
clinical relevance for improvements in QoL.
The current study showed overall symptomatic benefit in the first year after
cholecystectomy. Consistent with other studies+': 12,17, 22, 37, diarrhoea was the only symptom
that did not improve. In fact, diarrhoea often persists or emerges after cholecystectomy and
is associated with the post-cholecystectomy svndrome ". Symptoms, QoL, and psychological
variables improved all within the first six weeks after surgery. This is the time frame in which
patients normally return to work after cholecystectomy". A study investigating health status
at 2 and 12 months, also found that the improvements after cholecystectomy occurred
within the first two months after surgerv'", In contrast, another study using multiple
measurements (6, 12, and 60 rnonthsj''", found no long term improvements in psychological
well being and health status. This difference may be due to the longer period of follow-up
and small sample size. Besides another report from the same sample", no other studies
have investigated objective or subjective outcomes at six weeks postoperatively. The current
study suggests that postoperative recovery < 6 weeks is the most informative, which should
be further investigated by future studies.
So far, the current study appears to be the first study investigating QoL after
cholecystectomy. The WHOQOL group defined QoL as a multidimensional concept
integrating 'an individual's perception of his/hers position in life in the context of the culture
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and value systems in which he/she lives and in relation to his/her goals, expectations,
standards and concerns' 27. Other outcome studies assessed health status" 16, 26,41,42 17,19,43,
which is the objective degree of dtsabtlltv". In addition, several studies used subjective
ratings indicating satisfaction with the result of cholecvstectornv": 15, 45. Since QoL and
health status are related, but different concepts'" 47, a comparison with other studies is
hampered. Moreover, comparability of studies is also hampered by differences in time
points of investigation (3 months to 5 years postoperatively). At three months after
cholecystectomy, general improvements in health status were only found in patients with
low surgical risks'". At 4 and 17 months after cholecvstectornv'" 17, greatest improvements
in health status were found in the dimensions gastrointestinal symptoms, physical health
and bodily pain. With regard to psychological well-being long term improvements were
observed'?' 41, although psychological functioning did not seem to lrnprove ". In line with
these findings, the current study demonstrated large improvements in the domain Physical
health and in the general evaluative facet overall QoL and health, but also small
improvements within the domains Psychological health and Environment. Although other
studies demonstrated a small, but significant, improvement on the dimension of social
functioning '" 17 43, the current study did not find improvement in the QoL domain Social
Relationships. This discrepancy was also found in breast cancer patients".
The present study implicated that preoperative fatigue has a negative effect on QoL in the
domain Physical health. Trait anxiety had a negative impact on Psychological health,
Environment, and overall QoL and health. Trait anxiety is also found to be a predictor of QoL
in the irritable bowel svndrorne'" and breast cancer". Clinical biliary and dyspeptic
symptoms and pain have been identified as predictors of objective outcomes": 20-22 and
were found to be associates of postoperative satlsfactlon". However, preoperative clinical
biliary and dyspeptic symptoms had no impact on QoL at one year. Besides, the impact of
theses symptoms on health status in patients with symptomatic gallstone disease has not
been investigated so far. With the exception of one studv'", absolute QoL scores were
subject of this research whereas improvement in QoL should be the focus, as this gives an
impression of benefit from the perspective of the patient.
Predicting post-cholecystectomy improvements in QoL, psychosocial factors outweigh
clinical factors. Notably, patients with high preoperative depressive symptoms experienced
greater improvements in QoL within the domains Physical health and overall QoL and health.
This effect may be indirect as non-pathological depressive symptoms are moderately
correlated to QoL30, 50, 5148. As a reaction to physical illness and the prospect of undergoing
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surgery, patients may experience more depressive symptoms, preoperatively. Moreover,
non-specific clinical factors offer a small negative contribution to improvements in QoL,
whereas flatulence offers a positive contribution to QoL improvements.
The study has several limitations that need to be acknowledged. First of all, because of the
use of multiple measurements and a long term follow-up, the response rate is moderate.
However, the integration of three measurements in the design gives us valuable insights in
the process of post-cholecystectomy recovery that otherwise would be overlooked (e.g. the
fact that all improvements take place within 6 weeks). Secondly, as clinical experience shows
that patients experience greatest improvements within six weeks38 we selected six weeks as
appropriate moment for the first follow-up. Possibly, significant improvements take place
earlier. As evidence exist that patients generally return to work after one or two weeks37, 52
and take up activities at two to six days after cholecvstectornv'" 52, an earlier time point
would be more appropriate. Future studies may address this issue, determining the critical
period of post-cholecystectomy recovery with objective and subjective measures.
Furthermore, in the current study there was not controlled for the impact of co-morbidities,
age, and sex on QoL, as we aimed at a parsimonious model. However, as women are found
to have higher trait anxietl3, sex should at least be a factor controlled for in future studies.
Besides, special life events and changes in comorbid conditions in the course of one year
should also be an issue to control for. Moreover, we used a self-constructed checklist for
pre- and postoperative symptoms, based on clinical experience, information of focus groups,
and other existing checkltsts". To improve comparability with other studies, the use of a
standardised disease-specific symptom checklist should be preferred. However, to our
knowledge such a checklist is not yet developed for cholelithiasis.
The results of this study may have implications for clinical practice. Symptoms and
postoperative pain are traditionally used as benchmarks for surgical procedures. However,
from the perspective of a patient tailored approach, the patient's QoL should be leading in
the choice between treatment options. Information of patients should concentrate on
improvements in QoL, and patients should be involved weighing the pros and cons of
cholecystectomy in consultation with their surgeon. Secondly, as psychosocial factors
surpass the effect of clinical risk factors, these risk factors need to be more attended to
during surgical consultation. Preoperative screening for fatigue and trait anxiety would have
added value for the consideration of cholecystectomy and the information of patients.
Ultimately, it should be considered whether cholecystectomy is the preferred treatment for
gallstone disease in patients with high fatigue and high trait anxiety. If minimal
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improvements are to be expected wait and see could be an alternative, especially since the
risk of complications of such a wait and see policy is small (1% - 2% a year)54,55,whereas the
risk of peri- and postoperative complications is also small but not neglectable (0.6% -
5.0%)56, 6. Preoperatively, psychological interventions may be started to teach patients with
high trait anxiety how to cope with fatigue and heightened anxiety. Minimising the negative
effect of their psychological constellation, patients may report greater benefit in QoL after
cholecystectomy.
In conclusion, in the course of one year after cholecystectomy, QoL improves in all domains
of life, except the domain of Social Relationships. Fatigue and trait anxiety have a negative
impact on improvements in QoL at one year, whereas the impact of biliary and dyspeptic
symptoms on QoL is negligible. QoL should be the starting point for patient centered care in
gallstone disease, which implicates preoperative screening for fatigue and high trait anxiety,
careful consideration of cholecystectomy, and offering psychological interventions in
patients with psychological risk factors.
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General discussion and clinical implications
Chapter 8
This thesis describes the results of a prospective follow-up study investigating recovery
of patients with cholelithiasis in the first year after cholecystectomy. We investigated
symptomatic outcomes and quality of life (QoL) at postoperative intervals of different
lengths. The aim of the study was to identify predictors of negative outcomes after
cholecystectomy among clinical and psychosocial variables. In this final chapter, the
main findings of this research are discussed and put in the perspective of the
implications for clinical practice. Furthermore, methodological considerations and
recommendations for future research are presented.
Main findings of the research
Symptomatic outcome
Cholecystectomy is the preferred treatment in symptomatic gallstone disease
(cholelithtasls)" 2. Overall, previous outcome research after cholecystectomy lacks
distinctness and clarity. Earlier studies presented a variety of outcome measures and
described a multitude of predictors of symptomatic outcornes:". The majority of these
studies focussed on postoperative intervals longer than six months. To date no study has
investigated outcomes at six weeks after cholecystectomy, even though clinically this is
the most relevant interval as greatest recovery takes place in this time-perlod'".
Therefore, the aim of the research presented in chapter 2 was to identify predictors of
symptomatic outcome six weeks after cholecystectomy. At six weeks, patients with
preoperative biliary symptoms had a better chance to be free of symptoms after
cholecystectomy than patients reporting dyspeptic symptoms. Nevertheless a quarter of
the patients reported persisting biliary symptoms while even half of the patients
reported persisting dyspeptic symptoms six weeks after cholecystectomy. These
persistence rates are consistent with findings presented in a review on improvement of
upper abdominal pain and dyspeptic symptoms after cholecvstectornv". This finding
suggests that a shift from preoperative biliary to postoperative dyspeptic symptoms,
found at longer postoperative intervals", could already be observed at six weeks after
cholecystectomy. Investigation of risk factors in this study identified preoperative
dyspeptic symptoms, more specifically bad taste and flatulence, as risk factors for the
report of biliary symptoms at six weeks. In addition, patients with preoperative
flatulence had a three to four times greater risk of persistence of biliary and dyspeptic
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symptoms. In accordance with findings at later postoperative intervals" 6, 10, dyspeptic
symptoms seem to be a risk factor for persisting symptoms at six weeks post-
cholecystectomy. Stratification of the sample by sex, pointed out that these predictors
could only be identified in women.
The scope of predictors was broadened and personality traits were integrated in the
design as potential risk factors. So far, the impact of trait anxiety (TA), which is a
disposition to respond with heightened anxiety to threatening sttuatlons". was
examined at short postoperative intervals. TA is found to be a predictor of emotional
and physical well being and use of analgesics within five days after cholecvstectornv'" 17.
Inconclusive evidence suggests that TA is a predictor of early postoperative painl6-18.
However, long term impact of TA on post-cholecystectomy outcomes has not been
investigated before. Therefore, in chapter 3, the objective was to identify predictors,
clinical variables and TA, of negative symptomatic outcome at six weeks. Our study
demonstrated a lack of symptomatic improvements in patients with high trait anxiety
(HTA), whereas symptoms decreased in patient without this characteristic (NHTA
patients). Preoperative clinical symptoms and HTA both predicted the report of
postoperative symptoms. Another study also demonstrated that clinical symptoms and
personality traits both predicted post-cholecystectomy outcomes": Remarkably, the
persistence of biliary symptoms, which is associated with an unsuccessful procedure, is
predicted by HTA alone, and not by clinical symptoms. In addition, HTA patients had a
seven times greater risk of persistence of biliary symptoms than NHTA patients.
Although we established that HTA is an important predictor of post-cholecystectomy
outcomes, the mechanism of influence remains unknown. As patients with HTA have
higher pain sensitivity and more often suffer from gastrointestinal conditions19, 20 the
report of persistent symptoms may be subjective in nature.
In line with other studies in the field, Chapter 4 focussed on postoperative outcomes at
an interval of six months. Typically, persistence rates of biliary and dyspeptic symptoms
had not changed compared to the measurement at six weeks (chapter 2 and 3). At six
months, preoperative symptoms and HTA both predicted symptomatic outcomes. HTA,
the use of psychotropic medication, and non-specific symptoms were risk factors for the
report of biliary symptoms, whereas dyspeptic and non-specific symptoms were risk
factors for the report of dyspeptic symptoms at six months. Also, the risk of persistence
of preoperative biliary symptoms was heightened if patients were characterised by HTA,
used psychotropic medication, and reported non-specific symptoms preoperatively.
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Furthermore, patients with preoperative non-specific symptoms were also at risk for
persistence of dyspeptic symptoms. These results suggest that besides dyspeptic
symptoms and HTA, non-specific symptoms are also predictive of negative outcomes
after cholecystectomy. The current study suggests that the impact of non-specific
symptoms may only be noticeable at longer postoperative intervals, and not yet at six
weeks. The findings described in this chapter indicate that non-specific symptoms
should be regarded as an independent predictor, and not merely as the consequence of
comorbidities or cholelithiasis. To our knowledge, the impact of non-specific symptoms
like general malaise, fatigue, weight change, decreased sexual functioning, and other
non-specific symptoms, on post-cholecystectomy outcomes has not been investigated
before.
Previous studies investigating six months symptomatic outcome used a variety of criteria
for inclusion, designs, outcome measures, and moments of follow-up" 5, 6, 21. Therefore,
in chapter 5, the aim was to identify predictors of six months symptomatic outcome by a
categorisation that was based on disease-specific symptoms and which should be
helpful for surgeons and other physicians treating patients with cholelithiasis. To
enhance clinical applicability of our results, patients were stratified by preoperative
symptom report: biliary symptoms only, dyspeptic symptoms only, and a combination of
biliary and dyspeptic symptoms. Patients with preoperative biliary symptoms had the
best prognosis, as two thirds of these patients were free of symptoms at six months. In
contrast, two thirds of patients having only dyspeptic symptoms reported persistence of
these symptoms at six months. Investigation of predictors demonstrated that non-
specific symptoms were a risk factor for postoperative symptoms in patients with
preoperative biliary or in patients with preoperative dyspeptic symptoms only.
Furthermore, patients having only dyspeptic symptoms and patients using psychotropic
medication had a five times higher chance at persistence of the preoperative symptom
pattern. A differentiation between postoperative outcomes demonstrated that patients
with purely dyspeptic symptoms and non-specific symptoms both had a higher chance
to report only dyspeptic symptoms at six months. Compared to patients without these
characteristics, patients using psychotropic medication and patients with non-specific
symptoms had an eight to nine times higher risk at a combination of biliary and
dyspeptic symptoms at six months. HTA was the only risk factor for the experience of
biliary symptoms only at six months. Compared to NHTA patients, HTA patients had a
ten times higher chance to experience biliary symptoms at six months after surgery.
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Chapter 6 presented the investigation of one year symptomatic outcome and the
identification of predictors of outcome at this postoperative interval. Previous studies
established risk factors of post-cholecystectomy outcome and found dyspeptic
symptoms, pain characteristics, personality traits, and psychological symptoms to be risk
factors of negative outcome at one yearS,10. Although two other studies indicated that
symptomatic outcome at one year could not be predicted'" 22, we found that
preoperative symptomatology was decisive for postoperative outcomes. At one year,
patients suffering from preoperative biliary symptoms only had best convalescence as
they reported to be free of symptoms most often. This finding is in line with another
study indicating that patients with typical biliary symptoms have best convalescence
after a postoperative interval of ten years12. Furthermore, patients with non-specific
symptoms had a three times greater chance of biliary and dyspeptic symptoms at one
year after cholecystectomy. The findings described in this chapter indicate that the
presence of non-specific symptoms is a valuable predictor for longer postoperative
intervals (> 6 months). In contrast, HTA was not found to be a predictor for symptomatic
outcome at one year and could merely be considered as a predictor of symptomatic
outcome within six months after cholecystectomy.
In Chapter 7, the process of symptomatic improvement during the first year following
cholecystectomy was investigated. Symptomatic improvement only took place within
the first six weeks after cholecystectomy and not later during postoperative recovery,
which is in line with clinical experience ".
Taken together, the results of our study indicate that symptomatic recovery mainly
takes place within 6 weeks after cholecystectomy. Patients reporting only biliary
symptoms showed complete symptomatic relief most often, whereas patients with only
dyspeptic symptoms showed persistence of symptoms most frequently. The
preoperative symptomatology of cholelithiasis may be a valuable criterion for outcome
after cholecystectomy, as preoperative dyspeptic symptoms were found to be strongly
associated with negative symptomatic outcome. In addition, other characteristics also
appeared to be valuable for the prognosis of symptomatic outcome. Within the first six
months after cholecystectomy, HTA was a risk factor for persistent biliary symptoms.
However, these preliminary findings suggest that the impact of HTA is mainly noticeable
within six months after cholecystectomy, whereas HTA had no statistically significant
influence on symptomatic recovery at one year. Furthermore, preoperative non-specific
symptoms were a valuable predictor of negative symptomatic outcome at an interval of
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six months or longer after cholecystectomy. Finally, the use of psychotropic medication
may be a predictor of long term symptomatic outcome, although evidence of this work
is indecisive.
Quality of life
The concept quality of life (QoL) has become widely accepted as an outcome measure
for medical procedures and treatment. QoL is a broad ranging concept integrating the
individual patient's overall functioning (reaching beyond the scope of physical,
psychological, and social functioning), and the evaluation of that functioning. In chapter
6, we investigated overall QoL and general health at one year post-cholecystectomy and
found that patients with dyspeptic symptoms demonstrated no improvement in QoL,
whereas patients with biliary symptoms or with a combination of biliary and dyspeptic
symptoms did. Furthermore, preoperative symptom classification (based on biliary,
dyspeptic, or biliary and dyspeptic symptoms), abdominal comorbidity and HTA were
risk factors for lower QoL at one year.
Within the field of cholecystectomy, several studies have focussed on the subjective
experience of patients investigating health status and patients' satlsfactiorr" 11, 23.30.
However, there is a paucity of studies that measure the patients' evaluation of life after
a cholecystectomy. Improvements in QoL and the identification of predictors among
clinical and psychosocial variables, were further addressed in chapter 7. With the
exception of the dimension Social Relationships, multiple dimensions of QoL improved in
the course of one year. Typically, improvements of QoL, biliary and dyspeptic symptoms,
depressive symptoms, and anxiety all took place within the first six weeks after
cholecystectomy. TA had a negative impact on all QoL domains, except Physical Health,
Fatigue had a negative effect on QoL in the domain Physical Health and overall QoL and
general health. With regard to one year improvement of QoL in the domain Physical
health, fatigue and TA had a negative effect, whereas depressive symptoms and
flatulence had a positive effect. General malaise and other non-specific symptoms had a
negative impact on QoL in the domains Social Relationships and Environment,
respectively. Furthermore, TA had a negative effect on improvements in overall QoL and
general health, whereas depressive symptoms had a positive effect on improvements in
overall QoL and general health. As depressive symptoms can be reactive to situations or
conditions, long lasting symptoms and pain and the prospective of hospital admission
and surgery may worsen depressive symptoms preoperatively. As depressive symptoms
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are related to QOL31-33, relief of depressive symptoms may have an additional effect on
improvements QoL. Although TA is no predictor of symptomatic outcome (chapter 6), it
is a predictor of QoL and improvements of QoL at one year after cholecystectomy. This
finding emphasizes the difference between QoL and more objective measures such as
symptom report, even if these measures are based on self reports. With regard to
fatigue, to our knowledge no other prospective studies have investigated the impact of
fatigue on post-cholecystectomy outcomes.
In summary, improvements in QoL took place within the first six weeks after
cholecystectomy. Psychosocial variables, namely TA and depressive symptoms, had an
impact on improvements in QoL in the course of one year. Fatigue also had an impact on
QoL, but only on improvements within the domain Physical health.
Methodological considerations
Drawbacks
The work presented in this thesis has several drawbacks. First of all, data collection took
place within a single hospital, which may limit the generalisability of the results to the
entire population of patients. Secondly, the use of a self-constructed symptom checklist
may limit the comparability with results of other studies. We found that the majority of
studies in the field used self-constructed checklists and to our knowledge no
cholelithiasis-specific symptom checklist has been developed yet. Incidentally, some
studies used standardised gastrointestinal questionnaires to list cholelithiasis-specific
symptoms. However, we believe that checklist for gastrointestinal symptoms measure
more than only cholelithiasis-specific symptoms and therefore may be inappropriate for
this purpose. As the checklist used in the current work was based on the experience of
patients in focus groups, clinical experience of surgeons, and checklists used in other
studies, we believe that our checklist may be an appropriate solution. Thirdly, for
practical reasons, e.g. to enhance the applicability of our results in clinical practice, we
categorised biliary and dyspeptic symptoms in congruence with other studies" 34. The
categorisation used in this work may be disputable, as nausea and upper abdominal pain
could also be components of a dyspeptic pattern". However, as the clinical symptoms of
cholelithiasis are ambiguous and biliary colic may be the only discerning symptom'. the
use of individual symptoms may be preferred. Dependent on the aim of the study,
choice of individual symptoms or categories should be motivated. Fourthly, in chapters 2
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to 6, a single follow-up measurement was used to investigate symptomatic
improvement. Consequently it remains unclear whether symptoms actually persisted, or
disappeared and emerged at some time after cholecystectomy. The use of multiple
measurements, or different questioning, should clarify this matter. Fifthly, in the current
design we did not control for confounding variables. Especially at longer postoperative
intervals (chapter 5, 6, and 7) outcomes may be confounded by changes in comorbidity
or special life events. We acknowledge that we are unable to pronounce upon the pure
effect of cholecystectomy, but we believe that this appropriately mimics the real-life
situation of clinical practice where postoperative wellbeing has to be predicted based on
preoperative characteristics alone. Finally, response rates may be negatively influenced
by the number of follow-ups in our designs. Besides the preoperative measurement,
patients had to complete questionnaires at 10 days, 6 weeks, 6 months, and 1 year after
cholecystectomy. We believe that especially in the early stage participation might be
demanding for patients, which may result in a high number of non-responders and drop-
outs. After examination it was clear participants, non-responders and drop-outs did not
differ on demographic and clinical variables.
Strengths
The present work has several improvements over other studies in the field. First of all,
the study investigated a substantial cohort of consecutive patients. As approximately
95% of the patients agreed to participate, the results of the study could be easily
generalised to the average patient with symptomatic cholelithiasis. Furthermore, criteria
for in- and exclusion were clear-cut and guaranteed a homogeneous group of patients
with symptomatic cholelithiasis, undergoing a laparoscopic cholecystectomy.
Confounders such as different operative techniques, emergency procedures, previous
abdominal surgery, worse physical condition (ASA class III and IV), and psychiatric
disease, which all may have an impact on postoperative outcome were excluded from
the design. By contrast, former studies assessed heterogeneous or undifferentiated
samples" 11, 22, 23. The current work has a unique contribution to clinical research in
cholecystectomy, as it is the first study that addresses improvements in QoL (chapter 6
and 7), uses non-specific symptoms as predictor, and is the first to assess six weeks
recovery. Furthermore, the present work investigated QoL and broad psychosocial
variables at multiple intervals (chapter 7), and considered post-cholecystectomy
recovery as a dynamic process instead of a static inventory.
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Implications for future research
Several chapters of this thesis described postoperative recovery at six weeks after
cholecystectomy (Chapter 1, 3, and 7), which appeared to be a critical interval for post-
cholecystectomy recovery. Clinical experience teaches that greatest recovery takes place
within six weeks. Future research should investigate the process of improvement within
the first weeks after cholecystectomy and identify the critical period for recovery.
Chapter 2 demonstrated that predictors of negative outcome may be different in men
and women. As the sample of men was small, sex differences were not elaborated upon
in other chapters. As men and women differ with regard to preoperative presentation of
cholelithiasis and postoperative recovery", this preliminary finding should be
corroborated in future studies based on larger samples. So far, our work highlighted
preoperative characteristics and symptoms that have not been investigated with respect
to post-cholecystectomy outcomes. The impact of preoperative non-specific symptoms
and fatigue needs to be addressed further in future studies. Moreover, research in
personality traits predicting post-cholecystectomy outcome has been limited and only
few studies reported the effects of neuroticism, introversion, and trait anxiety. We
suggest that investigating the impact of other personality traits on post-cholecystectomy
recovery should be subject of future studies. Most important, the findings presented in
this thesis provide evidence that post-cholecystectomy recovery is a multidimensional
process containing both physical and psychological aspects. Future comprehensive
research should investigate the mechanisms through which these physical and
psychological aspects influence symptomatic recovery and QoL.
Clinical implications
Risk assessment in cholecystectomy is of interest to surgeons involved in the decision
process for cholecystectomy, but even more so to internists, gastroenterologists and
general practitioners who see patients with broad gastrointestinal symptoms and who
may refer patients with a suspicion of cholelithiasis for surgical consultation. These
professionals have to deal with the heterogeneous symptomatology of cholelithiasis and
the ongoing uncertainty whether preoperative gastrointestinal symptoms are related to
demonstrated gallstones or not. Relief of gastrointestinal symptoms and pain after
cholecystectomy provides the ultimate proof that symptoms and gallstones were indeed
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related. As preoperatively diagnostic criteria give little support for consideration about
cholecystectomy, the results presented in this thesis may hand physicians alternative
tools to improve clinical decision in cholelithiasis.
Results presented in this thesis principally show that the consideration for performing
cholecystectomy should be made from a holistic perspective. As both physical and
psychological aspects have an impact on outcome after cholecystectomy, physicians
should realise that insight into patients' psychological characteristics has an additional
value for their own medical practice. Collecting information about psychological
characteristics and non specific symptoms, e.g. trait anxiety, depressive symptoms,
fatigue, general malaise, weight-change, decreased sexual functioning, and other non-
specific symptoms, deserves special attention during anamnesis in selected patients. A
short psychological screening, consisting of checklists such as the STAI, CES-D,and FAS,
may have an additional value in the identification of patients at risk for negative
outcomes after cholecystectomy. Furthermore, information on expected postoperative
outcomes should be tailored to the patient's individual risks in order to create realistic
expectations of postoperative recovery. As cholecystectomy is an elective procedure,
which is ideally performed and planned in dialogue with the patient, sharing of realistic
prognostic information may facilitate the joint decision process by patient and surgeon.
The ability to recognise patients at risk for negative postoperative outcomes may have
implications for the management of cholelithiasis. As elective cholecystectomy is in fact
a prophylactic treatment", positive outcomes such as improvement of QoL and
prevention of complications may be the incentive to operate. However, surgeons and
other physicians also should be imbued with the fact that only half of the patients are
free of symptoms after cholecystectomy. Therefore, 'wait and see' management should
be considered as an alternative, especially in patients with a high risk profile for negative
outcomes. Actually, the risk of postoperative complications, such as cholecystitis, acute
pancreatitis, or biliary duct obstruction is quite small (1% - 2% yearly)38, 39. Biliary pain
only recurs in one third of the patients with previous biliary attacks longer than one year
before. Also, it is often neglected that cholecystectomy still entails the risk of mortality
(0.2% - 0.3%)40,4\ and local and systemic complications (3.5% and 2.7%, respectlvelvl'".
Therefore, in patients with a heightened risk for negative postoperative outcomes
conservative treatment may be preferred over cholecystectomy. Furthermore, general
practitioners and gastroenterologists may feel the necessity to refer patients for surgical
consultations immediately. As wait and see entails only a small risk of negative
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consequences, it may be a good alternative, especially in patients with dyspeptic
symptoms only, HTA, and non-specific symptoms, who show limited symptomatic
improvements after cholecystectomy.
Current clinical guidelines indicate cholecystectomy as the treatment of choice in
symptomatic cholelithiasis, despite the fact that many patients report persistent
symptoms. These guidelines focus on symptomatic outcomes and are primarily
developed from a surgical point of view'. As physicians generally underestimate the
number of symptoms and pain experienced by patlents'", classical endpoints may
inadequately represent patients' experience. Therefore, subjective outcome measures
should be incorporated in future guidelines. Further, the risk factors described in this
thesis may be elaborated in the indication of cholecystectomy. In patients with
dyspeptic symptoms only, HTA and non specific symptoms, tightening of the indication is
advisable. A patient-tailored approach, in which cholecystectomy is considered the
golden standard for patients with biliary symptoms only, but as a treatment option in
patients with dyspeptic symptoms, HTA and non-specific symptoms, should be
preferred. We recommend that future guidelines also integrate characteristics from a
broad perspective.
We advocate a multidisciplinary management of cholelithiasis in high risk patients.
Psychological expertise may not only be valuable in screening for high risk patients, but
also in the treatment of patients to minimise the negative effect of HTA on
postoperative recovery. As HTA is a stable personal trait, changing this characteristic will
be a laborious process that may overshoot the mark. We believe that interventions
aimed at dealing with anxiety provoking and otherwise threatening situations, such as
the expansion of coping strategies, should be the focus of psychological counselling.
From the perspective of cognitive behavioural therapl3-45, negative and unrealistic
thoughts make a situation more or less threatening to the individual. The identification
and challenge of negative automatic thoughts and attributions may neutralise negative
feelings and may consequently affect the patient's behaviour and reaction to
postoperative gastrointestinal symptoms. This approach has achieved successes in the
treatment of patients with functional dyspepsia and other gastrointestinal symptoms46,
47.Mindfulness based stress reduction (MBSR)48or mindfulness based cognitive therapy
(MBCT)49, which are successfully applied in patients with chronic pain and stress'" 5\
may help some HTA patients to accept their symptoms and avoid rumination, which may
be anxiety provoking itself. As HTA patients are more sensitive to gastrointestinal
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symptoms and pain19, 20, and report higher activation of the sympathetic nervous
svstern'", this approach may reduce the negative impact of HTA. Preoperative
interventions may diminish negative postoperative outcomes in these patients. Besides,
psychological counselling may be supportive in case of conservative management and
may help specific patients dealing with persistent symptoms after surgery. Clinical
intervention studies should investigate the postoperative benefits of psychological
interventions.
The implications identified above hold the promise that the number of unnecessary
cholecystectomies may be reduced. A turn should be made towards an approach with
the patient's subjective needs and expectations as core elements. Gaining a broad
perception of the patient's symptoms and characteristics and providing patient-specific
information on postoperative risks will be two essential steps in the process of change.
Secondly, the decision process for surgical intervention or alternative treatments will
lead to further innovation in the management of cholelithiasis, We believe that going
beyond the borders of individual professional fields will provide new insights that may
ultimately pave the way for optimized treatment approaches in cholelithiasis. Finally,
selective performance of cholecystectomy and preservation of the procedure to patients
with a good chance of positive outcomes will result in greater cost effectiveness in
health care.
Concluding remarks
The research presented in this thesis suggests there is potential for further
improvements in the treatment of cholelithiasis. Clinical decision making in cholelithiasis
could be better tuned to the individual patient by using a more comprehensive
approach, integrating both physical and psychological aspects. Patients reporting only
biliary symptoms show best symptomatic improvement and are most often free of
symptoms after cholecystectomy. Preoperative dyspeptic symptoms, trait anxiety, and
non-specific symptoms (e.g. fatigue) are identified as risk factors for negative
symptomatic improvements. In addition, trait anxiety and non-specific symptoms are
predictors for improvements in QoL. On the contrary, preoperative biliary and dyspeptic
symptoms do not have an impact on QoL at one year after cholecystectomy.
Insights in psychological risk factors, may lead to alternative decision criteria,
differentiation of treatment approaches, and tightening of the indication for
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cholecystectomy. Besides cholecystectomy, conservative treatment may be considered
as a viable alternative for high risk patients. Psychological counselling may have an
additional value for selected patients with a high risk of negative outcomes. We believe
that a multidisciplinary approach, going beyond the borders of individual professional
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Galsteenlijden, diagnostiek en behandeling
Galsteenlijden (cholelithiasis) komt veel voor. In Westerse landen lijdt 5 - 22% van de
bevolking aan deze aandoening en aileen in Nederland wordt jaarlijks bij 30.000 mensen
cholelithiasis gediagnosticeerd''". Naast hoge leeftijd en vrouwelijk geslacht, zijn hoge
Body Mass Index (BMI), de invloed van oestrogeen, etniciteit, roken, alcohol gebruik en
gebruik van cholesterolverlagende medicatie van invloed op het ontstaan van
galstenen", De meeste mensen met galstenen blijven klachtenvrij ' en slechts 10 - 30%
rapporteert klinisch significante symptomen, waarbij men spreekt van symptomatisch
galsteenlijdent' ". Galsteenkolieken, die gedefinieerd worden als 'een hevige,
aanhoudende pijn, die 15 - 30 minuten duurt, meestal gelokaliseerd is in de (rechter)
bovenbuik en soms uitstraalt naar de rug', vormen bij symptomatisch galsteenlijden het
meest onderscheidende svrnptoorn". Deze galsteenkolieken gaan vaak gepaard met
misselijkheid en braken". Overige gastrointestinale klachten, die men veelal aanduidt
met de term dyspeptische klachten, komen bij symptomatisch galsteenlijden eveneens
veelvuldig voor. Op basis van klinische symptomen aileen is het moeilijk om bij deze
aandoening een correcte diagnose te stellen. Aanvullend echografisch onderzoek naar
de aanwezigheid van galstenen wordt geadviseerd'".
Het operatief verwijderen van de galblaas (cholecystectomie) is de gouden standaard bij
symptomatisch galsteenlijden. Na een cholecystectomie rapporteert ongeveer een
derde van aile patlenten persistentie van klachten16.21. De risico's bij een
cholecystectomie worden onderschat, maar zijn zeker aanwezig. Het gaat daarbij om het
risico op postoperatieve complicaties (5.0%), galwegletsel (0.2% - 1.0%) en overlijden
(0% - 0.2%)22, 23. Een conservatief beleid lijkt veilig, aangezien slechts 31% van de
patienten binnen een jaar opnieuw een aanval van galsteenkolieken krijgt24 en de kans
op het optreden van complicaties, zeals acute cholecystitis, acute pancreatitis en
galwegobstructie, gering is (jaarlijks 1% - 2%)25,26. Patienten die een cholecystectomie
dan wei een conservatieve behandeling ondergaan, lijken vijf jaar na de diagnose niet te
verschillen ten aanzien van kwaliteit van leven en ervaren pijn27•
Samenvatting van de belangrijkste resultaten
In deze dissertatie wordt een prospectief follow-up onderzoek beschreven dat zich richt
op het identificeren van predictoren voor symptomatische uitkomsten en kwaliteit van
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leven zes weken, zes maanden en een jaar na cholecystectomie. Patienten met
symptomatisch galsteenlijden en een indicatie voor een electieve cholecystectomie
werden benaderd voor deelname aan het onderzoek. Voor de operatie vulden patienten
een set vragenlijsten in, die bestond uit een symptomen checklist en vragenlijsten over
ervaren pijn (VAS), situationele en dispositionele angst (SlAI state en trait), depressieve
gevoelens (CES-D), vermoeidheid (FAS) en ervaren kwaliteit van leven (WHOQOL-BREF).
lien dagen, zes weken, zes maanden en een jaar na de operatie ontvingen patienten
opnieuw dezelfde vragenlijsten per post. Cholecystectomie werd uitgevoerd volgens een
standaard chirurgische procedure en onder een standaard anaesthetisch regime.
Symptomatische uitkomsten
In onderzoek naar uitkomsten van cholecystectomie richt het merendeel van de studies
zich op een postoperatieve periode langer dan 6 maanden en 'klassieke' uitkomstmaten,
zeals complicaties en symptomen. Na cholecystectomie lijken typisch biliaire
symptomen te verbeteren, terwijl dyspeptisch symptomen vaker aanhouden. Ongeveer
een derde van de patienten rapporteert persistentie van symptomen en pijn, waarbij
met name flatulentie en diarree postoperatief vaak voorkomen. Voorgaand onderzoek
toonde aan dat slechte resultaten na cholecystectomie samenhangen met preoperatieve
dyspeptische klachten, het ervaren van pijn en symptomen, het gebruik van
psychofarmaca en psychologische factoren, zeals bepaalde persoonlijkheidstrekken. Na
een korte inleiding en uiteenzetting van de onderzoeksopzet (hoofdstuk 1), beschrijft
hoofdstuk 2 de resultaten zes weken na cholecystectomie. Na zes weken rapporteerden
respectievelijk een kwart en de helft van de patienten persistentie van biliaire en
dyspeptische klachten. Preoperatieve dyspeptische symptomen, met name flatulentie
en een vieze smaak in de mond, waren risicofactoren voor aanhoudende symptomen
zes weken na cholecystectomie. Bovendien bleken risicofactoren aileen bij vrouwelijke
patienten aantoonbaar en niet bij mannen.
In hoofdstuk 3 wordt aangetoond dat naast klinische factoren, ook
persoonlijkheidstrekken van invloed zijn op het postoperatief herstel. Op het gebied van
persoonlijkheid is gekeken naar patienten met een hoge dispositionele angst. Deze
patienten hebben een sterke neiging om met verhoogde angst te reageren op
bedreigende situaties. Zes weken na een cholecystectomie rapporteerden patienten met
een hoge dispositionele angst geen verbetering van symptomen, in tegenstelling tot
patlenten zonder een hoge dispositionele angst. Naast klinische factoren blijkt hoge
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dispositionele angst een belangrijke risicofactor voor persistentie van symptomen zes
weken na de operatie. Hoofdstuk 4 beschrijft het onderzoek naar aanhoudende biliaire
en dyspeptische klachten zes maanden na cholecystectomie. Patienten met hoge
dispositionele angst, niet-specifieke klachten (zoais algehele malaise en vermoeidheid)
en patienten die psychofarmaca gebruikten hadden een groter risico op persistentie van
biliaire symptomen zes maanden na cholecystectomie. Bovendien hadden patienten
met niet-specifieke symptomen een verhoogd risico op persistentie van dyspeptische
symptomen.
In hoofdstuk 5 worden patienten op basis van preoperatieve symptomen ingedeeld in
verschillende groepen (aileen biliaire symptomen, aileen dyspeptische symptomen, een
combinatie van biliaire en dyspeptische symptomen). Zes maanden na cholecystectomie
waren vooral patienten met aileen biliaire symptomen symptoomvrij. Patienten met
aileen dyspeptische symptomen rapporteerden vooral persistentie van symptomen.
Over het geheel genomen, hadden patienten met nlet-specifleke symptomen een
verhoogde kans op biliaire en/of dyspeptisch symptomen zes maanden na
cholecystectomie. In vergelijking met patienten zonder hoge dispositionele angst,
hadden patienten met hoge dispositionele angst hadden een tien maal zo grote kans op
postoperatieve biliaire symptomen. In hoofdstuk 6 en 7 voigt onderzoek naar de
resultaten een jaar na cholecystectomie. Na een jaar waren patienten met aileen biliaire
symptomen het meest vaak vrij van symptomen. Patienten met niet-specifieke
symptomen hadden een drie maal zo grote kans op biliaire en/of dyspeptische
symptomen na een jaar, dan patienten zonder niet-specifleke symptomen. In hoofdstuk
7 wordt beschreven dat symptomatische verbetering aileen plaatsvindt in de eerste zes
weken na cholecystectomie.
Kwaliteit van leven
De laatste jaren zien we bij de evaluatie van chirurgische procedures een toenemende
belangstelling voor de subjectieve ervaring van de patient. Kwaliteit van leven (KvL) is
een subjectieve uitkomstmaat die niet aileen aangeeft hoezeer een patient beperkt is in
zijn/haar fysiek, psychisch en sociaal functioneren. KvL omvat het functioneren in brede
zin en de wijze waarop de individuele patient zijn/haar niveau van functioneren zelf
ervaart.
In hoofdstuk 6 werd algehele KvL en gezondheid voor de verschillende groepen
patienten in kaart gebracht. Patienten met aileen dyspeptische symptomen ervoeren
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geen verbetering in algehele KvL en gezondheid in het eerste jaar na cholecystectomie,
in tegenstelling tot patlenten met aileen biliaire symptomen of biliaire en dyspeptische
symptomen. Preoperatieve symptomen (dyspeptisch, biliair, of dyspeptisch en biliair),
hoge dispositionele angst en comorbide abdominale aandoeningen hadden een effect
op algehele KvL en gezondheid na een jaar. Hoofdstuk 7 beschrijft verbeteringen in
verschillende domeinen van KvL. In het eerste jaar na cholecystectomie vonden
verbeteringen in KvL, depressieve symptomen en angst aileen plaats gedurende de
eerste zes weken. Vermoeidheid verbeterde niet in het eerste jaar na cholecystectomie.
Dispositionele angst had een negatief effect, terwijl preoperatieve depressieve
symptomen een positief effect hadden op KvL een jaar na cholecystectomie.
Preoperatieve vermoeidheid had aileen een effect op de fysieke aspecten van KvL.
Afsluitende opmerkingen en conclusies
Concluderend kan worden vastgesteld dat op lange termijn de helft van aile patienten
niet symptoomvrij is na een cholecystectomie. Het vroegtijdig herkennen van patienten
met een verhoogd risico op negatieve resultaten na cholecystectomie is van belang om
tot de keuze voor een optima Ie behandeling te komen. Patienten met zuiver biliaire
symptomen hebben de grootste kans om helemaal van hun klachten af te komen. Met
name patlenten met zuiver dyspeptische symptomen lopen het risico dat de klachten
blijven voortbestaan na cholecystectomie. Naast ziektespecifieke symptomen, hebben
psychosociale factoren en niet-specifieke symptomen een effect op het symptomatisch
beloop en KvL na een cholecystectomie. Hoge dispositionele angst en niet-specifieke
symptomen zijn risicofactoren voor negatieve symptomatische uitkomsten na
cholecystectomie. Dispositionele angst en preoperatieve vermoeidheid hebben beide
een negatief effect op verbeteringen in KvL een jaar na cholecystectomie, terwijl
preoperatieve biliaire en dyspeptische symptomen geen effect hebben. Aanvullend
onderzoek is noodzakelijk om andere psychosociale variabelen als voorspellers van
negatieve uitkomsten te identificeren.
Dit proefschrift onderschrijft het belang van een multidisciplinaire diagnostiek en
behandeling van patienten met een verdenking op symptomatisch galsteenlijden.
Psychologische en fysieke patientkenmerken moeten ge"integreerd worden om op basis
van het totaalbeeld tot een optimaal behandeladvies te komen voor de individuele
patient. Aangezien een conservatieve behandeling van galsteenlijden veiliger is dan over
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het algemeen wordt verondersteld, dient men bij patienten met een hoog risico op
negatieve postoperatieve uitkomsten zeker de afweging te maken tussen
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